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Adaptation to environmental change is a hallmark of life, and fundamental factors 
including oxygen, lipids, nutrients, pH, and temperature are in a constant state of flux in many 
cellular environments. All organisms, from single-celled yeast to multicellular humans, must 
sense and adapt to these changing environmental conditions in order to survive and reproduce. 
This sensing and response is often regulated on the level of transcription factors, so that a broad 
set of genes can be altered in concert through changes in a single or small number of sensors. Due 
to the essential nature of these adaptations, the relevant transcription factor pathways are often 
conserved across species and can be highly complex in order to precisely tune the response. 
Therefore, study of these transcription factor pathways in the non-pathogenic fungus 
Schizosaccharomyces pombe may establish universal paradigms that are broadly applicable to 
other fungal species or to eukaryotes in general.  
In this thesis, I defined a novel role for the AAA+ ATPase Cdc48 and its cofactor Ufd1 in 
the Golgi localization of the Dsc E3 ligase complex. This role ultimately impinges on cleavage of 
the SREBP transcription factor responsible for regulation of sterol biosynthesis in response to low 
oxygen in fission yeast. Through that work I also generated the first list of Cdc48 binding 
proteins in S. pombe, which can be used in the future to identify new Cdc48 cofactors and 
pathways that may be important to other cellular processes. I also uncovered a new regulator of 
the low oxygen response - Mga2. I demonstrated that Mga2 transcriptionally regulates 
phospholipid biosynthesis in response to low oxygen, acting alongside SREBPs to regulate lipid 
homeostasis. Further, I showed evidence of potential coordination of SREBP and Mga2 activation, 
suggesting broader co-regulation of these two pathways to keep overall lipid homeostasis in 
balance. In the future, I hope these insights will lead to establishment of Mga2 as important for 
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1.1 Environmental sensing in human disease 
Environmental variability is a major challenge for life. Indeed, it can be argued that it is 
the constant flux of the environment that drives evolution. Within the human body, variations in 
temperature, pH, oxygen, carbon dioxide, nutrients, toxins, and hormones are common depending 
on location. For example, atmospheric air contains 21% oxygen, but human tissues have oxygen 
concentrations of 2.5-14% and oxygen can fall below 1% at sites of wounding or at the center of 
a poorly vascularized tumor (1). Sensing and adaptation to these environmental changes is crucial 
for maintenance of homeostasis and optimal growth and reproduction. As a result, sensing defects 
have been implicated in numerous human diseases. Many of these diseases are related to hormone 
insensitivity - mutations in the androgen receptor cause androgen insensitivity syndrome, 
resulting in genetic males that present with a female appearance (2). Growth hormone 
insensitivities, such as Laron dwarfism, are caused by defects in growth hormone receptor (3). 
Insulin resistance is caused by defects in the insulin receptor and is associated with type-2 
diabetes, atherosclerosis, and hepatic steatosis in obese individuals (4).  
Aside from hormone sensing, aberrant nutrient and metabolite sensing is also associated 
with human diseases. Defects in the extracellular calcium receptor cause diseases of abnormal 
calcium homeostasis leading to parathyroid gland dysfunction (5). Aberrant HIF-1 activity, which 
normally responds to oxygen levels, is associated with cancer progression and mortality (6). And 
dysregulated lipid sensing via SREBP is implicated in metabolic syndrome, hypertriglyceridemia, 
hepatic steatosis, and Huntington’s disease (7-9). Study of the ways in which organisms sense and 
respond to their environment can lead to increased understanding of how homeostasis is 
maintained during constant environmental change and generate targets for treatments of disease 
in which environmental sensing is defective.  
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1.2 Cellular lipid homeostasis and physiological roles 
Our lab seeks to elucidate the mechanisms of lipid and oxygen sensing and the resulting 
transcriptional response in eukaryotes. In the cell, lipid homeostasis is important for maintenance 
of membrane structure, barrier function, fluidity, and curvature, formation of lipid rafts, signaling, 
energy storage, and as substrates for posttranslational protein modification (10-13). The lipid 
category encompasses multiple classes, including sterols, sterol esters, and other isoprenoids 
(such as dolichol), free fatty acids, glycerophospholipids (such as phosphatidylcholine, 
lysophosphatidic acid, and cardiolipin), ether lipids, glycerolipids (such as diacylglycerol), 
sphingolipids, and polyketides. Lipid homeostasis is maintained through the balance of synthesis 
and breakdown. In eukaryotes, lipid synthesis centers around acetyl-CoA, which is primarily 
generated in the mitochondrion from pyruvate (at the end of glycolysis) and fatty acid oxidation.  
To participate in lipid synthesis, mitochondrial acetyl-CoA must be converted to citrate 
through the TCA cycle, transported out of the mitochondrion and then converted back to acetyl-
CoA in the cytoplasm by ATP citrate lyase (10). For this reason, all substrates of the TCA cycle 
that can generate citrate (many of which derive from amino acids such as glutamine) can also 
feed into the acetyl-CoA pool available for lipid synthesis. Acetyl-CoA becomes committed to 
isoprenoid and sterol synthesis upon condensation with another acetyl-CoA molecule to 
acetoacetyl-CoA, followed by conversion to HMG-CoA and then to mevalonate at the ER  
(10,12,14). Sterol synthesis is a highly oxygen-consumptive process, with synthesis of a single 
molecule of cholesterol requiring 11 molecules of oxygen. Synthesis of polyketides occurs by a 
unique mechanism involving decarboxylative condensation of acetate, proprionate, and butyrate 
into ring structures by polyketide synthase in a mechanism similar to fatty acid synthesis (15).  
In contrast, synthesis of all other lipids begins with acetyl-CoA conversion to malonyl-
CoA and then coupling of that malonyl-CoA to additional units of acetyl-CoA by fatty acid 
synthase to produce a long chain saturated acyl-CoA (10). At this point, the acyl-CoA may be 
mono- or poly-desaturated, or further elongated at the ER (16). Approximately 70-80% of all 
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fungal fatty acids are monounsaturated, and every bond desaturated on the acyl-CoA expends a 
molecule of oxygen (17). The acyl-CoA is then combined with glycerol 3-phosphate to form 
lysophosphatidic acid and a second acyl-CoA to form phosphatidic acid (PA) (11). The bond 
between the glycerol and the acyl-CoA is usually an ester bond, although ether bonds are 
produced at the peroxisome to generate ether lipids (18). At this point, the PA can be 
dephosphorylated to form diacylglycerol, which is then converted to phosphatidylcholine, 
phosphatidylethanolamine, phosphatidylserine, or triacylglycerol (11). Alternatively the PA can 
react with cytidine triphosphate to create CDP-diacylglycerol, which is then converted to 
phosphatidylglycerol, phosphatidylinositol (and its derivatives such as phosphatidylinositol 
phosphate), or cardiolipin (11) (16). Finally, an acyl-CoA can instead be combined with serine to 
start down the sphingolipid biosynthesis pathway or may be transferred to a sterol to generate a 
sterol ester (19,20).  
Lipid catabolism is crucial to retrieve energy from lipids stored in lipid droplets or taken 
up from the extracellular environment, and to reformulate dietary essential fatty acids, damaged 
lipids, or excess lipids to rebalance the levels of different lipid classes in the cell. Most lipids are 
hydrolyzed to acyl-CoA and glycerol in the cytosol (21). However, lipid droplets are also shunted 
to the lysosome via lipophagy, where the triacylglycerols and sterol esters are hydrolyzed by 
lysosomal acid lipase (22). After hydrolysis, fatty acids are then catabolized in the mitochondrion 
(or peroxisomes if very long chain fatty acids) through the process of fatty acid oxidation (21,22). 
The acyl-CoA is first converted to acylcarnitine by carnitine palmitoyltransferase for transport 
across the membrane, at which point they are reconverted to acyl-CoA (21). In the mitochondrion 
(or peroxisome), the acyl-CoA is shortened two carbons at a time, producing acetyl-CoA, NADH, 
and FADH2. The acetyl-CoA can enter the TCA cycle while the NADH and FADH2 serve as 
electron carriers for the electron transport chain (21). Comparatively, sterol degradation is much 
less well understood, although in mammalian cells oxidation to bile acids is thought to be a major 
catabolic pathway and sterol and bile acid excretion is used to maintain sterol homeostasis (23). 
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Aside from lipid synthesis, acetyl-CoA is crucial for the TCA cycle and mitochondrial respiration 
and protein acetylation. Due to the many roles for acetyl-CoA in the cell, lipid synthesis is 
carefully coordinated with overall cellular metabolism. 
1.3 Mammalian lipid and oxygen sensing pathways 
We study both oxygen and lipid sensing because lipid biosynthesis is an oxygen-intensive 
process and therefore it is important to coordinate the regulation of lipid homeostasis with oxygen 
availability. Previous work from our lab and others has characterized the transcription factors that 
regulate lipid and oxygen sensing in mammals. Mammalian cells respond to changing lipid 
availability through a conserved family of ER membrane-bound SREBP transcription factors. 
SREBPs are bound and regulated by SCAP, a multi-pass transmembrane protein that senses 
sterols (24,25). Under conditions of low sterols, SCAP transports SREBPs from the ER to the 
Golgi. SREBPs in the Golgi are first cleaved by the Site-1 protease, releasing a membrane-bound 
N-terminal fragment that is further processed and released by the Site-2 protease, producing the 
active N-terminal transcription factor fragment (SREBP-N) (26). This process leaves the C-
terminal fragment still bound to SCAP. At some point the C-terminus is removed and SCAP 
recycles back to the ER (27). After cleavage, the SREBP-N transcription factor domain enters the 
nucleus and upregulates transcription of target genes. In mammals, there are three isoforms of 
SREBP. SREBP-1 (a and c) regulate TAG and glycerophospholipid synthesis through activation 
of target genes including fatty acid synthase, stearoyl CoA desaturase, and long-chain fatty acid 
CoA ligase (24). SREBP-2 regulates cholesterol biosynthesis through genes such as HMG-CoA 
synthase, HMG-CoA reductase, and CYP51, as well as cholesterol uptake through control of 
LDL receptor expression (24,28). Interestingly, despite extensive experimentation, SREBP 
activation has not been found to be responsive to oxygen availability. 
Instead, the mammalian oxygen response is largely regulated by the hypoxia-inducible 
factor (HIF) bHLH-PAS transcription factors, HIF1 and 2 (29). HIF is a heterodimer of an 
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unstable alpha subunit and a stable beta subunit (29). Under normoxic conditions, HIFα is 
hydroxylated on an asparaginyl residue by the Fe(II)- and 2-oxoglutarate-dependent dioxygenase 
FIH1, and on two different prolyl residues by the PHD family of prolyl hydroxylases (30,31). The 
asparaginyl hydroxylation interferes with HIF binding to transcriptional coactivators, while the 
prolyl hydroxylation targets HIFα to the pVHL ubiquitin ligase for ubiquitylation and 
proteasomal degradation. The FIH hydroxylase is functional at lower oxygen concentrations than 
the PHD, therefore together these inhibitors produce a graded response to oxygen availability. In 
response to low oxygen, HIF upregulates glycolysis, autophagy, and angiogenesis, and 
downregulates ATP consumption and oxidative phosphorylation (29). HIF also downregulates 
fatty acid oxidation and lipid synthesis genes (likely via downregulation of the SREBP pathway) 
and upregulates lipid uptake and storage in response to low oxygen, perhaps forming a link 
between the oxygen response and lipid homeostasis (32,33).  
1.4 Pathogenic fungal infections 
I study oxygen and lipid sensing in the fungus Schizosaccharomyces pombe as a model 
for sensing in fungal pathogens. Pathogenic fungi annually cause an estimated 1.6 million deaths 
worldwide (34). Mortality for invasive fungal infections can be high, with invasive Candida 
infections resulting in a mortality rate of 10-49% depending on the species (35-37). While most 
fungal infections are not life-threatening in immunocompetent hosts, an immunocompromised 
state is a major risk factor for invasive fungal infection (35). With improvements in HIV 
treatments, cancer immunotherapy, and organ transplant, as well as shifting demographics, the 
number of people living in an immunocompromised state is growing, leading to an increase in the 
number of fungal infections (35,38). Both Candida and Aspergillus infections have increased in 
incidence over the past two decades, and once-rare threats, such as Mucor, have gained in 
importance (37,39-41).  
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Moreover, antifungal resistance is increasing faster than new therapies are developed (42). 
The three main classes of antifungal drugs are azoles, polyenes, and echinocandins (35,42). 
Azoles, the largest class, target ergosterol biosynthesis by inhibiting the action of lanosterol 
demethylase (43). Polyenes, including amphotericin B, bind ergosterol to create pores in the 
fungal cell membrane (42). Introduced in 2001, echinocandins target cell wall integrity and were 
the last new class of antifungal therapies to become available (44,45). Due to increased, 
sometimes inappropriate, antifungal use in hospital and agricultural settings, antifungal resistance 
is increasing and becoming a serious public health threat. Fluconazole resistance in all Candida 
species is currently 7% (46). However, many pathogenic species show higher resistance and 
resulting increases in mortality. For example, 30% of C. glabrata cases are resistant to the first 
line antifungal fluconazole, and there has been a doubling of C. glabrata resistance to the second 
line antifungal echinocandin over the past 10 years (46-48). In 2009, a rare strain of Candida 
auris resistant to all three major antifungal classes was identified in Japan, and was since found in 
nine countries on four continents with high rates of mortality (49). Therefore, identification of 
new antifungal therapies, and particularly new fungal-specific targets outside the three major 
classes, will be crucial in future efforts to reduce mortality due to fungal infection. 
The estimated 3.5-5 million species comprising the fungal kingdom populate a wide 
variety of environments including soil, tropical forests, city indoor air, dust, deserts, human tissue, 
and animal feces (50-52). Many of these environments differ greatly in oxygen availability and 
fungi that travel between environments of varying oxygen saturation must adapt in order to 
survive. This is particularly relevant for pathogenic fungi, which live in both the terrestrial 
environment and the low oxygen host environment (1,51,53). We predict that oxygen adaptation 
is a crucial aspect of host infection that leaves pathogens vulnerable to drugs targeting sensing 
and response pathways. 
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1.5 Conserved low oxygen transcriptional response in fungal species 
Fungi do not have HIF homologs, and instead have developed different mechanisms for 
regulating the response to low oxygen. Numerous studies have identified hypoxic responsive 
transcriptional programs in different fungal species (54-60). As a foundation for my thesis, I 
analyzed the significantly up and down-regulated genes from those studies for gene ontology 
(GO) term enrichment and assembled broad categories of regulation from those GO terms. It is 
important to note that experimental protocols varied greatly among these reports, with oxygen 
concentrations ranging from 0-1% (or not defined when flasks were flushed with nitrogen) and 
low oxygen incubation times from 1.5-12 h. Despite these experimental differences and millions 
of years of divergence, we observed a shared program of transcriptional regulation among species. 
A large proportion of genes regulated in response to low oxygen fall into four significantly 
enriched categories: upregulation of lipid anabolism including sterols and glycerophospholipids, 
upregulation of carbohydrate catabolism, downregulation of gene expression including 
transcription and translation, and downregulation of aerobic respiration (Fig. 1.1). Lipid 
biosynthesis is a highly oxygen consumptive process and is crucial for maintenance of membrane 
integrity, cell growth, and proliferation. In order to adapt to low oxygen environments and 
maintain lipid homeostasis, fungi upregulate lipid biosynthetic enzymes to more efficiently utilize 
available oxygen. Lipid synthesis is also dependent on acetyl-CoA produced by pyruvate 
dehydrogenase during carbohydrate catabolism. Therefore, upregulating carbohydrate catabolism 
and acetyl-CoA production and downregulating aerobic respiration may serve to increase acetyl-
CoA pools and free up molecular oxygen for lipid biosynthesis under hypoxic conditions. In 
contrast, non-specific downregulation of gene expression serves to reduce energy expenditure for 
protein synthesis, suggesting that general transcription is sacrificed during low oxygen stress. 
Thus, lipid biosynthesis seems to be the uniformly conserved anabolic pathway upregulated under 
low oxygen, while regulation of other pathways occurs with the purpose of generating energy and 
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components for lipid biosynthesis. Based on this finding, I focused my studies on the regulation 
of lipid homeostasis during low oxygen adaptation in fission yeast. 
1.6 Ergosterol regulation in response to oxygen 
GO biological process terms significantly upregulated in multiple fungal species under 
low oxygen include lipid metabolic process (GO:0006629), sterol biosynthetic process 
(GO:0016126), and ergosterol metabolic process (GO:0008204), implicating sterol anabolism in 
low oxygen adaptation (Fig. 1.1). The major fungal sterol, ergosterol, is essential for membrane 
organization and function. Synthesis of one molecule of ergosterol requires 12 molecules of 
oxygen (61). Accordingly, the ergosterol synthesis pathway is regulated by transcription factors 
that sense and respond to cellular oxygen availability in order to maintain lipid homeostasis.  
Early work in our lab showed that fission yeast has SREBP transcription factor homologs, 
most notably sre1 (54,62). Sre1 regulates ergosterol homeostasis in a way that is analogous to 
SREBP-2 in mammals (54,62). Interestingly, Sre1 also regulates a low oxygen response, 
representing the sole low oxygen-responsive program described in S. pombe (54,62). In fact, sre1 
is required for fission yeast survival under low oxygen conditions and regulates 22% of all 
oxygen responsive genes (54).  
Sre1 is a basic-helix-loop-helix (bHLH) leucine zipper transcription factor that is initially 
synthesized as an inactive precursor form integral to the endoplasmic reticulum (ER) membrane 
(62). In the ER, Sre1 is bound by the multi-pass transmembrane protein and mammalian SCAP 
homolog, Scp1, which senses sterols through an N-terminal domain containing eight 
transmembrane segments (62) (Fig. 1.2). Whereas Insig proteins inhibit SREBP-SCAP binding 
under cholesterol-replete conditions in mammals, Sre1-Scp1 binding in fission yeast is not 
regulated by Insig (62). Instead, S. pombe Insig directly binds and inhibits the key ergosterol 
biosynthesis enzyme HMG-CoA reductase (63). Sre1 that is not bound by Scp1 in the ER is 
degraded by ER-associated degradation (ERAD); therefore it is probable that all Sre1 in the ER is 
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bound by Scp1 (64). There is a basal level of Sre1-Scp1 traffic to the Golgi under normoxia, but 
when oxygen (and subsequently ER ergosterol) is low, the rate of trafficking is greatly increased 
(65). These steps of Sre1 processing closely mirror the mammalian system for SREBP processing. 
In addition to Sre1, fission yeast has a second SREBP, Sre2, which is cleaved through the same 
mechanism as Sre1 but does not bind Scp1 and therefore is not regulated by ergosterol or oxygen 
levels (62,66). The constitutive activity of this homolog is useful for studying SREBP processing 
independent of Scp1 and the oxygen environment. The biological role of Sre2 is largely unknown, 
although it has been shown to repress flocculation (67). 
Once S. pombe Sre1 reaches the Golgi, the remaining steps of activation are markedly 
different from the mammalian system. Large-scale genetic screens using the S. pombe deletion 
collection and methyl methanesulfonate (MMS) chemical mutagenesis identified seven genes 
(dsc1-dsc5, cdc48, rbd2) that are required for both Sre1 and Sre2 activation in the Golgi (68-71). 
Dsc1-Dsc5 are subunits of a Golgi-resident E3 ligase complex (the Dsc E3 ligase complex), 
which is homologous to the Saccharomyces cerevisiae Tul1 E3 ligase that has a recently ascribed 
function in vacuolar quality control (68,72). It is yet to be shown whether the Dsc E3 ligase 
ubiquitylates Sre1 itself or another pathway component during this process (73). Proper 
localization of the Dsc E3 ligase in the Golgi requires that it is a functional ligase, because Dsc 
E3 ligase subunits are retained in the ER when Dsc1 is catalytically dead or when complex 
members are missing (73). Therefore, ER-to-Golgi transport of multiple Sre1 pathway 
components, including Sre1-Scp1 and the Dsc E3 ligase, is required for Sre1 activation. Evidence 
in S. cerevisiae suggests that the Dsc E3 ligase plays a role in protein quality control outside of 
SREBP activation (72,74). In support of this role, over 30 fungal species have homologs of at 
least four of the five Dsc E3 ligase subunits, many species of which do not have Sre1 homologs 
(Table 1.1).  
Rbd2 is a Golgi-resident rhomboid protease that is required for cleavage of SREBPs at 
the Golgi. Our current model is that the Dsc E3 ligase complex ubiquitylates SREBP to target it 
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to Rbd2 for cleavage. However, Rbd2 may not be the only protease involved as it is predicted to 
cleave the SREBP in the second transmembrane segment or luminal loop, whereas the active N-
terminal transcription factor terminates before the first transmembrane segment (71). Indeed, in 
Aspergillus nidulans, where this system is conserved, a signal peptide peptidase provides the 
second cleavage of the SREBP homolog SrbA, indicating a requirement for two proteases in that 
species (75). However, the homologous peptidase is not required for SREBP cleavage in S. 
pombe (71). Alternatively, the cytosolic SREBP N-terminus could be mechanically extracted 
from the membrane before it can act as a transcription factor. In the mammalian system, Fleig et 
al. showed that Cdc48 acts downstream of substrate cleavage by the rhomboid protease RHBDL4 
during ERAD (76). 
cdc48 is the fission yeast homolog of mammalian VCP (also known as p97), a highly 
conserved gene that codes for an essential AAA+ ATPase making up 1% of total cellular protein 
(77). Cdc48 is a separase, using the energy from ATP hydrolysis for mechanical remodeling of 
ubiquitylated substrates (78). This function is required for many cellular processes including 
ERAD, autophagy, endosomal trafficking, chromosome-associated degradation, ribosomal 
quality control, membrane fusion, and cell cycle control (77-79). Cdc48 exists as a homohexamer, 
each monomer consisting of a N-terminal domain (N-domain), a D1 domain, a D2 domain, and a 
C-terminal domain (C-domain). Each D1 and D2 domain has an ATP binding and hydrolysis site, 
for a total of 12 ATP binding sites in the hexamer. ATP binding to D1 is required for ATP 
hydrolysis by the D2 domain, while ATP hydrolysis by D2 accounts for the majority of ATP 
hydrolysis by Cdc48 (80). Substrate binding inhibits ATP hydrolysis in the D1 domain but 
stimulates ATP hydrolysis in the D2 domain, resulting in an overall increase in Cdc48 ATP 
hydrolysis upon substrate binding (81). Recent in vitro work suggests that substrate unfolding 
occurs via ATP driven transport of ubiquitylated substrate through the central pore of the Cdc48 
hexamer, after which the substrate is partially deubiquitylated and released (81). A series of 
Cdc48 cofactors target this ubiquitous protein to specific substrates and regulate its ATPase 
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activity (78,82). Autosomal dominant disease mutations clustered at the interface between the 
human VCP N and D1 domains change the balance of cofactors binding to VCP (83,84). These 
mutations lead to degenerative neuronal disorders including familial ALS, parkinsonism, and 
Inclusion Body Myopathy associated with Paget disease of bone and Frontotemporal Dementia 
(IBMPFD) (84-91).  
Previous studies regarding the role of Cdc48 in SREBP cleavage highlight its versatility. 
Dsc5, the fission yeast homolog of FAF1, contains a canonical Cdc48-binding UBX domain that 
allows Cdc48 to bind the Dsc E3 ligase, but this domain is not required for SREBP cleavage (69). 
This suggests that the interaction between Cdc48 and the Dsc E3 ligase is not required for SREBP 
activation, but could be involved in the potential quality control role of the Dsc E3 ligase. 
Additionally, recent studies showed that Cdc48 binds Rbd2 through the SHP domain at the C-
terminus of Rbd2, and that loss of this interaction inhibits SREBP cleavage (71). Rbd2 is not 
stably associated with the Dsc E3 ligase, therefore Cdc48 may serve to shuttle ubiquitylated 
SREBP from the Dsc E3 ligase to Rbd2. Indeed, experiments suggest that Cdc48 serves as a 
substrate adaptor between Rbd2 and SREBP because the block in SREBP cleavage due to a 
failure to form the Rbd2-Cdc48 complex can be overcome by overexpression of Rbd2 (71).  
Following cleavage in the Golgi, cytosolic Sre1N is further regulated by the prolyl-
hydroxylase Ofd1 and its inhibitor Nro1 (92-94). The Nro1 structure resembles that of known 
importins, and nro1 is required for Ofd1 nuclear localization (93). Under normoxic conditions, 
Ofd1 binds Sre1N and inhibits DNA binding, leading to Sre1N degradation (95,96). However 
under low oxygen conditions, Nro1 binds and inhibits Ofd1, freeing Sre1N to exert transcription 
factor activity (97). Interestingly, Ofd1 and its human homolog OGFOD1 bind and hydroxylate 
the ribosomal protein Rps23, ultimately impacting translation termination (98). Whether the roles 
of S. pombe Ofd1 in Sre1N turnover and Rps23 hydroxylation are integrated is an unresolved 
question. Upon entering the nucleus, Sre1N binds SRE promoter elements and upregulates 
expression of hypoxic responsive and ergosterol biosynthesis pathway genes, including C-5 sterol 
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desaturase, C-4 methylsterol oxidase, cytochrome P450s, and coproporphyrinogen III oxidase, to 
scavenge the available oxygen and increase flux through the ergosterol biosynthesis pathway 
(54,62). Sre1N also binds to SRE elements in its own promoter, creating a positive feedback loop 
that amplifies small changes in ergosterol or oxygen availability into larger changes in pathway 
regulation (64). Ultimately, the Sre1 pathway in fission yeast is regulated by oxygen at two points 
– once indirectly through ergosterol and once through the oxygen-sensing Ofd1. In combination 
with the positive feedback present in the system, this results in a rapid and highly regulated 
transcriptional response to changing oxygen concentrations.   
1.7 Phospholipid regulation in response to low oxygen 
In addition to sterol synthesis, fungi regulate triacylglycerol (TAG) and 
glycerophospholipid (GPL) synthesis as well as fatty acid desaturation in response to changing 
oxygen availability. Enriched GO terms in this category include fatty acid biosynthetic process 
(GO:0006633), acyl-CoA biosynthetic process (GO:0071616), sphingolipid biosynthetic process 
(GO:0030148), long-chain fatty acid metabolic process (GO:0001676), membrane lipid metabolic 
process (GO:0006643), and triglyceride mobilization (GO:0006642). As with sterols, fatty acid 
desaturation requires oxygen and therefore desaturases are upregulated as oxygen decreases in 
order to maintain lipid homeostasis (54,99,100). Because desaturated fatty acids are incorporated 
into GPL and TAG, synthesis of these macromolecules is also oxygen-dependent.  
In S. cerevisiae, Mga2 transcription factor homologs regulate these pathways in response 
to oxygen (101,102). Mga2 transcription factors have an IPT DNA-binding domain and an 
ankyrin repeat protein-protein interaction domain (103,104). Mga2 and its homolog Spt23 have 
overlapping functions in the low-oxygen response (103,105). Deletion of both MGA2 and SPT23 
results in disrupted nuclear membrane morphology and is ultimately lethal even under normoxic 
conditions. Addition of exogenous unsaturated fatty acid rescues these defects (103). Mga2 is 
functionally more important in the oxygen response than Spt23 and will be the focus here 
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(101,105,106). The most-studied target of Mga2-Spt23 is OLE1, the only Δ9 fatty acid desaturase 
in S. cerevisiae (106). Mga2 upregulates transcription of OLE1 and other target genes through 
binding to Low Oxygen Response Elements (LORE) in their promoters in response to low 
oxygen, unsaturated fatty acids (UFA), or temperature (101,106,107). Mga2 also regulates 
stability of the OLE1 mRNA, although it is not known whether this activity is conserved for other 
target genes (101).  
Like Sre1, Mga2 is initially membrane-bound and is activated by cleavage and release of 
the N-terminal transcription factor domain (103,104,108). Mga2 and Spt23 are activated by 
regulated ubiquitin/proteasome-dependent processing (RUP) (Fig. 1.3) (108). Prior to processing, 
inactive Mga2 dimerizes through the IPT domain in the N-terminus (109). During RUP, Mga2 
precursor is ubiquitylated by the NEDD4 E3 ligase Rsp5, which targets Mga2 to Cdc48 and the 
proteasome to release the N-terminal transcription factor domain through endoproteolytic 
cleavage, similar to NF-κB processing (108). It is still unknown what amino acid is ubiquitylated 
or how the proteasome selects a cleavage site (108). It was believed that Mga2 cleavage is 
regulated by membrane fatty acid saturation, with UFA blocking cleavage in a product inhibition 
mechanism similar to that observed for ergosterol and Sre1 (108). Recently however, it was 
shown that the transmembrane helix of Mga2 oligomerizes in the ER membrane where it senses 
the overall membrane lipid environment. Increased membrane order through saturated 
phospholipid or sterol incorporation stabilized a transmembrane helix rotational conformation 
that promoted Mga2 cleavage and activation (110). Therefore, it may be the fluidity of the 
membrane, rather than fatty acid saturation per se, that is sensed by the Mga2 pathway to regulate 
TAG and GPL biosynthesis. These results confirm that the S. cerevisiae Mga2 transcription factor 
is product inhibited in a very similar manner to the S. pombe transcription factor Sre1. Both 
systems detect the presence of product in the ER membrane and are only activated for cleavage 
when product is decreased. What if any transcription factor(s) regulates this fatty acid pathway 
under low oxygen in fission yeast is unknown.  
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1.8 Thesis aims 
My work in the Espenshade lab sought to address three aspects of the transcriptional 
response to low oxygen adaptation in fission yeast:  
(1) In response to the discovery of a requirement for cdc48 in SREBP activation, I wanted to 
elucidate the role played by this multifunctional protein in the fungal SREBP pathway.  
(2) Given that Sre1 regulates only 22% of all oxygen-responsive genes in fission yeast, I wanted 
to identify the transcriptional regulator(s) of those lipid metabolism genes not regulated by Sre1 
under low oxygen conditions, namely, those involved in phospholipid metabolism.  
(3) Finally, based on the fact that sterol and phospholipid biosynthesis pathways are coordinated 
in mammals via a shared activation mechanism of SREBP-1 and SREBP-2, I hypothesized that 
these two pathways may also be coordinated in fission yeast and sought to identify the 
mechanism of coordination. 
1.9 Figures 
FIGURE 1.1. Pathways transcriptionally regulated in response to oxygen. Genes significantly 
up and down regulated under low oxygen conditions in S. pombe (1.5 h, 0% O2) (54), S. 
cerevisiae (12 h, 0% O2) (55), C. albicans (3.5 h, 1% O2) (56), C. parapsilosis (3 h, 1% O2) (57), 
A. fumigatus (2 h, 0.2% O2) (60), A. nidulans (6 h, low O2) (58), and Y. lipolytica (~6 h, 1% O2) 
(59) were analyzed for GO term enrichment using AmiGO for S. cerevisiae, and FungiFun2 for 
the remaining species (111). Biological process annotations were identified using directly and 
indirectly annotated associations. Resulting enriched GO terms were grouped using REVIGO 
with an allowed similarity of 0.5 (112) and additional hand categorization. Broad categories were 
then analyzed for enrichment in each fungal species, represented as colored (enriched) or blank 
(not enriched) wedges. 
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FIGURE 1.2. Sre1 cleavage activation pathway. In the presence of oxygen or sterols, Sre1 is 
retained in the ER by the sterol sensor Scp1. Additionally, Sre1N produced from basal cycling is 
bound by Ofd1 and degraded. In the absence of oxygen or sterols, Sre1-Scp1 traffics to the Golgi 
where the Dsc E3 ligase complex, the rhomboid protease Rbd2, and Cdc48 are required for Sre1 
cleavage and Sre1N release. Also under low oxygen, Ofd1 is inhibited by Nro1, releasing Sre1N 
to enter the nucleus and upregulate its own transcription as well as additional hypoxic responsive 
genes. 
 
FIGURE 1.3. Mga2 cleavage activation pathway. Under conditions of high unsaturated fatty 
acids (UFA) when membranes are relatively disordered and loosely packed, Mga2 homodimers in 
the ER are in a rotational conformation that is not permissive to Rsp5 E3 ligase interaction and 
cleavage. When UFA decrease and the membrane becomes more ordered, the Mga2 
transmembrane domains rotate into a cleavage-competent orientation. Rps5 then ubiquitylates 
Mga2 and the proteasome performs regulated ubiquitin-dependent partial proteolysis. Cdc48 
releases the cleaved Mga2N from the homodimer complex and Mga2N enters the nucleus to bind 



















Table 1.1. Gene conservation across select fungal species  
Orthologs to genes of interest were identified by protein sequence using OrthoMCL. The S. pombe or S. 
cerevisiae genes were used to initiate the search with standard parameters. The below list is not 
comprehensive of all fungal species. An X represents detection of an ortholog, which may not be validated. 























































S. cerevisiae X X X X X  X X X X X X X X 
S. pombe X X X X X X X X X X X X 
H. sapiens X X X       X X 
Human 
 A. clavatus X X X  X X X X X X X X X X 
A. flavus X X X  X  X X X X X X X X 
A. fumigatus X X X  X X X X X X X X X 
A. niger X X X  X X X X X X X X X 
A. terreus X X X  X  X X X  X X X 
B. cinerea X X X X X X X  X  X X 
C. albicans X X X X X X X X X X X X X X 
C. dubliniensis X X X X X X X X X X X X X X 
C. glabrata X X X X X X  X X X X X X X 
C. parapsilosis X X X X X X X X X X X X X X 
C. tropicalis X X X X X X X X X X X X X X 
C. immitis X X X  X X X X X X X X 
C. posadasii X X X  X X X X X X X X 
C. gattii X X X  X X X  X  X X X 
C. neoformans X X X  X X X  X  X X X 
H. capsulatum X X X  X X X X X X X X X 
M. globosa X X X X X X X X 
P. brasiliensis X X X X X X X X X X 
P. lutzii X X X X X X X X X X 
P. marneffei X X X X X X X X X X X 
P. jirovecii X X X X X X X X 
R. oryzae X X X X   X X X X X X 
 Plant pathogens 
A. aculeatus X X  X  X X X X X  X X X X 
F. verticillioides X X X X X X X X X X X X X X X 
M. oryzae X X  X X X X X X X X X X 
M. larici-
 
X X     X   X  X X X 
M. circinelloides X X X X X X X X X X 
P. graminis X X X X X X X 
S. sclerotiorum X X X X X X X X X X  S. reilianum X X X X X X X X 
U. maydis X X X X X X X X 
 Non-pathogenic 
A. nidulans X X X X X X X X X X X X 
A. oryzae X X X X  X X X X X X X 
K. lactis X X X X X 
N. crassa X X X X X X X X X X X X X 
T. reesei X X X X X X X X X X X X 
Y. lipolytica X X X  X X X X X X X X 
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Dsc E3 ligase Golgi localization requires the ATPase Cdc48 and cofactor 
















This chapter is an edited version of the manuscript, “Dsc E3 ligase localization to the Golgi 
requires the ATPase Cdc48 and cofactor Ufd1 for activation of Sterol Regulatory Element-
binding Protein in fission yeast” by R. Burr, D. Ribbens, S. Raychaudhuri, E. V. Stewart, J. Ho, 
and P. J. Espenshade, under revision at the Journal of Biological Chemistry 
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2.1 Summary 
Schizosaccharomyces pombe sterol regulatory element-binding proteins (SREBP) 
regulate lipid homeostasis and the hypoxic response under conditions of low sterols or oxygen. 
SREBPs are cleaved in the Golgi through the combined action of the Dsc E3 ligase complex, the 
rhomboid protease Rbd2, and the essential AAA+ (ATPases Associated with diverse cellular 
Activities) ATPase Cdc48. The soluble SREBP N-terminal transcription factor domain is then 
released in the cytosol to enter the nucleus and regulate gene expression. Previously, we reported 
that Cdc48 binding to Rbd2 is required for the cleavage of SREBPs by Rbd2. The exact function 
of Cdc48 at Rbd2 is unknown, and Cdc48 may have additional roles in the pathway before or 
after cleavage of substrate by Rbd2. To determine whether Cdc48 performs additional roles 
during SREBP activation, we extended our analysis of cdc48 point mutants in S. pombe (69). 
Here, we report identification of two new alleles of cdc48 that impact SREBP cleavage. Five 
cdc48 mutants show defects in both Sre1 and Sre2 cleavage, but had minimal impact on Cdc48 
protein level or cellular growth rate. We also perform affinity chromatography and mass 
spectrometry to identify Cdc48 binding proteins in S. pombe, generating a list of many previously 
unknown potential binding partners. Of these binding partners, we demonstrate that the substrate-
recruiting Cdc48 cofactor Ufd1 is required for SREBP cleavage. Importantly, we find that the 
Cdc48-Ufd1 complex is functionally distinct from the previously described Cdc48-Rbd2 complex. 
Cdc48-Ufd1 is instead required at a step prior to Rbd2 function, during Golgi localization of the 
Dsc E3 ligase complex. Together, these data demonstrate that two distinct Cdc48 complexes – 
Cdc48-Ufd1 and Cdc48-Rbd2 – are required for SREBP activation and low oxygen adaptation in 
S. pombe.  
2.2 Results 
Identification of cdc48 alleles – cdc48 is required for SREBP cleavage in fission yeast 
(69,71), but whether this multipurpose enzyme has additional functions in the SREBP pathway is 
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unknown. Further analysis of our four cdc48 mutants revealed that two of the four showed 
relatively weak SREBP cleavage defects that are not suitable for dissecting the role of Cdc48 
during SREBP cleavage (69). To expand our set of cdc48 alleles and to identify other genes 
involved in SREBP activation, we revisited our MMS mutagenesis screen and performed 
additional linkage analysis on uncharacterized mutants (69). As previously reported, this screen 
was performed by generating a reporter strain in which Sre1 binding sites were in the promoter of 
the ura4 gene, such that when Sre1 is functional, orotidine 5'-phosphate decarboxylase (Ura4) is 
produced (69). This reporter strain was mutagenized with either 0.024% or 0.012% MMS and the 
resulting isolates were plated on 5-fluoroorotic acid (5-FOA), which is converted to the toxic 5-
fluorouracil by Ura4, thereby selecting for isolates with deficient Sre1 activity. The majority of 
surviving mutants (86%) from the original screen phenocopied sre1 deletion and were sensitive to 
cobalt chloride (CoCl2), a hypoxia mimetic (Fig. 2.1A).  
Cobalt-sensitive mutants were transformed with plasmids expressing sre1+ and scp1+ to 
identify these frequent mutants. For mutants not rescued by these plasmids, we performed linkage 
analysis by mating uncharacterized mutants with known SREBP pathway mutants and tested if 
the resulting spores grew on CoCl2. Matings from which no spores grew on CoCl2 indicated 
linkage of the uncharacterized mutant to the known gene, most likely because the uncharacterized 
mutation was also within the known gene. In many cases, we identified the precise mutation in 
these strains by PCR amplification and sequencing of the gene of interest. After this analysis, 196 
of the 305 cobalt chloride-sensitive mutants (64%) were assigned to linkage groups, while 109 
strains remain to be tested (Fig. 2.1A). The specific mutations in the sequenced genes are 
available in Supplementary Table 2.1. The only new gene identified in this search was the 
essential translation initiation RNA helicase sum3, which was identified via whole genome 
sequencing of two linked mutagenized strains. Further analysis indicated that the sum3 mutants 
were not rescued by Sre1N expression and had intermediate Sre1 cleavage defects (Fig. A.1). We 
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concluded that the role of sum3 in this pathway was likely a non-specific stress-response and did 
not study it further. 
As expected, for non-essential genes we observed a linear relationship between the 
number of strains isolated and the length of the coding sequence (Fig. 2.1B). Notably, cdc48 and 
sum3 are essential and lie below the line, with fewer strains identified than would be expected for 
the given coding region length. In other words, the gene sequence that can be viably mutated is 
smaller for essential genes than non-essential genes. Analysis of the number of strains per gene 
found through the MMS screen indicated that the screen could identify non-essential genes larger 
than 750 base pairs (Fig. 2.1B). An additional 1100 S. pombe non-essential genes fall below this 
threshold, indicating that additional non-essential and essential genes required for Sre1 activity 
may remain unidentified.  
This new analysis identified two cdc48 point mutations (A366D and R764C) in addition 
to the four previously described (Fig. 2.1C) (69). To further examine these mutants, we compared 
the S. pombe cdc48 point mutants to the human VCP sequence, to which the fission yeast protein 
shares 70% identity. All six mutated fission yeast cdc48 residues are identical in human (Fig. 
2.1C). These six mutations are dispersed throughout this essential protein and are not clustered in 
three-dimensional space (Fig. 2.1D and data not shown). Importantly, none of these cdc48 
mutants are temperature sensitive (data not shown). Additionally, none are found in the N-domain, 
which is the major site of cofactor binding (78). One of these mutants, cdc48-8, is in the known 
ATP hydrolysis region of the D1 domain (Fig. 2.1D).  
SREBP activation requires cdc48 - Cdc48 is a versatile protein that may function in 
multiple steps of SREBP activation. Our previous studies of cdc48 mutants used the original 
isolates from the MMS mutagenesis screen (69). To evaluate and directly compare the cdc48 
alleles, we recreated all six cdc48 mutations in a wild-type, non-mutagenized strain background. 
These strains were generated by homologous recombination and all strains, including the isogenic 
wild-type, were marked with the nourseothricin resistance gene (see Experimental Procedures). 
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Because these strains are in a non-mutagenized, marked background, we gave them the new allele 
numbers cdc48-5 through cdc48-10 to differentiate them from those previously studied (Fig. 
2.1C).  
To characterize these new mutant strains, we first assayed growth on CoCl2. We observed 
no growth defect for cdc48-7 and complete CoCl2 growth defects for the other five mutants (Fig. 
2.2A). To compare Sre1N production in all cdc48 mutant strains, we assayed Sre1 cleavage by 
western blot. We cultured wild-type and the indicated cdc48 mutant strains for 0 or 4 h minus 
oxygen. We then probed whole cell lysates with anti-Sre1N, which detects both the full-length 
ER-membrane bound precursor form (P) as well as the cleaved N-terminal transcription factor 
form (N). Wild-type cells accumulated Sre1N after 4 hours of growth under low oxygen (Fig. 
2.2B, lanes 1-2). The cdc48 mutant strains showed a range of Sre1N production defects, from 
complete blocks (cdc48-8,-9,-10) to partial defects (cdc48-5,-6) (Fig. 2.2B, lanes 3-14). 
Additionally, we examined cleavage of a N-terminally FLAG-tagged Sre2 model substrate, Sre2-
MS, which recapitulates Sre2 constitutive activation (66). The cdc48 mutant strains showed Sre2-
MS cleavage defects consistent with their Sre1 cleavage defects, as had been previously shown 
for cdc48-4 (Fig. 2.2C) (66). Notably, we observed no CoCl2 growth, Sre1, or Sre2-MS cleavage 
defects in cdc48-7, which is inconsistent with our previously published results (Fig. 2.2B, lanes 
7-8, 2.2C, lanes 7-8) (69). This may be due to the highly mutagenized background of the original 
mutant, and validates our decision to remake these strains in a non-mutagenized strain. Therefore 
we conclude that cdc48-7 is a mutant allele with no effect on SREBP cleavage and serves as a 
wild-type control. Together, these data indicate that cdc48 is required for SREBP cleavage in S. 
pombe at a step that is common to both Sre1 and Sre2 activation.  
cdc48 mutations do not exhibit major defects in Cdc48 expression or cell growth – To 
better understand how these cdc48 mutations affect SREBP cleavage, we characterized their 
effects on Cdc48 protein accumulation and cell growth. To assay Cdc48 expression, we probed 
whole cell lysates from each strain with anti-Cdc48 polyclonal antibody (Fig. 2.3A). Despite 
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some statistically significant changes, all mutants had levels of Cdc48 protein similar to wild-type, 
and expression levels did not show a correlation with strength of SREBP cleavage defect (Fig. 
2.3B). This is consistent with the fact that cdc48 is an essential gene and large changes in 
expression may not be tolerated. These data suggest that differential expression is not the cause of 
the observed SREBP cleavage defects.  
To further examine the overall cellular effects of these cdc48 point mutations, we assayed 
growth rate. We grew wild-type and cdc48 mutants in liquid culture in the presence of oxygen for 
12 h and calculated doubling time. Of the six cdc48 mutants, only cdc48-9 had a dramatically 
slower doubling time than wild-type cells under normoxic conditions (Fig. 2.3C). Because the 
cdc48-8, cdc48-9, and cdc48-10 mutants have equally strong blocks in SREBP cleavage but 
different growth rates, it is unlikely that the change in growth rate is responsible for the block in 
SREBP cleavage. These results suggest that the effects of our cdc48 mutations on essential Cdc48 
activities are minimal. 
Identification of Cdc48 binding proteins in S. pombe – It is well established in the 
literature that a complex network of cofactors direct Cdc48 to specific targets. However, we did 
not identify any Cdc48 cofactors that are required for SREBP cleavage in this MMS mutagenesis 
or a previous screen of non-essential genes (Fig. 2.1A) (70). Identification and assessment of 
Cdc48 cofactors could clarify the roles for Cdc48 in SREBP cleavage. To identify Cdc48 
cofactors in fission yeast, we purified Cdc48 using a C-terminal 5xFLAG tag and quantitatively 
identified all bound proteins using TMT mass spectrometry (113). Tagging Cdc48 with 5xFLAG 
did not alter Cdc48 function as judged by the ability to accumulate Sre1N to wild-type levels 
under low oxygen (Fig. 2.4A, lane 2 vs 4). Purification of Cdc48-5xFLAG with anti-FLAG 
conjugated magnetic beads recovered the majority of Cdc48 protein, and no Cdc48 was isolated 
in the untagged strain (Fig. 2.4B, lanes 5-6). Quantitative mass spectrometry analysis of the 
bound fractions from wild-type and Cdc48-5xFLAG lysates identified 2283 proteins, of which 52 
were enriched in the Cdc48-5xFLAG sample at least 2 standard deviations from the mean (fold 
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change ≥3.2) (Fig. 2.4C, red dots and Table 2.1). The full list of identified proteins and peptides 
is available in Supplementary Table 2.2. Of note, Dsc1, Dsc2, Dsc3, and Dsc5 were highly 
enriched in the Cdc48-bound population (Table 2.1). This result is consistent with our published 
observation that Cdc48 binds the Dsc E3 ligase through the Dsc5-UBX domain independent of 
any role in SREBP cleavage (69). Interestingly, Rbd2 was not identified as a Cdc48 binding 
protein. This could either be due to an inability to detect Rbd2 peptides by mass spectrometry or 
the reported transient nature of the Cdc48-Rbd2 interaction (71).  
To determine which Cdc48 binding proteins were required for SREBP processing we 
tested deletions of the non-essential genes in S. pombe for growth on CoCl2 (114). In addition, we 
created deletions of those genes not present in the Bioneer deletion collections and also tested 
temperature-sensitive mutants of the essential cofactor ufd1 (kind gift of Boddy Lab) (115). We 
were unable to test a number of essential genes due to lack of availability of temperature-sensitive 
mutations and a failure to knock them down. Results of the CoCl2 growth assays can be found in 
Table 2.1. Interestingly of all the genes tested, only the ufd1 point mutants and ubx3∆ were 
sensitive to CoCl2 and not previously known components of the SREBP pathway. Both of these 
genes code for known Cdc48 cofactors (Table 2.1, grey rows). Upon further examination, the 
CoCl2 growth defect in ubx3∆ cells was minor, and we observed minor effects on Sre1 cleavage 
(Fig. A.2). Therefore, we focused our analysis on Ufd1. 
Ufd1 is a Cdc48 cofactor required for SREBP cleavage – Ufd1 is an established Cdc48 
cofactor with homologs from yeast to humans (116,117). Together with the cofactor Npl4, it is 
thought to direct Cdc48 to ERAD functions (118,119). To test the requirement for ufd1 in SREBP 
activation, we tested three temperature-sensitive mutations in this essential gene using strains 
generated by the Boddy Lab (115). These wild-type and ufd1 mutant strains express ufd1-13xMyc 
from the endogenous locus. ufd1-7 and ufd1-8 have mutations in the conserved UFD1 domain, 
while ufd1-5 and ufd1-7 have mutations outside of that domain, near the C-terminus (Fig. 2.5A) 
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(115). We assayed growth of these wild-type and ufd1 mutant strains on CoCl2 and observed 
complete growth defects in the mutant strains consistent with Table 2.1 (Fig. 2.5A). We also 
observed decreased growth at semi-permissive temperature on rich medium (30°C) (Fig. 2.5A) 
and in a liquid culture growth assay (Fig. 2.5B). These results are consistent with the previously 
published report that these strains are temperature-sensitive (115).  
We next examined Ufd1-13xMyc and Cdc48 expression in the wild-type and ufd1 
mutants at 30°C. All point mutants had lower Ufd1-13xMyc protein than wild-type cells, 
although Cdc48 levels were normal (Fig. 2.5C). We then assayed Sre1 and Sre2-MS cleavage in 
each strain. ufd1 mutants were deficient for Sre1 cleavage induction by low oxygen and had 
defects in Sre2-MS cleavage (Fig. 2.5D-E). Notably, ufd1-5 and ufd1-7 had complete blocks in 
Sre2-MS cleavage, while ufd1-8 had a partial block indicating an incomplete defect. Importantly, 
all ufd1 mutants had normal Sre1 precursor levels, indicating no defect in Sre1 expression in 
these strains (Fig. 2.5D). These data suggest that ufd1-5 and ufd1-7 are the strongest mutants but 
that all three have significant effects on SREBP cleavage. Therefore, we concluded that ufd1 is a 
new component of the SREBP activation pathway. 
SREBP activation requires Cdc48-Ufd1 during Dsc E3 ligase Golgi localization – 
SREBP activation requires ER-to-Golgi transport of SREBP, the Dsc E3 ligase, and Rbd2, as 
well as Dsc E3 ligase activity and cleavage by Rbd2. Defects in any of these steps would result in 
the cleavage defect observed in cdc48 and ufd1 mutants. We previously demonstrated that Cdc48 
is required for Rbd2 cleavage of SREBPs in the Golgi. Rbd2 binds Cdc48 through its C-terminal 
SHP domain, and disruption of Rbd2-Cdc48 binding blocks cleavage (71). To determine whether 
Ufd1 is involved in the function of Cdc48 at Rbd2, we tested whether Ufd1 physically associates 
with Cdc48 when bound to Rbd2. We performed an in vitro pull-down experiment from wild-
type and ufd1-13xmyc lysates using GST-tagged Dsc5 UBX domain, GST-tagged Rbd2 SHP 
domain, or GST alone. As expected, both GST-UBX and GST-SHP efficiently purified Cdc48 
from lysates (Fig. 2.6A, lanes 9-14) (71). However, only GST-UBX also purified Ufd1-13xMyc 
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(Fig. 2.6A, lane 12 vs 14). The ability of Dsc5 UBX domain to purify Ufd1 suggests that a 
Cdc48-Ufd1 complex may interact with the Dsc E3 ligase in an uncharacterized function 
independent of SREBP cleavage (69). The fact that Ufd1-13xMyc is not bound to Cdc48 when 
Cdc48 is bound to the Rbd2-SHP domain suggests that Ufd1 is not part of the Cdc48-Rbd2 
complex required for SREBP cleavage. These data indicate that two distinct Cdc48 complexes – 
Cdc48-Ufd1 and Cdc48-Rbd2 – are required for SREBP activation in fission yeast. 
To determine whether Cdc48-Ufd1 is required prior to SREBP cleavage by Rbd2, we 
performed a genetic epistasis test that takes advantage of a useful rbd2Δ phenotype. In rbd2Δ 
cells, uncleaved SREBP precursor proteins do not accumulate as in wild-type cells, but are 
instead degraded (71). This degradation requires both the Dsc E3 ligase and the proteasome, and 
we proposed that it results from degradation of the ubiquitylated SREBP precursor when Rbd2 
cleavage does not occur. In contrast, all dsc deletions, cdc48, and ufd1 mutants have wild-type 
SREBP precursor levels (Fig. 2.2B-C, 2.5B-C) (68,69). Because these phenotypes are opposing, 
we can create double mutants between rbd2Δ and other pathway components and perform 
epistasis tests to determine their order of action in this SREBP activation pathway.  
As previously shown, in wild-type cells endogenous Sre2 is constitutively cleaved and 
only the N-terminal form was detected (Fig. 2.6B-C, lane 1). In contrast, rbd2 deletion resulted in 
a failure to cleave Sre2 without a corresponding increase in Sre2 precursor, resulting in minimal 
Sre2 signal (Fig. 2.6B-C, lane 2) (71). As expected, rbd2Δ dsc1Δ cells accumulated Sre2 
precursor (Fig. 2.6B, lane 3, Fig. 2.6C, lane 4), because the Dsc E3 ligase acts before Rbd2 
during SREBP activation and is required for precursor degradation by the proteasome (71). This 
is consistent with our model that the SREBP is ubiquitylated by the Dsc E3 ligase before transfer 
to Rbd2 for cleavage.  
In cdc48 mutant cells, Sre2 cleavage defects ranged from none (cdc48-7), partial (cdc48-
5,-6), to strong (cdc48-8,-9,-10) (Fig. 2.6B), consistent with observed Sre1 and Sre2-MS defects 
(Fig. 2.2). When the cdc48 mutants were combined with rbd2Δ, the Sre2 precursor was retained 
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in the strongest mutants (cdc48-8,-9,-10) and partially retained in the weaker mutants (cdc48-5,-
6) (Fig. 2.6B, lanes 3-14). This is consistent with the magnitude of the SREBP cleavage defect in 
each cdc48 allele (Fig. 2.2B-C, 2.6B). These results demonstrate that cdc48 functions prior to 
rbd2. Likewise, ufd1 rbd2Δ double mutants also accumulated Sre2 precursor, confirming that 
Ufd1 and Cdc48 act before Sre2 cleavage by Cdc48-Rbd2 (Fig. 2.6C, lane 2 vs lanes 6 and 8). 
The ufd1-5 rbd2Δ combination could not be tested because we were unable to generate this strain 
by mating or homologous recombination. Together, these data suggest that distinct Cdc48 
complexes play multiple roles during SREBP cleavage, one of which is prior to Rbd2 cleavage at 
the Golgi. 
Cdc48-Ufd1 is required for SREBP activation prior to cleavage by Rbd2, but it is unclear 
what role it performs at that stage. To test which step of SREBP cleavage is defective in cdc48 
and ufd1 mutants, we assayed Dsc E3 ligase localization in these cells by taking advantage of the 
fact that the Dsc1 subunit is glycosylated in the Golgi. Glycosylation causes a change in apparent 
molecular weight on an SDS-PAGE gel with a high molecular weight band representing Golgi 
localization and a low molecular weight band representing ER localization (73). The Dsc E3 
ligase is retained in the ER when dsc1-dsc4 are deleted, when the Dsc E3 ligase is catalytically 
inactivated, or when the cognate E2, ubc4, is inactivated (73).  
To examine Dsc E3 ligase localization, we subjected microsomal protein preparations 
from cdc48 and ufd1 mutant cells to SDS-PAGE and probed for Dsc1. As previously reported, 
wild-type cells showed primarily a higher molecular weight (Golgi) Dsc1 band representing 55% 
maturely glycosylated, while dsc2Δ cells showed only a lower molecular weight (ER) Dsc1 band 
representing 23% maturely glycosylated (Fig. 2.6D, lane 1 vs 8, 2.6E) (73). Consistent with the 
wild-type Sre1 cleavage observed in dsc5-ΔUBX cells, deletion of the UBX domain also had no 
effect on Dsc1 glycosylation (Fig. 2.6D, lane 9). Importantly, rbd2 deletion also showed a wild-
type Dsc1 glycosylation pattern, indicating that Rbd2 is not required for Dsc1 Golgi localization 
(Fig. 2.6D, lane 10). When we examined Dsc1 glycosylation in the strongest cdc48 and ufd1 
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mutant strains (cdc48-8,-9,-10,ufd1-5,-7), we observed accumulation of the lower molecular 
weight form and between 25-35% maturely glycosylated, phenocopying dsc2Δ (Fig. 2.6D, lanes 
5-7, 12-13, 2.6E). cdc48-7 had wild-type Dsc1 glycosylation while cdc48-5,-6 and ufd1-8 had 
partial Dsc1 glycosylation defects with 38-48% maturely glycosylated form, consistent with their 
SREBP cleavage effects (Fig. 2.6D, lanes 2-4, 14, 2.6E). Because neither the dsc5-ΔUBX nor the 
rbd2Δ cells showed Dsc1 glycosylation defects, the impacts of the cdc48 mutants on Dsc1 
glycosylation are likely not due to Cdc48 binding to either of these proteins. These data suggest 
that the Cdc48-Ufd1 complex is required for Dsc E3 ligase Golgi localization in a role separate 
from the binding of Cdc48 to Dsc5 or Rbd2. 
2.3 Discussion 
Our previous efforts to discover components of the S. pombe SREBP activation pathway 
identified the AAA+ ATPase Cdc48, but failed to identify any Cdc48 cofactors. Here, we 
analyzed six cdc48 point mutations and performed mass spectrometry identification of Cdc48 
binding proteins to further elucidate the role of Cdc48 and any cofactors in SREBP activation. 
These data add to a growing body of evidence supporting multiple interactions between Cdc48 
and SREBP pathway components. First, in this report we used cdc48 and ufd1 point mutants to 
show that the Cdc48 cofactor Ufd1 is required for SREBP cleavage and that Cdc48-Ufd1 act at an 
early step in the activation pathway, namely Golgi localization of the Dsc E3 ligase complex (Fig. 
2.6). cdc48 and ufd1 mutants show defects in Dsc1 glycosylation, suggesting that the Dsc E3 
ligase is trapped in the ER where it is unable to participate in SREBP activation (Fig. 2.6D). 
Importantly, in all cases, the strength of the Dsc1 glycosylation defect is consistent with the 
strength of the SREBP cleavage defect, indicating that the Dsc E3 ligase localization defect 
causes the SREBP cleavage defect. In our characterization of the ufd1 mutants, we also observed 
growth and Ufd1 expression defects (Fig. 2.5A-C). This is likely due to the temperature-sensitive 
nature of these strains, but may have contributed to the SREBP cleavage defects (115). However, 
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we believe the consistency between the cdc48 and ufd1 mutant results support our conclusion that 
Cdc48-Ufd1 plays this essential role during Dsc E3 ligase localization.  
Interestingly, ufd1 was not identified in our MMS screen (Fig. 2.1B). This may be due to 
the fact that ufd1 is an essential gene with a coding sequence of only 1029 bp, likely too small to 
come through our screen (Fig. 2.1B). Similarly, the Ufd1 binding partner Npl4 is also essential 
and could have been missed in our screen. While the literature suggests that Ufd1 usually is in 
complex with the binding partner Npl4 when bound to Cdc48, we were unable to generate 
temperature-sensitive mutants or tagged versions of npl4, and therefore cannot comment on its 
role in SREBP activation. 
 The second role for Cdc48 in the SREBP activation pathway is during SREBP cleavage 
by the rhomboid protease Rbd2. We previously showed that Cdc48 interacts with Rbd2 through 
the Rbd2 SHP domain, and that this interaction is required for SREBP cleavage (71). The 
function performed by Cdc48 at Rbd2 is unknown but could be as a substrate adaptor, as an 
activator of Rbd2 enzymatic activity, and/or to release the cleaved SREBP N-terminus into the 
cytosol. Here we show that both cdc48 and ufd1 mutants are epistatic to rbd2Δ and retain the Sre2 
precursor in the absence of rbd2 (Fig. 2.6B-C). This phenocopies dsc1Δ rbd2Δ and supports the 
requirement for Cdc48-Ufd1 in Dsc E3 ligase function. Further, we showed that the Rbd2-SHP 
domain binds to Cdc48 but not Ufd1 in vitro (Fig. 2.6A). While it is possible that Ufd1 interacts 
with Rbd2 at a location separate from the SHP domain, this suggests that Ufd1 cannot interact 
with Rbd2 through Cdc48. Together, these data indicate that Cdc48-Ufd1 is distinct from Cdc48-
Rbd2, and that two Cdc48 complexes are required for the SREBP activation pathway. 
Finally, we previously published the interaction between Cdc48 and the Dsc E3 ligase 
through the Dsc5 UBX domain (69). This interaction is not required for SREBP activation. 
However, it could play a role in a non-SREBP function of the Dsc E3 ligase in the Golgi, such as 
Golgi quality control. Indeed, there are homologs of the Dsc proteins in S. cerevisiae, despite a 
lack of SREBP homologs in that organism (120). There, the homologous Tul1 E3 ligase regulates 
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turnover of certain vacuolar membrane proteins in budding yeast during vacuolar quality control 
(72). These three related roles for Cdc48 highlight the versatility of this powerful molecular 
machine and the necessity of cofactors to target it to specific substrates. 
Interestingly, although cdc48 is an essential gene, none of these mutations is lethal, 
suggesting that they have relatively minor functional defects. However, we observe strong defects 
in SREBP cleavage in many of the mutants (Fig. 2.2). This may indicate synthetic effects 
between the roles for Cdc48 during Dsc E3 ligase Golgi localization and Rbd2 cleavage. The 
impacts of deficient Cdc48 activity on each step of the pathway may be relatively minor, but 
together they strongly affect SREBP cleavage. Therefore, the requirement for Cdc48 at multiple 
steps may make SREBP activation uniquely sensitive to alterations in Cdc48 function. 
In addition to describing a novel role for Cdc48-Ufd1 during SREBP cleavage, this study 
generated two valuable resources for future studies of this pathway and low oxygen adaptation in 
fission yeast. Through the MMS screen, we report point mutations in sum3, sre1, scp1, Dsc E3 
ligase subunits, cdc48, and rbd2 that exhibit low oxygen adaptation defects (Fig. 2.1A, 
Supplemental Table 2.1). These mutants will provide insight into the molecular function of 
these proteins in this and other pathways. Additionally, the mass spectrometry data contains a 
number of leads for future studies. 18 of the 51 proteins enriched at least two standard deviations 
from the mean in the Cdc48-bound fraction of our Cdc48-5xFLAG pull-down were known Cdc48 
cofactors in S. pombe and/or other species (Table 2.1). In addition to Ufd1 and many known 
Cdc48 cofactors, four Dsc E3 ligase complex members were identified as Cdc48-binding proteins, 
consistent with our previously published results that Cdc48 interacts with the Dsc E3 ligase by 
binding to the Dsc5 UBX domain (69). These data validate our data set and suggest that the 33 
unexpected binding proteins are very interesting candidates for future study. Included in this list 
are three predicted E3 ligases and an ubiquitin-metalloprotease fusion protein (Table 2.1). 
Interestingly, mammalian VCP was shown to interact with a large number of E3 ligases through 
UBX domain-containing proteins, including the Dsc5 homolog FAF1 (121). These proteins are 
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therefore likely Cdc48-binding proteins. The remaining candidates may be unidentified 
components of Cdc48-interacting complexes or possibly substrates. Further analysis of the 
interaction between Cdc48 and these binding partners may identify new pathways requiring 
Cdc48 function. 
Together, these results highlight the ubiquitous value of Cdc48/VCP separase activity in 
organisms from yeast to humans. As careful structural and biochemical studies of Cdc48/VCP 
rapidly advance our understanding of Cdc48 mechanical function, future work will need to turn 
toward understanding the regulation of numerous cofactor interactions with Cdc48, as it is these 
interactions that ultimately define the fate of Cdc48 and the essential pathways in which it 
functions. 
2.4 Experimental procedures 
Materials – General chemicals and materials were obtained from Sigma or Fisher. Other 
sources include: yeast extract, peptone, and agar from BD Biosciences; Brefeldin A, Igepal CA-
630 (NP-40), cobalt (II) chloride, amino acid supplements, 1X protease inhibitors (PI) (10 μg/ml 
leupeptin, 5 μg/ml pepstatin A, 0.5 μM PMSF), acid washed glass beads (425-600 μm), and 
FLAG M2 monoclonal IgGs (F1804 and F3165) from Sigma; alkaline phosphatase (Cat 
#713023) and complete EDTA-free PI from Roche Applied Sciences; oligonucleotides from 
Integrated DNA Technologies; IRDye donkey anti-rabbit and donkey anti-mouse from Li-Cor; 
Myc monoclonal 9E10 IgG, and GST monoclonal IgG from Santa Cruz Biotechnology, Inc; 
prestained protein standards from Bio-Rad; Dynabeads Coupling Kit from Life Technologies 
(14311D); Glutathione HiCap Matrix beads from Qiagen; MagneGST beads and Trypsin/Lys-C 
mix (Cat #V5073) from Promega; 5-fluoroorotic acid (Cat #F595000) from Thermo Fisher. 
Strains and media - Yeast strains are described in Table 2.2. Strain PEY1516 was 
generated as described previously using seven tandem copies of the Tf2–1 sterol-regulatory 
element to drive ura4+ reporter gene activation (92). S. pombe were cultured to exponential phase 
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at 30°C in rich YES medium (0.5% (w/v) yeast extract plus 3% (w/v) glucose supplemented with 
225 μg/ml each of uracil, adenine, leucine, histidine, and lysine) or Edinburgh minimal medium 
plus supplements (EMM) (20 g/L glucose, 225 mg/L each of uracil, adenine, leucine, histidine, 
and lysine) unless otherwise indicated. YES+CoCl2 medium was prepared by dissolving cobalt 
(II) chloride in H2O and adding to a final concentration of 1.6 mM in YES medium.  
Antibodies - Rabbit polyclonal antibody anti-Sre1 IgG (aa 1-260) was generated using a 
standard protocol as described previously (62). Briefly, antigen was expressed in E. coli and 
affinity purified by an N-terminal polyhistidine tag. Sre1-specific antibodies were isolated from 
rabbit serum by affinity to the polyhistidine-tagged Sre1 antigen. Specificity of this antibody was 
assayed by loss of immunoreactivity in an sre1∆ strain. We generated rabbit polyclonal antibody 
anti-Sre2 IgG (aa 1-426) using a standard protocol as described above for anti-Sre1 (62).  
We generated monoclonal antibody 5B4 IgG1κ to Sre1 (aa 1–260) as described 
previously using recombinant protein that was purified from E. coli by nickel-affinity 
chromatography (Qiagen) and injected into BALB/c mice (70). Antibody specificity was tested 
by immunoblotting against S. pombe extracts from cells overexpressing sre1.  
Generation of polyclonal antibodies to Dsc E3 ligase complex members (Dsc1 and Dsc5) 
was described previously (68,69). Hexa-histidine tagged recombinant protein antigens, Dsc1 (aa 
20-319) and Dsc5 (aa 251-427) were purified from E. coli using Ni-NTA (Qiagen). Antisera were 
generated by Covance using a standard protocol. Dsc1 antibody was affinity purified by passing 
over a column containing Dsc1 N terminus (aa 1–300) coupled to agarose beads (AminoLink Plus 
immobilization kit, Thermo Scientific) according to the manufacturer's protocol as previously 
described (73). Antiserum to Cdc48 was the kind gift of R. Hartmann-Petersen (University of 
Copenhagen) (122). 
Yeast mutagenesis and selection – S. pombe were mutagenized using methyl 
methanesulfonate (MMS) as previously described (69). Briefly, PEY1516 cells were grown to a 
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cell density of 1 × 107 cells/ml, washed in sterile water, and resuspended at a concentration of 1 × 
108 cells/ml in EMM containing 0.024% or 0.012% (w/v) MMS. Cultures were then grown for 3 
h at room temperature. Cells were washed with sterile water and resuspended in sterile water at a 
density of 5 × 106 cells/ml. Cells were plated onto selection medium [SM: EMM, 2% (w/v) agar, 
20 g/L glucose, 225 mg/L each of adenine, leucine, and histidine, 50.25 mg/L uracil, 0.1% (w/v) 
5-FOA, 0.2 mm CoCl2] at a density of 5 × 105 cells/plate. Plates were wrapped in foil and 
incubated at 30°C. Colonies were picked and streaked onto SM. Single colonies were then 
patched onto SM and then streaked onto YES + CoCl2. CoCl2-sensitive isolates were then 
streaked from the SM patch a second time onto SM to isolate single colonies.  
Mutant identification – Mutant genes were identified as previously described (69). To test 
whether strains contained mutations in sre1 and scp1, CoCl2-sensitive isolates were co-
transformed with plasmids expressing sre1+ and scp1+ from the cauliflower mosaic virus 
promoter or the empty vector control plasmids pSLF101 and pSLF102 (123), respectively, and 
then screened again for CoCl2 sensitivity. Strains whose growth on CoCl2 was not rescued by 
plasmids expressing sre1 and scp1 were evaluated by western blotting for Sre1 cleavage. Strains 
that exhibited deficient Sre1 cleavage were mated to dsc1–5Δ, cdc48-8, rbd2Δ, sre1Δ, and scp1Δ 
cells. A suspension of spores from the mating was plated on YES or YES + CoCl2. The inability 
to recover CoCl2-resistant spores indicated tight linkage between the mutations. To identify the 
nucleotide mutations in each gene, genomic DNA was prepared, the full coding sequence of the 
relevant locus was PCR-amplified, and the coding region was sequenced. 
Recreation of cdc48 point mutations – cdc48 point mutations were created in a non-
mutagenized wild-type KGY425 background by generating a plasmid containing cdc48 (bp 4-
2504) followed by the NatMX6 marker. This wild-type plasmid was mutated using site-directed 
mutagenesis to create plasmids with the cdc48 mutations of interest. Plasmids were digested to 
release the cdc48-NatMX6 sequence and cdc48 fragment was transformed into KGY425 wild-
type yeast for homologous recombination. Successful transformants were selected by 
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nourseothricin resistance (Nat) and tested for sensitivity to CoCl2. An isogenic wild-type cdc48 
strain with the nourseothricin resistance cassette was also generated. All mutant strains were then 
confirmed by sequencing of genomic DNA as described above. Because these strains were 
generated in a non-mutagenized background and contained nourseothricin resistance, they were 
assigned allele numbers cdc48-5 – cdc48-10 to distinguish them from the mutagenized versions 
published in Stewart et al 2012 (69). 
SREBP cleavage assay – For Sre1 cleavage, cells were grown in YES medium to 
exponential phase inside an InVivo2 400 hypoxic workstation (Biotrace, Inc) at 30°C. For Sre2 
and Sre2-MS cleavage, cells were grown in YES medium (Sre2) or EMM medium minus leucine 
(Sre2-MS) in normoxic conditions at 30°C.  
Whole cell lysis - Cells were harvested for protein extraction and immunoblotting by the 
whole cell lysis method as previously described, unless otherwise indicated (124). Briefly, cell 
pellets were resuspended in 1.85 M NaOH/7.4% (v/v) BME and incubated on ice for 10 min. 
Tricholoroacetic acid (TCA) was added to a final concentration of 30% (w/v) and the samples 
were incubated on ice again. Lysate was centrifuged at 20,000 x g for 10 min at 4°C and pellet 
was washed with cold acetone. Samples were centrifuged at 20,000 x g for 5 min at 4°C and dried 
completely under vacuum. Pellets were resuspended in SDS lysis buffer (1% SDS, 150 mM NaCl, 
50 mM Tris-HCl pH 8.0, 1x protease inhibitors) and sonicated 10 s. Protein was quantified using 
the BCA protein assay (Pierce). For alkaline phosphatase treatment, 20-50 μg lysate was diluted 
at least 1:2 in 50 mM Tris-HCl pH 8.0, then alkaline phosphatase was added to 20% (v/v). 
Samples were incubated at 37°C for 1 h then 1x loading dye was added (30 mM Tris-HCl, 3% 
SDS, 5% glycerol, 0.004% bromophenol blue, 2.5% 2-mercaptoethanol). Entire phosphatase-
treated sample was loaded onto SDS-polyacrylamide gels and consistent loading was confirmed 
following electroblotting by staining the membrane with Ponceau S. Blots were imaged using the 
Odyssey CLx infrared imaging system (LI-COR Biosciences). Protein signal was quantified using 
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the LI-COR Biosciences Image Studio software to box the bands of interest, normalized to blot 
background, and then normalized to the indicated loading control. 
Cdc48-5xFLAG affinity chromatography - Exponentially growing cells (1 x 1010) were 
pelleted then washed with H2O. Cell pellets were resuspended in 15 ml cold B88 buffer [20 mM 
HEPES pH 7.2, 150 mM KOAc, 5 mM Mg(OAc)2, 250 mM sorbitol] + 1X protease inhibitors, 1x 
Complete EDTA-free PI. Cells were lysed by high pressure emulsifier (EmulsiFlex-C-3, Avestin), 
lysate was centrifuged for 10 min at 100,000 x g to pellet insoluble material, and supernatant was 
saved. Monoclonal FLAG antibody F3165 (Sigma) was conjugated to Dynabeads using the 
Dynabeads Coupling Kit (Life Technologies 14311D) to a final concentration of 10 μg 
antibody/1 mg beads. FLAG-conjugated Dynabeads (1.5 mg) were washed with IP buffer (B88 + 
1x PI, 1x Complete EDTA-free PI, 0.5% Triton X-100). Lysate (25 mg) was diluted in IP buffer 
to 550 μl total volume, and Triton X-100 concentration was returned to 0.5%. Lysate (50 μl) was 
saved as input and 500 μl was incubated with the FLAG-Dynabeads for 30 min at 4°C. Beads 
were collected by magnet and unbound fraction was reserved. Beads were washed 3x in 200 µl IP 
buffer and transferred to a new tube on the last wash to minimize background. The bound fraction 
was eluted into SDS lysis buffer + 1x PI at 95°C for 5 min and transferred to a new tube. Aliquots 
of all fractions were run on SDS-PAGE and silver stained to analyze pull-down before sending 
total bound fraction for mass spectrometry analysis. 
TMT labeling and proteomics analysis – Protein samples from three biological replicates 
of wild-type and Cdc48-5xFLAG samples subjected to anti-FLAG purification were pH adjusted 
to 8.0 using 500 mM Triethylammonium bicarbonate (TEAB) added dropwise. Cysteine residues 
were reduced using 0.5 μg/μl DTT for 1 h at 60°C then alkylated with 1 μg/μl iodoacetomide for 
30 min in the dark. Samples were precipitated with 8x volume of 10% TCA-acetone at -20°C for 
5 h, centrifuged at max speed for 10 min to remove supernatant, then washed with 8x acetone at -
20°C for 20 min. Samples were centrifuged at max speed to remove supernatant and protein 
pellets were air-dried. For protein digestion, samples were incubated with 2 μg trypsin/LysC mix 
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in 50 μl 400 mM TEAB at 37°C for 4 h. After proteolysis, samples were labeled with amine 
reactive 6-plex tandem mass tag reagents (TMT, Thermo Scientific) dissolved in 41 μl anhydrous 
acetonitrile at room temperature for 1 h. Labels are as follows: 1_ctr: 126; 1_exp: 129; 2_ctr: 130; 
2_exp: 127; 3_ctr: 131; 3_exp: 128. After labeling, 8 μl of 5% (v/v) hydroxylamine was added to 
quench the reaction. After labeling, all samples were mixed and dried, resulting in a total protein 
quantity of 140 μg.   
The combined mixture of TMT 6-plex labeled tryptic peptides was reconstituted in 2 ml 
basic Reverse Phase (bRP) solvent A (10 mM TEAB pH 8.5), then pH checked and fractionated 
over 8 min on a XBridge C18 Column, 5 μm, 2.1 x 100 mm analytical column (Waters) with a 
XBridge C18 Guard Column, 5 μm, 2.1 x 10 mm (Waters), using an Agilent HPLC system 
containing 1100 series binary pump, 1200 series UV detector and a 1200 series micro-fraction 
collector. Fractionation of peptides were carried out by a linear gradient (starting at 16 min) 
between solvent A and solvent B (10 mM TEAB in 90% Acetonitrile), flow rate 250 μl/min. 12 
flow through fractions between 1-20 min were not used for MS/MS.  84 x 225 μl bRP fractions 
collected between 20-95 min (0-100% solvent B), were recombined into 28 fractions for MS/MS 
analysis.  
Each bRP fraction was completely dried then reconstituted in 2% (v/v) acetonitrile/0.1% 
(v/v) formic acid and 50% was loaded on a 75 μm x 2.5 cm ODS-A C18 HPLC column trap 
(YMC) at 600 nl/min 0.1% formic acid (solvent A). Peptides were fractionated by reverse-phase 
HPLC on a 75 um x 100 mm ProntoSil C18H reverse-phase column (5 μm, 120Å, Bischoff 
Chromatography) at 300 nl/min using a 2-10% solvent B (90% acetonitrile in 0.1% formic acid) 
gradient over the first 2 min, then up to 25% B by 55 min, 45% B by 67 min, and 100% B by 75 
min. Eluting peptides were sprayed through 1 μm emitter tip (New Objective) at 2.0 kV directly 
into an LTQ Orbitrap Velos mass spectrometer in FTFT (Thermo Fisher Scientific) interfaced 
with nano-Acquity LC system (Waters). Survey scans (full MS) were acquired from 350 to 1800 
m/z. Precursor ions were individually isolated with 15 ppm tolerance between 2.5-5.5 Da and 
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fragmented (MS/MS) using an HCD activation collision energy of 35 and dynamic exclusion of 
30 s. Fragment ions were isolated with 0.03 Da tolerance. Precursor and the fragment ions were 
analyzed at resolution 30,000 and 15,000, respectively.  
Protein quantification - MS/MS spectra (.RAW) were analyzed via Proteome Discoverer 
software (v1.4 Thermofisher Scientific) using 3Nodes (extracted, processed by MS2Processor, 
and PD1.4), with Mascot (v 2.2, Matrix Science) using the RefSeq2012 Complete Database with 
concatenated decoy database specifying S. pombe species (5020 entries). Fixed modifications of 
TMT 6-plex of N-termini and carboamidomethyl on Cys, and variable modifications of TMT 6-
plex on Lys and oxidation of Met, were allowed. One missed cleavage was allowed. 80498 PSMs 
were matched to 16290 peptides. The peptide identifications and reporter ions with the highest 
Mascot score for the same peptide matched spectrum from the different extraction methods were 
processed within the Proteome Discoverer to identify peptides with a confidence threshold 1% 
False Discovery Rate. Peptides were grouped by mass and sequence into 2355 protein groups, 
considering only PSMs with delta Cn better than 0.15. Spectra were assessed using principle 
component analysis, quantile-quantile plots, and box and whisker plots using Partek statistical 
software (Genomic Solutions). Based on that analysis, spectral intensities were subjected to 
logarithmic transformation to more closely approximate a normal distribution. The relative 
protein abundance was obtained by taking the median value of all reporter ion intensities assigned 
to that protein. Protein abundance values were quantile normalized prior to averaging of the three 
biological replicates and fold change calculation between the FLAG-tagged experiment and the 
untagged control. p-values were calculated by 2-way ANOVA because principle component 
analysis showed evidence of significant batch effects among our three biological replicates.  
GST in vitro pull-down – Exponentially growing KGY425 (WT) and NBY3824 (ufd1-
13xmyc) cells (3.0 x 108) were collected and washed with H2O. Cell pellets were resuspended in 
500 μl cold B88 buffer + 1X protease inhibitors and lysed using glass beads for 20 min at 4°C. 
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Beads were washed with 400 μl B88 buffer and lysate was centrifuged at 47,000 rpm for 10 min 
at 4°C. Supernatant was saved as cleared lysate.  
Recombinant GST-HA-V5, GST-Dsc5-UBX, and GST-Rbd2-SHP were purified from E. 
coli (4.0 x 1010) after 4 h induction with IPTG. Bacterial pellets were resuspended in 5 ml PBS 
pH 7.2 and sonicated for 3 min total, with 15 sec on and 59 sec off. Triton X-100 was added to a 
final concentration of 1% (v/v) and lysate was rotated for 30 min at 4°C. Lysate was centrifuged 
at 15,000 x g for 20 min at 4°C. Supernatant was saved as unpurified protein. For purification, 
500 μl Glutathione Hi-Cap Matrix beads (Qiagen) were washed 3x with 2.5 ml PBS-EW wash 
buffer (50 mM NaH2PO4, 150 mM NaCl, pH 7.2, 1 mM EDTA, 1 mM DTT) and centrifuged 
4000 x g for 1.5 min after each wash. Cell lysate was added to beads and nutated for 1 h at 4°C. 
Beads were centrifuged 4000 x g for 1.5 min and washed 2x with 1.3 ml PBS-EW. Beads were 
washed 1x with 1.25 ml wash buffer (50 mM Tris pH 8.0, 0.4 M NaCl, 0.1% Triton X-100, 1 mM 
DTT). Elution buffer (250 μl) (50 mM Tris pH 8.0, 0.4 M NaCl, 0.1% Triton X-100, 1 mM DTT, 
50 mM reduced glutathione) was added to beads and incubated for 10 min at 4°C. Beads were 
centrifuged 4000 x g for 1.5 min, eluate was removed, and beads were incubated 2x in elution 
buffer for 5 min each, saving eluates separately. SDS lysis buffer and loading dye was added to 
aliquots of eluates and intermediate steps. These samples were run on an SDS-PAGE gel and 
Coomassie stained to evaluate purity and concentration.  
For pull-down, 25 μl of MagneGST beads (Promega) were washed 3x with 1 ml PBS pH 
7.2 then blocked for 1 h with PBS + 5% BSA at 4°C. Beads were washed 1x with PBS then 50 μg 
purified GST-tagged protein was added, and volume was brought up to 500 μl with PBS before 
binding for 1 h at 4°C. Beads were collected by magnet and washed 3x with 1 ml PBS. Beads 
were washed 1x with 1 ml binding buffer (B88, 0.2% NP-40, 1X protease inhibitors). Cytosol 
(250 μg) and binding buffer was added to beads to a final volume of 200 μl and incubated 30 min 
at 4°C. Beads were collected by magnet and unbound fraction was saved before washing beads 
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3x with 1 ml binding buffer. Beads were resuspended in 100 μl SDS lysis buffer and 1x loading 
dye and boiled at 95°C for 5 min to elute bound proteins. 
Dsc1 glycosylation assay - Exponentially growing cells (2.5 x 108) were collected and 
resuspended in 300 μl B88 buffer + 1X protease inhibitors, 1x Complete EDTA-free PI. Cells 
were lysed using glass beads for 12 min at 4°C then centrifuged for 5 min at 500 x g to clear cell 
debris. The supernatant was centrifuged at 20,000 x g for 20 min, and the pelleted membranes 
were resuspended in 100 μl B88 buffer with 1% NP-40 (v/v) then sonicated for 5 s. Membranes 
were solubilized at 4oC for 1 h, samples were centrifuged at 20,000 x g for 20 min, and the 
supernatant was collected as detergent-solubilized membrane. Loading dye was added and 
samples were incubated at 37oC for 30 min before running an SDS-PAGE gel. At no time were 
samples boiled, as Dsc1 aggregates at high temperature. % mature was calculated by quantifying 
the higher molecular weight band and the lower molecular weight band on the LiCor, and 
dividing the high signal by the total signal. 
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2.5 Figures 
FIGURE 2.1. Identification of cdc48 alleles A, flow chart of results from two MMS mutagenesis 
screens [0.024% and 0.012% (w/v)]. Red numbers denote the number of isolates in each category. 
Numbers in parentheses are the number of isolates with mutations confirmed by sequencing (see 
Supplementary Table 2.1 for specific mutations). Aside from the first box, all numbers are 
pooled from the two MMS dosages. B, comparison of gene coding sequence size with number of 
isolated mutants in MMS mutagenesis screen. Best-fit line calculated against non-essential genes 
(filled markers), R2=0.87. C, table of remade cdc48 alleles showing amino acid changes in S. 
pombe, corresponding homologous amino acid in human, and corresponding allele from our 
previous report (69). D, line diagram of S. pombe cdc48, where the orange box indicates the N-
domain to which the majority of cofactors bind. The blue box indicates the minor ATPase D1 
domain required for hexamer formation. The green box indicates the major ATPase D2 domain 
required for force generation. Yellow boxes in both domains indicate sequences essential for ATP 
binding and hydrolysis. The grey box indicates the C-domain to which a minority of cofactors 
bind. Red asterisks indicate the locations of our cdc48 point mutations. 
 
FIGURE 2.2. SREBP cleavage requires cdc48 A, wild-type cells or the indicated mutants (5000 
cells) were grown on rich medium plus or minus cobalt chloride (CoCl2) for 2 or 10 days, 
respectively. B, western blots, probed with monoclonal anti-Sre1 IgG (5B4) and polyclonal anti-
Dsc5 IgG (for loading), of lysates treated with alkaline phosphatase for 1 h from wild-type cells 
and the indicated cdc48 mutants grown for 0 or 4 h in the absence of oxygen. P and N denote 
precursor and cleaved N-terminal transcription factor forms, respectively. Asterisk denotes 
nonspecific band. The blot is representative of three biological replicates. C, western blots, 
43
probed with monoclonal anti-FLAG M2 and polyclonal anti-Dsc5 IgG (for loading), of lysates 
treated with alkaline phosphatase for 1 h from wild-type cells and the indicated cdc48 mutants 
containing a plasmid expressing sre2-MS (+) or the empty vector (-) grown in the presence of 
oxygen. P and N denote precursor and cleaved N-terminal transcription factor forms, respectively. 
The blot is representative of three biological replicates. 
 
FIGURE 2.3. cdc48 mutants have minimal effect on Cdc48 expression or growth rate A, 
western blots, probed with polyclonal anti-Cdc48 IgG and polyclonal anti-Dsc5 IgG (for loading), 
of lysates from wild-type cells and the indicated cdc48 mutants. B, quantification of A from three 
biological replicates, each indicated by a different marker shape, normalized for loading to Dsc5 
and then normalized to wild-type cells for comparison among blots. Error bars are 1 S.D. (*, p < 
0.05; **, p < 0.01 vs WT by two-tailed Student’s t-test). C, indicated strains were grown in liquid 
culture for 12 h. Cell density was measured by absorbance at 600 nm every 3 h. Doubling times 
were calculated using 3- and 9-h optical density readings using the formula: doubling time = 
(culture time x log(2))/log(final OD) - log(initial OD). Doubling times are displayed as 
mean±S.D. from four biological replicates as indicated by marker shape. (*, p < 0.05; **, p < 
0.01 vs WT by two-tailed Student’s t-test). 
 
FIGURE 2.4. Identification of Cdc48 binding proteins in S. pombe A, western blots, probed 
with monoclonal anti-Sre1 IgG (5B4) and polyclonal anti-Dsc5 IgG (for loading), of lysates 
treated with alkaline phosphatase for 1 h from wild-type cells, cdc48-5xFLAG (cdc48-F) cells, or 
sre1Δ cells grown for 0 or 4 h in the absence of oxygen. P and N denote precursor and cleaved N-
terminal transcription factor forms, respectively. Asterisks denote nonspecific bands. The blot is 
representative of two biological replicates. B, Cdc48 was immunoprecipitated (IP) from wild-type 
or cdc48-5xFLAG cells using monoclonal anti-FLAG M2 IgG as described in Experimental 
Procedures. Input, unbound, and 10-fold enriched bound fractions were analyzed by western 
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blotting using polyclonal anti-Cdc48 IgG. The blot is representative of four biological replicates. 
C, volcano plot of all proteins identified during TMT mass spectrometry of Cdc48-5xFLAG 
bound proteins. Points in red are proteins with enrichment > 2 S.D. from the mean in the Cdc48-
5xFLAG versus wild-type samples. p-values were calculated using two-way ANOVA with 
quantile normalization for 3 biological replicates.  
 
FIGURE 2.5. Ufd1 is a Cdc48 cofactor required for SREBP cleavage A, wild-type cells or the 
indicated mutants (5000 cells) were grown on rich medium plus or minus CoCl2 for 10 days. B, 
indicated strains were grown in liquid culture for 12 h. Cell density was measured by absorbance 
at 600 nm every 3 h. Doubling times were calculated using 3- and 9-h optical density readings 
using the formula: doubling time = (culture time x log(2))/log(final OD) - log(initial OD). 
Doubling times are displayed as mean±S.D. for three biological replicates as indicated by marker 
shape. (**, p < 0.01 vs WT by two-tailed Student’s t-test). C, western blots, probed with 
monoclonal anti-Myc IgG, polyclonal anti-Cdc48 IgG, and polyclonal anti-Dsc5 IgG (for 
loading), of lysates from wild-type cells and the indicated ufd1 mutants. The blot is representative 
of three biological replicates. D, western blots, probed with monoclonal anti-Sre1 IgG (5B4) and 
polyclonal anti-Dsc5 IgG (for loading), of lysates treated with alkaline phosphatase for 1 h from 
wild-type cells, sre1Δ, or the indicated ufd1 mutants grown for 0 or 4 h in the absence of oxygen. 
P and N denote precursor and cleaved N-terminal transcription factor forms, respectively. 
Asterisk denotes nonspecific band. The blot is representative of three biological replicates. E, 
western blots, probed with monoclonal anti-FLAG M2 and polyclonal anti-Dsc5 IgG (for 
loading), of lysates treated with alkaline phosphatase for 1 h from wild-type cells and the 
indicated ufd1 mutants containing a plasmid expressing sre2-MS (+) or the empty vector (-) 
grown in the presence of oxygen. P and N denote precursor and cleaved N-terminal transcription 
factor forms, respectively. The blot is representative of three biological replicates.  
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FIGURE 2.6. SREBP cleavage requires Cdc48-Ufd1 during Dsc E3 ligase Golgi localization 
A, recombinant GST-HA-V5 control (GST), GST-Dsc5 UBX (Dsc5323–425, UBX), and GST-Rbd2 
C-terminus (Rbd2200–251, SHP) were bound to GST magnetic beads and incubated with S. pombe 
cytosol from wild-type (-) or ufd1-13xmyc (+) cells. Input, unbound, and 10-fold enriched bound 
fractions were probed with monoclonal anti-Myc IgG, polyclonal anti-Cdc48 IgG, and 
monoclonal anti-GST IgG. The blot is representative of five replicates. B-C, western blots, 
probed with polyclonal anti-Sre2 IgG and polyclonal anti-Dsc5 IgG (for loading), of lysates 
treated with alkaline phosphatase for 1 h from wild-type, dsc1Δ (1Δ), or the indicated cdc48 (B) 
or ufd1 (C) mutant cells.  rbd2 (+) or rbd2Δ (-) genotype is indicated. P and N denote precursor 
and cleaved N-terminal transcription factor forms, respectively. The blot is representative of three 
(B) or five (C) biological replicates. D, western blot, probed with polyclonal anti-Dsc1 IgG, of 
Nonidet P-40-solubilized membrane protein from wild-type, dsc2Δ, dsc5ΔUBX (ΔUBX), rbd2Δ, 
or the indicated cdc48 or ufd1 mutant cells. M and I indicate mature and intermediate 
glycosylated forms, respectively. The blot is representative of three biological replicates. E, 
quantification of Dsc1 from (D) of three biological replicates each denoted by different marker 
symbols. The quantity of the mature form was divided by total Dsc1 signal for percent mature, 
allowing comparison between lanes and blots. Error bars are 1 S.D. (*, q < 0.05 FDR by one-way 
ANOVA with post-hoc comparison to matched wild-type and Benjamini, Krieger, Yekutieli 




Table 2.1. Cdc48 binding proteins in S. pombe. Cdc48 binding proteins, identified by TMT 
mass spectrometry, of 3 biological replicates, enriched at least 2 S.D. from the mean. Rows 
highlighted in grey are known Cdc48 binding proteins. 





Systematic ID Gene Descriptiona Log2 
(FC) 
p-value CoCl2 sensitive 
SPBC1711.10c npl4 Hrd1p ubiquitin ligase complex Npl4 (predicted) 6.03 0.05   
SPCC1442.07c wss2 ubiquitin/metalloprotease fusion protein Udp7 5.45 0.03 NO 
SPBC21C3.11 ubx4 UBX domain protein Ubx4 (predicted) 5.11 0.02 NO 
SPCC1020.01c pma2 P-type proton ATPase, P3-type Pma2 4.94 0.03 NO 
SPBC16A3.09c ufd1 Hrd1 ubiquitin ligase complex subunit Ufd1 (predicted) 4.71 0.02 YES 
SPAC6G10.08 idp1 isocitrate dehydrogenase Idp1 (predicted) 4.66 0.09 NO 
SPAC343.09 ubx3 UBX domain protein Ubx3, Cdc48 cofactor 4.53 0.05 YES 
SPBC947.10 dsc1 Golgi Dsc E3 ligase complex subunit Dsc1 4.51 0.06 YES 
SPAP32A8.03c bop1 ubiquitin-protein ligase E3 (predicted) 4.39 0.01 NO 
SPAC2C4.15c ubx2 Hrd1 ubiquitin ligase complex UBX domain Ubx2 4.31 0.02 NO 
SPAC1565.08 cdc48 AAA family ATPase, ubiquitin-mediated degradation 4.21 0.03 YES 
SPAC17C9.11c SPAC17C9.11c zf-C2H2 type zinc finger protein/UBA domain protein 4.06 0.05 NO 
SPAC20H4.02 dsc3 Golgi Dsc E3 ligase complex subunit Dsc3 3.65 0.12 YES 
SPCC1827.04 vms1 Cdc48p-Npl4p-Vms1p AAA ATPase complex subunit  3.59 0.09 NO 
SPAC26H5.09c SPAC26H5.09c oxidoreductase involved in NADPH regeneration  3.58 0.02 NO 
SPCC4G3.12c SPCC4G3.12c ubiquitin-protein ligase E3 (predicted) 3.30 0.01 NO 
SPAC6B12.13 SPAC6B12.13 protein phosphatase inhibitor (predicted) 3.23 0.04  
SPAC26A3.16 dph1 UBA domain protein Dph1 3.22 0.01 NO 
SPCC285.11 dsc5 UBX domain protein required for Sre1 cleavage 3.21 0.10 YES 
SPCC1281.07c gst4 glutathione S-transferase (predicted) 3.21 0.04 NO 
SPBC1105.07c pci2 TREX complex subunit Pci2 (predicted) 3.12 0.08  
SPBC21B10.05c pop3 WD repeat protein Pop3 2.96 0.09 NO 
SPAC29A4.06c SPAC29A4.06c splicing protein, human NSRP1 ortholog 2.94 0.03  
SPAC4A8.12c sds22 protein phosphatase regulatory subunit Sds22 2.71 0.11  
SPAC57A7.08 pzh1 serine/threonine protein phosphatase Pzh1 2.63 0.08 NO 
SPAC1486.02c dsc2 Golgi Dsc E3 ligase complex subunit Dsc2 2.63 0.05 YES 
SPBC354.07c SPBC354.07c oxysterol binding protein (predicted) 2.45 0.07 NO 
SPBP4H10.07 SPBP4H10.07 ubiquitin-protein ligase E3 (predicted) 2.37 0.04 NO 
SPAC2F3.15 lsk1 P-TEFb-associated cyclin-dependent protein kinase  2.16 0.28 NO 
SPBC216.03 SPBC216.03 conserved fungal protein 2.13 0.23 NO 
SPAC1A6.04c plb1 phospholipase B homolog Plb1 2.12 0.26 NO 
SPAC24C9.14 otu1 ubiquitin-specific cysteine protease, OTU family, Otu1 2.09 0.19 NO 
SPAC18B11.03c SPAC18B11.03c N-acetyltransferase (predicted) 2.09 0.34 NO 
SPAC4F8.07c hxk2 hexokinase 2 2.05 0.06 NO 
SPBC29A10.08 gas2 1,3-beta-glucanosyltransferase Gas2 (predicted) 2.03 0.21 NO 
SPCC4B3.01 tum1 thiosulfate sulfurtransferase, tRNA wobble thiolation  1.97 0.39 NO 
SPBC15D4.11c SPBC15D4.11c mitochondrial Mam33 family protein (predicted) 1.94 0.15  
SPAC343.12 rds1 conserved fungal protein 1.93 0.10 NO 
SPAC22E12.06c gmh3 alpha-1,2-galactosyltransferase Gmh3 1.92 0.02 NO 
SPBC354.13 rga6 Rho-type GTPase activating protein Rga6 (predicted) 1.88 0.11 NO 
SPCC306.08c mdh1 malate dehydrogenase Mdh1 (predicted) 1.86 0.31 NO 
SPBC365.06 pmt3 SUMO 1.85 0.09 NO 
SPAC2C4.17c msy2 MS ion channel protein 2 (predicted) 1.85 0.04 NO 
SPAC637.07 moe1 translation initiation factor eIF3d Moe1 1.83 0.15 NO 
SPAC1B3.03c wis2 cyclophilin family peptidyl-prolyl cis-trans isomerase  1.83 0.08 NO 
SPAC25G10.05c his1 ATP phosphoribosyltransferase 1.83 0.04 NO 
SPAC13G7.02c ssa1 heat shock protein Ssa1 (predicted) 1.81 0.09 NO 
SPBC106.03 SPBC106.03 DUF1776 family protein 1.78 0.26 NO 
SPBC18H10.04c sce3 translation initiation factor (predicted) 1.77 0.03 NO 
SPBC887.05c cwf29 RNA-binding protein Cwf29 1.74 0.22  
SPAC19B12.11c SPAC19B12.11c zinc finger protein, human ZNF593 ortholog 1.70 0.09 NO 
SPBC17D11.02c hrd1 Hrd1 ubiquitin ligase complex E3 subunit, Hrd1 1.67 0.06 NO 
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Table 2.2. S. pombe strain list 
Strains Genotype Source Figure 
PEY1516 h- leu1-32 ade6-M210 ura4-D18::7xSRE ura4+ kanR, his3-
D1::7xSRE lacZ 
(Stewart et al., 2012) 1 
KGY425 h- leu1-32 ura4-D18 ade6-M210 his3-D1 ATCC 2,4,6 
PEY522 h- leu1-32 ura4-D18 ade6-M210 his3-D1 ∆sre1-D1::kanMX6 (Hughes et al., 2005) 2,4,5 
PEY1653 h- leu1-32 ura4-D18 ade6-M210 his3-D1 cdc48+::natMX6 This study 2,3,6 
PEY1654 h- leu1-32 ura4-D18 ade6-M210 his3-D1 cdc48-N558I::natMX6 This study 2,3,6 
PEY1655 h- leu1-32 ura4-D18 ade6-M210 his3-D1 cdc48-A586V::natMX6 This study 2,3,6 
PEY1656 h- leu1-32 ura4-D18 ade6-M210 his3-D1 cdc48-E731D::natMX6 This study 2,3,6 
PEY1657 h- leu1-32 ura4-D18 ade6-M210 his3-D1 cdc48-E325K::natMX6 This study 2,3,6 
PEY1659 h- leu1-32 ura4-D18 ade6-M210 his3-D1 cdc48-A366D::natMX6 This study 2,3,6 
PEY1660 h- leu1-32 ura4-D18 ade6-M210 his3-D1 cdc48-R764C::natMX6 This study 2,3,6 
PEY1820 h- leu1-32 ura4-D18 ade6-M210 his3-D1 cdc48-5xFLAG::kanMX6 This study 4 
ED666 h+ leu1-32 ura4-D18 ade6-M210 Bioneer Inc. Table 1 
deletion 
strains 
h+ leu1-32 ura4-D18 ade6-M210 ∆[GOI]-D1::kanMX4 (GOI: 
SPCC1442.07c, ubx4, idp1, bop1, ubx2, SPAC17C9.11c, vms1, 
SPAC26H5.09c, dph1, SPCC1281.07c, pop3, pzh1, 
SPBC354.07c, lsk1, plb1, otu1, SPAC18B11.03c, tum1, fds1, 
gmh1, rga6, SPCC306.08c, pmt3, msy2, moe1, wis2, his1, ssa1, 
SPBC106.03, sce3, SPAC19B12.11c, hrd1) 
Bioneer Inc. Table 1 
PEY1831 h- leu1-32 ura4-D18 ade6-M210 his3-D1 ∆ubx3-D1::natMX6 This study Table 1 
PEY1832 h- leu1-32 ura4-D18 ade6-M210 his3-D1 ∆SPCC4G3.12c-
D1::natMX6 
This study Table 1 
PEY1833 h- leu1-32 ura4-D18 ade6-M210 his3-D1 ∆SPBP4H10.07-
D1::natMX6 
This study Table 1 
PEY1834 h- leu1-32 ura4-D18 ade6-M210 his3-D1 ∆SPBC216.03-
D1::natMX6 
This study Table 1 
PEY1835 h- leu1-32 ura4-D18 ade6-M210 his3-D1 ∆pma2-D1::natMX6 This study Table 1 
PEY1836 h- leu1-32 ura4-D18 ade6-M210 his3-D1 ∆gas2-D1::natMX6 This study Table 1 
PEY1837 h- leu1-32 ura4-D18 ade6-M210 his3-D1 ∆hxk2-D1::natMX6 This study Table 1 
NBY3824 h+ leu1-32 ura4-D18 ade6-M210 his3-D1 ufd1-13xmyc::kanMX6 (Nie et al., 2012) 5-6 
NBY3921 h+ leu1-32 ura4-D18 ade6-M210 his3-D1 ufd1 (L281S)-
13xmyc::kanMX6 
(Nie et al., 2012) 5,6 
NBY4402 h+ leu1-32 ura4-D18 ade6-M210 his3-D1 ufd1 (L68P, G226D)-
13xmyc::kanMX6 
(Nie et al., 2012) 5-6 
NBY4403 h+ leu1-32 ura4-D18 ade6-M210 his3-D1 ufd1 (L78P)-
13xmyc::kanMX6 
(Nie et al., 2012) 5-6 
PEY1821 h- leu1-32 ura4-D18 ade6-M210 his3-D1 Δrbd2-D1::kanMX6, 
cdc48+::natMX6 
This study 6 
PEY1822 h+ leu1-32 ura4-D18 ade6-M210 his3-D1 Δrbd2-D1::kanMX6, 
cdc48-N558I::natMX6 
This study 6 
PEY1823 h+ leu1-32 ura4-D18 ade6-M210 his3-D1 Δrbd2-D1::kanMX6, 
cdc48-E325K::natMX6 
This study 6 
PEY1824 h90 leu1-32 ura4-D18 ade6-M210 his3-D1 Δrbd2-D1::kanMX6, 
cdc48-A366D::natMX6 
This study 6 
PEY1825 h- leu1-32 ura4-D18 ade6-M210 his3-D1 Δrbd2-D1::kanMX6, 
cdc48-R764C::natMX6 
This study 6 
PEY1826 h90 leu1-32 ura4-D18 ade6-M210 his3-D1 Δrbd2-D1::kanMX6, 
cdc48-A586V::natMX6 
This study 6 
PEY1827 h90 leu1-32 ura4-D18 ade6-M210 his3-D1 Δrbd2-D1::kanMX6, 
cdc48-E731D::natMX6 
This study 6 
PEY1828 h+ leu1-32 ura4-D18 ade6-M210 his3-D1 ufd1-13xmyc::kanMX6, 
Δrbd2-D1::natMX6 
This study 6 
PEY1829 h+ leu1-32 ura4-D18 ade6-M210 his3-D1 ufd1 (L68P, G226D)-
13xmyc::kanMX6, Δrbd2-D1::natMX6 
This study 6 
PEY1830 h+ leu1-32 ura4-D18 ade6-M210 his3-D1 ufd1 (L78P)-
13xmyc::kanMX6, Δrbd2-D1::natMX6 
This study 6 
PEY1569 h+ leu1-32 ura4-D18 ade6-M210 his3-D1 ∆dsc1-D1::kanMX6 (Burr et al., 2017) 6 
PEY1685 h+ leu1-32 ura4-D18 ade6-M210 his3-D1 Δdsc1-D1::kanMX6 
Δrbd2-D1::natMX6 
(Hwang et al., 2016) 6 
PEY1792 h+ leu1-32 ura4-D18 ade6-M210 his3-D1 ∆dsc2-D1::kanMX6 (Burr et al., 2017) 6 
PEY1681 h+ leu1-32 ura4-D18 ade6-M210 his3-D1 Δrbd2-D1::natMX6 (Hwang et al., 2016) 6 
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Mga2 transcription factor regulates an oxygen-responsive lipid homeostasis 











This chapter is an edited version of the manuscript, “Mga2 transcription factor regulates an 
oxygen-responsive lipid homeostasis pathway in fission yeast” by R. Burr, E. V. Stewart, W. 
Shao, S. Zhao, H. K. Hannibal-Bach, C. S. Ejsing, and P. J. Espenshade, published in the Journal 
of Biological Chemistry, Volume 291, Issue 23, 12171-12183. © 2016 American Society for 
Biochemistry and Molecular Biology, Inc. 
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3.1 Summary 
Eukaryotic lipid synthesis is oxygen-dependent with cholesterol synthesis requiring 11 
oxygen molecules and fatty acid desaturation requiring 1 oxygen molecule per double bond. 
Accordingly, organisms evaluate oxygen availability to control lipid homeostasis. The sterol 
regulatory element-binding protein (SREBP) transcription factors regulate lipid homeostasis. In 
mammals, SREBP-2 controls cholesterol biosynthesis, while SREBP-1 controls triacylglycerol 
and glycerophospholipid biosynthesis. In the fission yeast Schizosaccharomyces pombe, the 
SREBP-2 homolog Sre1 regulates sterol homeostasis in response to changing sterol and oxygen 
levels. However, notably missing is an SREBP-1 analog that regulates triacylglycerol and 
glycerophospholipid homeostasis in response to low oxygen. Consistent with this, studies have 
shown that the Sre1 transcription factor regulates only a fraction of all genes upregulated under 
low oxygen. Our previous study identified 404 genes that are upregulated under low oxygen but 
are not Sre1 targets (54). Therefore, additional low oxygen-responsive pathways remain to be 
discovered. Given that fission yeast adaptation to low oxygen is a model for low oxygen 
responses in pathogenic fungi, identification of these pathways could highlight novel targets for 
inhibitors of fungal pathogenesis (125-128). 
To identify new regulators of low oxygen adaptation, we screened the S. pombe 
nonessential haploid deletion collection and identified 27 gene deletions sensitive to both low 
oxygen and cobalt chloride, a hypoxia mimetic. One of these genes, mga2, is a putative 
transcriptional activator. mga2 has homologs in S. cerevisiae that are ER membrane-bound 
transcriptional activators required for expression of the ∆9 fatty acid desaturase OLE1 (103,106). 
In the absence of mga2, fission yeast exhibited growth defects under both normoxia and low 
oxygen conditions. We demonstrate that fission yeast Mga2 regulates a low oxygen-responsive 
gene expression program distinct from Sre1. Genes regulated by Mga2 include the fatty acid 
synthases fas1 and fas2, the fatty acid desaturase ole1, and the long chain fatty acid CoA ligase 
lcf1, all of which are homologs of SREBP-1 targets in mammals. We also find that mga2∆ cells 
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showed disrupted triacylglycerol and glycerophospholipid homeostasis, most notably with an 
increase in fatty acid saturation. Indeed, addition of exogenous oleic acid to mga2∆ cells rescued 
the observed growth defects. Together, these results establish Mga2 as a transcriptional regulator 
of triacylglycerol and glycerophospholipid homeostasis in S. pombe, analogous to mammalian 
SREBP-1. 
3.2 Results 
Identification of genes required for growth under low oxygen and on cobalt chloride – 
Adaptation to low oxygen in fission yeast requires the coordinated regulation of many genes (54). 
The Sre1 transcription factor only regulates expression of 22% of low oxygen-responsive genes, 
suggesting that additional oxygen-regulated transcription factors exist (54). Successful low 
oxygen adaptation can be assayed by growth of fission yeast under low oxygen or on the low 
oxygen mimetic, CoCl2. Indeed, sre1Δ cells fail to grow under both of these conditions (68). To 
identify genes required for hypoxic adaptation we screened 2,601 mutants from the 
Schizosaccharomyces pombe non-essential, haploid deletion collection for growth in these two 
conditions. We found that 105 gene deletions were sensitive to low oxygen and/or CoCl2, 
exhibiting reduced growth in these conditions (Fig. 3.1A). This included 38 deletion mutants 
sensitive to only low oxygen (1.5% of all tested gene deletions, Supplementary Table 3.2), 40 
mutants sensitive to CoCl2 (1.5%, Supplementary Table 3.3), and 27 mutants sensitive to both 
conditions (1.0%, Table 3.2). Growth data for the complete screen can be found in 
Supplementary Table 3.1. GO term enrichment analysis of deletions sensitive to both low 
oxygen and CoCl2 (Table 3.2) showed enrichment for genes involved in “retrograde transport, 
endosome to Golgi” and the retromer complex (p < 4E-3).  
Our previous work identified four of the 27 genes required for growth under low oxygen 
and on CoCl2 as dsc1-dsc4, members of the Dsc E3 ligase complex required for Sre1 cleavage in 
the Golgi (68). Genes required for Sre1 cleavage fail to accumulate the N-terminal transcription 
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factor (Sre1N) in the absence of oxygen (68). To identify genes functioning in the Sre1 pathway, 
we assayed low oxygen induction of Sre1N in a number of deletion strains, including the 
remaining 23 mutants required for growth under low oxygen and on CoCl2 (Fig. 3.1B and Table 
3.2). Immunoblotting against the Sre1 N-terminus permits detection of both the full-length 
precursor form of Sre1 and the transcriptionally active cleaved N-terminus. Wild-type cells 
showed robust cleavage and Sre1N production after 6 h at low oxygen (Fig. 3.1B, lanes 7-8), and 
four of the deletions sensitive to both low oxygen and CoCl2 (mga2, cpp1, ppr6, trx2) showed 
reduced Sre1N accumulation (Fig. 3.1B and Table 3.2). These deletions represent new 
candidates for genes required for Sre1 activation in S. pombe. The remaining 19 deletions showed 
normal Sre1N accumulation (Table 3.2) and thus are genes that could be involved in low oxygen-
responsive pathways distinct from Sre1 target gene transcription. 
To test whether a failure to produce Sre1N caused the observed growth defects in the 
absence of these four genes (mga2, cpp1, ppr6, trx2), we expressed sre1N from a plasmid and 
assayed growth on CoCl2. Notably, none of these deletion strains was rescued by sre1N 
expression (Fig. 3.1C-D), suggesting that either the Sre1N production defect occurs after 
cleavage (e.g. Sre1N is highly unstable) or that the deletion mutant is CoCl2-sensitive for reasons 
unrelated to Sre1N function.  
Of the four genes, we focused our studies on mga2 because Mga2 is a putative 
transcriptional activator in fission yeast based on homology to two related transcriptional 
activators in S. cerevisiae, MGA2 and SPT23 (103). Therefore Mga2 was a candidate for a new 
regulator of a low oxygen response. To confirm that the defect in growth of mga2∆ cells on 
cobalt chloride was not due to the observed Sre1 cleavage defect, we expressed the sre1N 
transcription factor from the endogenous sre1 locus and assayed transcription factor activity and 
growth on CoCl2. As with the plasmid-based sre1N previously examined, expression of sre1N 
from the endogenous locus did not rescue CoCl2 growth of mga2∆ cells (Fig. 3.1E). Importantly, 
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full activation of Sre1 production under low oxygen requires positive feedback regulation in 
which Sre1 stimulates sre1 transcription (92). In the absence of mga2, Sre1N upregulated its own 
expression under low oxygen through positive feedback to wild-type levels (Fig. 3.1F). These 
data suggest (1) that mga2∆ cells are defective for proteolytic activation of Sre1 precursor, rather 
than at a step downstream of cleavage, and (2) that the Sre1 cleavage defect cannot fully account 
for the observed growth defects of mga2∆ cells on CoCl2. Based on our interest in the hypoxic 
transcriptional response and the known function of S. cerevisiae mga2 homologs as 
transcriptional activators, we further analyzed the requirement for mga2 in fission yeast low 
oxygen adaptation. 
Cell growth requires mga2 in the presence and absence of oxygen – To characterize the 
requirement for mga2 in response to changes in environmental oxygen, we measured growth in 
liquid culture of wild-type and mga2∆ cells in either the presence or absence of oxygen. mga2∆ 
cells showed significantly reduced growth compared to wild-type cells in both conditions, and 
further reduced growth in the absence of oxygen compared to the presence of oxygen (Fig. 3.2A). 
Consistent with the observation that functional Sre1N transcription factor does not rescue CoCl2 
growth in the absence of mga2 (Fig. 3.1E-F), Sre1N did not rescue either the plus oxygen or 
minus oxygen liquid growth defects (Fig. 3.2B). Given that sre1∆ cells exhibit wild-type growth 
in the presence of oxygen (54), these growth assays demonstrate that mga2 functions in 
adaptation to low oxygen and CoCl2 through Sre1-independent pathway(s).   
Mga2 functions as a transcriptional regulator of lipid metabolism – Uncharacterized in S. 
pombe, mga2 is the sole fission yeast homolog of S. cerevisiae MGA2 and SPT23. S. cerevisiae 
MGA2, but not SPT23, is required for low oxygen induction of transcription of the Δ9 fatty acid 
desaturase OLE1 and modulates the stability of OLE1 mRNA in response to fatty acid availability 
(101,106). S. cerevisiae Mga2 also upregulates transcription of other genes involved in fatty acid 
and sterol homeostasis under oxidative stress, including ERG1, FAS1, ELO1, FAA4 and ATF1 
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(129). Although a combined deletion of both MGA2 and SPT23 in S. cerevisiae is lethal, deletion 
of mga2 in S. pombe was slow growing but viable under normoxia (Fig. 3.1D, 3.2A). The low 
oxygen sensitivity of the mga2∆ mutant led us to investigate Mga2-dependent transcription in S. 
pombe under low oxygen.  
To determine the transcriptional targets of S. pombe Mga2, we performed genome-wide 
expression profiling under low oxygen. We compared gene expression in sre1∆ cells to 
sre1∆ mga2∆ cells after 1.5 h growth in the absence of oxygen. We deleted sre1 in both strains so 
that observed changes in gene expression would be due to loss of mga2, and not indirect effects 
of the Sre1 cleavage block that occurs in mga2∆ cells (Fig. 3.1B). Of the 5,057 genes examined, 
291 (5.8%) were significantly decreased in mga2∆ cells by SAM. The full list of Mga2-dependent 
genes can be found in Supplementary Tables 3.4-3.5. GO term enrichment analysis of the 
decreased genes identified fatty acid metabolism and lipid metabolism as affected pathways (p-
value <0.0001). Table 3.3 lists genes that decreased expression at least two standard deviations 
from the mean in mga2∆ cells. These included long-chain fatty acid CoA ligases (lcf1 and lcf2), 
TAG lipases (ptl1 and ptl2), and the Δ9 fatty acid desaturase (ole1). Additionally, Mga2 controls 
expression of the biotin transporter vht1 and biotin synthase bio2, as well as hem1. Biotin is 
required for acetyl-CoA carboxylase function while heme is a prosthetic group for Ole1 in S. 
cerevisiae (130). While transcriptome profiling for S. cerevisiae MGA2-dependent genes under 
low oxygen conditions has not been performed, homologs of known S. cerevisiae Mga2-
dependent genes were decreased in our mga2∆ cells (Table 3.3 and Supplementary Table 3.5). 
Our microarray results suggest that fission yeast Mga2 regulates many lipid metabolism genes. 
To confirm the microarray results, we assayed low oxygen expression of candidate Mga2 
target genes in wild-type and mga2∆ cells by quantitative real-time PCR. Expression of ole1, lcf1, 
vht1, ptl1, fas1, and fas2 increased in the absence of oxygen, and this induction required mga2 
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(Fig. 3.3A). Expression of ole1, lcf1, and fas2 was also reduced even in the presence of oxygen, 
indicating that mga2 is required for gene expression both in the presence and absence of oxygen.  
To assess the oxygen regulation of all Mga2 targets, we compared our microarray results with 
known data sets. A previous study in our lab identified S. pombe genes upregulated after 1.5 h 
low oxygen treatment (54). 37% of Mga2 target genes were upregulated under low oxygen in that 
study (Supplementary Table 3.5, Fig. 3.3B). This accounts for 21% of all low oxygen 
upregulated genes (54). If we consider those genes most dependent on Mga2 (those showing 
expression reduced more than 2 standard deviations from the mean in the absence of mga2), 68% 
of these genes were upregulated under low oxygen in our previous study (Table 3.3, underlined 
IDs). Only 21% of Sre1 target genes were also regulated by Mga2 under low oxygen, confirming 
that Mga2 promotes a low oxygen-responsive pathway that is distinct from the Sre1 pathway 
(Table 3.3, Supplementary Table 3.5, Fig. 3.3B) (54). We conclude that S. pombe Mga2 
regulates lipid metabolism gene expression in the presence of oxygen, and that there is an 
additional requirement when oxygen is limiting.  
Maintenance of lipid homeostasis requires mga2 - We hypothesized that failure to 
upregulate genes involved in lipid biosynthesis in mga2∆ cells may lead to alterations in lipid 
homeostasis. To measure levels of cellular lipids, we performed quantitative mass spectrometry-
based lipidomics on wild-type and mga2∆ cells grown in the presence of oxygen (131). We 
examined cells in the presence of oxygen because oxygen is required for fatty acid desaturation 
and ergosterol synthesis (132-134), so the absence of oxygen would alter lipid synthesis 
regardless of strain background. Additionally, Mga2 target genes showed reduced expression in 
mga2∆ cells in the presence of oxygen (Fig. 3.3A). Full data and data analysis of this lipidomics 
experiment can be found in Supplementary Table 3.6. 
Our lipidomics experiment showed that in mga2∆ cells, diacylglycerol (DAG) and TAG 
levels decreased, while glycerophospholipid levels varied, with PA and PE increasing, PI 
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decreasing, and PS and CL levels unchanged (Fig. 3.4A). Interestingly, these alterations in 
glycerophospholipids were largely not reflected in the lysophospholipids that are inputs and 
products of glycerophospholipids. LPC and LPE levels decreased, despite the fact that PC was 
unchanged and PE levels were higher in mga2∆ cells (Fig. 3.4A). Although levels of both 
ceramide and MIPC were unchanged, levels of the intermediate IPC increased in the absence of 
mga2 (Fig. 3.4A). Levels of ergosterol increased in mga2∆ cells, while lanosterol decreased 
(Supplementary Table 3.6).  
In the absence of mga2, glycerophospholipids decreased in chain length, especially in PC, 
PA and PE, although PI chain lengths increased slightly (Fig. 3.4B). No significant changes 
occurred in lysophospholipid chain length (Supplementary Table 3.6).  Decreased acetyl-CoA 
carboxylase cut6 and enoyl reductase tcs13 expression (Table 3.3) may play a role in the 
observed decreases in fatty acid chain length. Taken together, these data demonstrate widespread 
lipidome disruption in the absence of mga2, and thus position this transcriptional activator as a 
crucial regulator of TAG and glycerophospholipid homeostasis. 
Glycerophospholipid saturation increases in the absence of mga2 – MGA2 and SPT23, 
the S. cerevisiae homologs of mga2, regulate the ∆9 fatty acid desaturase OLE1 required for fatty 
acid desaturation. Notably, Mga2 in fission yeast also regulated the ∆9 fatty acid desaturase ole1 
(Fig. 3.3A). To determine if decreased expression of ole1 resulted in altered glycerophospholipid 
saturation in mga2∆ cells, we examined fatty acid saturation in our lipidomics experiment. All 
glycerophospholipids measured, as well as LPA, LPI, LPE, LPS, DAG, and TAG showed 
increased saturation in mga2∆ cells (Fig. 3.5A). Together, these data suggest that even in the 
presence of oxygen, mga2∆ cells exhibit strongly decreased levels of lipid molecules with 
unsaturated fatty acid moieties. 
To test whether the observed plus and minus oxygen growth defects resulted from 
reduced fatty acid desaturation, we grew wild-type and mga2∆ cells in liquid medium 
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supplemented with monounsaturated oleic acid (18:1) conjugated to BSA (oleic acid), or with 
BSA alone. Oleic acid is the most abundant unsaturated fatty acid in fission yeast, representing 
about 75% of all fatty acids in the cell (135). Oleic acid or BSA was added to the media at the 0 h 
time point and cell density was measured for the following 12 h. Oleic acid addition had no effect 
on growth of wild-type cells, but rescued growth of mga2∆ cells in both the presence and absence 
of oxygen (Fig. 3.5B).  
Although the oleic acid-treated mga2∆ cells did not reach a density equal to that of wild-
type after 12 h, calculation of the cellular growth rates showed rescue. Oleic acid-treated 
mga2∆ cells exhibited a doubling time similar to that of BSA-treated mga2∆ cells during the first 
6 hours of treatment, but grew like wild-type cells during the second 6 hours of treatment (Table 
3.4). These data suggest that normal growth of mga2∆ cells requires a lag phase, perhaps to allow 
oleic acid uptake and incorporation into cellular lipids.  
To test this hypothesis, we grew wild-type and mga2∆ cells under normoxia for 16 hours plus 
oleic acid, then diluted the cells into fresh oleic acid-containing medium and grew the cells in the 
presence or absence of oxygen for another 12 hours (Fig. 3.5C). As expected, preincubation of 
mga2∆ cells with oleic acid eliminated the lag phase and mga2∆ cells showed wild-type growth 
from the 0 hour time point (Fig. 3.5C and Table 3.5). Therefore, we conclude that addition of 
exogenous oleic acid fully rescues growth defects of mga2∆ cells both in the presence and 
absence of oxygen.  
3.3 Discussion 
While Sre1 is regarded as the SREBP-2 analog that regulates sterol synthesis in S. pombe, 
no SREBP-1 analog regulating TAG and glycerophospholipid synthesis has been described. 
Given the results described in this study, we propose that mga2 is the SREBP-1 analog in fission 
yeast. Mga2 regulates 21% of all oxygen responsive genes, primarily those involved in TAG and 
glycerophospholipid homeostasis, including the fatty acid synthases fas1 and fas2, the fatty acid 
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desaturase ole1, and the long chain fatty acid CoA ligase lcf1 (Table 3.3, Fig. 3.3A).  This list of 
Mga2 gene targets is strikingly similar to the known gene targets of mammalian SREBP-1 (8/9 
targets conserved, Supplementary Table 3.5) (24,136). Further, overall lipid homeostasis, and 
especially fatty acid saturation, is disrupted in the absence of mga2, even under normoxic 
conditions (Fig. 3.4). Therefore, we conclude that Mga2 serves as the analogous transcription 
factor to SREBP-1 in S. pombe by coordinately regulating TAG and glycerophospholipid 
metabolism.  
Multiple lines of evidence support the conclusion that Mga2 regulates this oxygen-
responsive transcriptional program independent of the Sre1 pathway. First, transcriptionally 
active Sre1N did not rescue low oxygen and CoCl2 growth of mga2∆ cells (Fig. 3.1E-F, 3.2B). 
Second, mga2∆ cells exhibited a growth defect in the presence of oxygen, whereas sre1∆ cells 
have no normoxia growth defects (Fig. 2A) (62); Third, Mga2 regulates numerous genes not 
known to be oxygen-dependent, while Sre1 activity is only required under low oxygen (Fig. 
3.3A-B, Supplementary Table 3.5) (54); Finally, comparison of our list of Mga2 low oxygen 
gene expression targets with the known list of Sre1 expression targets showed only 22% overlap 
(most notably csr101, lcf2, fsh2, hmg1) (Table 3.3, Fig. 3.3B). This study positions Mga2 at the 
head of a new oxygen-responsive pathway in fission yeast. 
While this study is the first characterizing the transcriptional regulation of 
glycerophospholipid and TAG metabolism in fission yeast, glycerophospholipid regulation is 
much better characterized in S. cerevisiae. There, PA signals the glycerophospholipid state of the 
cell, as all membrane phospholipids and TAG are synthesized from PA. Low levels of membrane 
PA cause the Opi1 repressor to leave the perinuclear ER membrane and enter the nucleus. There 
it represses phospholipid synthesis genes to maintain lipid homeostasis (137). Interestingly, there 
is no known Opi1 homolog in S. pombe, raising the question as to whether a different method is 
used to sense PA availability. Given the high degree of functional conservation between fission 
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yeast and mammals, studies of phospholipid homeostasis in fission yeast may provide insight into 
the regulation of this pathway in mammals. 
These results support a model for S. pombe low oxygen lipid homeostasis in which 
decreased oxygen availability results in reduced ergosterol synthesis. This activates Sre1, 
increasing expression of enzymes required for ergosterol synthesis and restoring homeostasis (62). 
At the same time, low oxygen availability also results in reduced fatty acid desaturation. This 
activates Mga2, increasing expression of ole1 and upregulating unsaturated fatty acid synthesis. 
Interestingly, while both SREBP-1 and SREBP-2 are activated by the same machinery in 
mammalian cells, Sre1 and Mga2 are not processed coordinately (26). Instead, Sre1 is activated 
through the function of a Golgi-resident Dsc E3 ligase and a rhomboid protease, while S. 
cerevisiae Mga2 and Spt23 are activated by the Rsp5 ubiquitin ligase and the proteasome 
(68,108,138). Independent activation of Sre1 and Mga2 is supported by the fact that cells lacking 
a Dsc E3 ligase component show wild-type normoxic growth unlike mga2∆ cells, indicating that 
the Dsc E3 ligase is not required for Mga2 activation (data not shown). 
Despite differing mechanisms of regulation, both of these pathways are likely product 
inhibited. Work in mammalian cells has shown that SREBP trafficking by Scap is inhibited by 
exogenous cholesterol, although the parallel experiment cannot be performed in S. pombe as 
fission yeast do not uptake ergosterol (62,139,140). Similarly, work in S. cerevisiae showed a 
block in Mga2 activation when exogenous unsaturated fatty acid was added to the medium (108). 
Consistent with this result, activation of SREBP-1, but not SREBP-2, is inhibited by addition of 
exogenous arachidonate (20:4) in HEK293 cells (141). An important next step will be to examine 
whether unsaturated fatty acids regulate Mga2 through protein levels or activation. Alternatively, 
there could be other modes of regulation of these genes by oxygen. Our observation that Mga2 
activates genes under normoxia and that expression is further increased under low oxygen 
conditions (Fig. 3.3A) suggests that there may be constitutive activation of Mga2 under all 
oxygen conditions, and that an additional oxygen-responsive transcription factor may cooperate 
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with Mga2 under low oxygen. Interestingly, a recent report suggested that the CSL transcription 
factor Cbf11 binds to the promoters of 7 Mga2 target genes in S. pombe (142). While cbf11 is not 
itself an Mga2 target gene (Supplementary Table 3.4), deletion of cbf11 results in a low oxygen 
growth defect in our screen (Supplementary Tables 3.1 and 3.2), and Cbf11 was found to bind 
Mga2 in an affinity capture screen for the fission yeast protein interactome network (143). The 
human homologs of Cbf11, RBPJ and RBPJL, share ~19% protein sequence identity (clustered in 
the functional domains), raising the possibility that these proteins perform similar functions. 
These RBP family transcription factors mediate Notch signaling and are required for pancreas 
development (144,145). It is intriguing to speculate that fission yeast Mga2 and Cbf11 may act 
together to regulate phospholipid and TAG metabolism in response to low oxygen. More work is 
required to determine if and how these two transcription factors work together to regulate lipid 
homeostasis. Because both ergosterol and unsaturated fatty acids require oxygen for synthesis, 
product inhibition of these two pathways would allow indirect sensing of oxygen availability. 
Additionally, as membrane production requires coordinated supply of both ergosterol and 
glycerophospholipids, crosstalk between these two pathways is likely. Future studies will 
examine coordination of these two oxygen-responsive pathways.  
3.4 Experimental procedures 
Materials – We obtained general chemicals and materials from Sigma or Fisher. Other 
sources include: yeast extract, peptone, and agar from BD Biosciences; S. pombe haploid deletion 
collection version 1 from Bioneer; cobalt (II) chloride and amino acid supplements from Roche 
Applied Sciences; M-MuLV Reverse Transcriptase from New England Biolabs; RNA STAT-60 
from Tel-Test; GoTaq qPCR Master Mix from Promega; oligonucleotides from Integrated DNA 
Technologies; horseradish peroxidase-conjugated, affinity-purified donkey anti-rabbit IgG from 
Jackson ImmunoResearch; IRDye donkey anti-rabbit and from Li-Cor; prestained protein 
standards from Bio-Rad; fatty acid free bovine serum albumin from SeraCare Life Sciences.  
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Antibodies - Rabbit polyclonal antibody against amino acids 1-260 of Sre1 (anti-Sre1 
IgG) was generated using a standard protocol as was previously described: we purified the 
antigen with an N-terminal polyhistidine tag and a tobacco etch virus (TEV) protease cleavage 
sequence from E. coli using Ni-NTA agarose (Qiagen). We then cleaved with TEV protease 
(Invitrogen) to remove the histidine tag. We isolated Sre1-specific antibodies from rabbit serum 
by affinity chromatography using NHS-Sepharose resin (Pierce) conjugated to the polyhistidine-
tagged Sre1 antigen (62). Specificity of this antibody was assayed by loss of immunoreactivity in 
a sre1∆ strain.  
We generated monoclonal antibody 5B4 IgG1κ to Sre1 (aa 1-260) using recombinant 
protein that was purified from E. coli by nickel-affinity chromatography (Qiagen). We 
immunized BALB/c mice with this antigen and screened for immunoreactivity by ELISA and 
Western blotting. We fused spleen cells from immunopositive mice with SP2/0 myeloma cells to 
make monoclonal antibodies. We identified positive clones by ELISA screening using the 
immunizing antigen. After dilution cloning, antibody specificity was tested by immunoblotting 
against S. pombe extracts from cells overexpressing Sre1. We determined isotype using Mouse 
Isotyping Kit (Boehringer Mannheim). We purified final antibodies from either tissue culture 
supernatant or ascites fluid using protein-G Sepharose (Pharmacia).  
Yeast culture - Yeast strains are described in Table 3.1. S. pombe cells were grown to 
exponential phase at 30°C in rich YES medium [0.5% (w/v) yeast extract plus 3% (w/v) glucose 
supplemented with 225 μg/ml each of uracil, adenine, leucine, histidine, and lysine (20)]. 
YES+CoCl2 medium was prepared by dissolving cobalt (II) chloride in H2O and adding to a final 
concentration of 1.6 mM in YES medium. For fatty acid supplementation, fatty acids were added 
to 1 mM in YES medium from a 12.7 mM stock in 12% (w/v) fatty acid free BSA.  
BSA conjugation of free fatty acids - Fatty acid free BSA (24% w/v) was made by adding 
12 g of fatty acid free bovine serum albumin to 35 mL of 150 mM NaCl in six 2 g doses over 5 h. 
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pH was adjusted to 7.4 with 5N NaOH and the volume was brought up to 50 mL with 150 mM 
NaCl. This solution was diluted 1:1 with 150 mM NaCl to produce 12% fatty acid free BSA prior 
to use as an experimental control.  
Fatty acid conjugation to BSA was performed by dissolving 319 µmoles of the 
conjugating fatty acid in 2 mL EtOH. 100 µl of 5N NaOH was added to precipitate sodium salt of 
the fatty acid. EtOH was evaporated under nitrogen gas. 10 mL of 150 mM NaCl were added to 
the dried fatty acid, and the solution was heated until the fatty acid dissolved. The solution was 
then stirred and slowly cooled to just before the fatty acid precipitated, at which point 12.5 mL of 
ice-cold fatty acid free BSA (24% w/v) was added. The solution was stirred for 10 min and the 
final volume was adjusted to 25 mL with 150 mM NaCl.  
S. pombe deletion collection screen - The Bioneer Haploid Deletion Mutant Library v1.0 
was screened as described previously (21). 2,601 deletion mutants were streaked for single 
colonies on YES or YES+CoCl2 medium and placed at 30°C in the presence of oxygen. An 
additional YES plate was grown at 30°C in anaerobic conditions using the BBL GasPak system 
[Becton Dickson]. Mutants were compared to wild-type and sre1∆ strains and scored for growth 
after 7 days. Full screen results can be found in Supplementary Table 3.1. 
Sre1 cleavage assay – Cells were grown in YES medium to exponential phase inside an 
InVivo2 400 hypoxic workstation [Biotrace, Inc] and collected for protein extraction and 
immunoblotting as described previously using polyclonal or monoclonal 5B4 anti-Sre1 antibody 
as indicated (8). SDS-PAGE gels were equally loaded for total protein, which was quantified 
using the BCA protein assay (Pierce). Consistent loading was confirmed following electroblotting 
by staining the membrane with Ponceau S. Blots were imaged using enhanced 
chemiluminescence and film or the Odyssey CLx infrared imaging system [Li-Cor], as noted in 
the figure legend. 
68
Microarray - Data in Supplementary Tables 3.4 and 3.5 represent the log2 fold changes 
in expression between sre1∆ and sre1∆ mga2∆ cells grown anaerobically for 1.5 h. Microarray 
analysis was performed as described previously (11). Total RNA was isolated using RNA STAT-
60 and amplified and labeled using the RNA Amplification and Labeling Kit [Agilent 
Technologies] with oligo dT primers [System Bioscience] and cyanine CTPs [Perkin Elmer]. 
RNA was fragmented, denatured and hybridized to a custom Agilent array at 60°C for 17 h. Two 
dye-reversal hybridizations were performed with cells cultured on different days (biological 
replicates), yielding two data points per probe. Arrays were scanned by an Agilent G2505B 
Scanner and features were flagged using Agilent Feature Extraction Software. These data were 
imported into Partek Genomics Suite as the median of the arrays' three replicate probes' g/r 
processed signals. These log2 signal values were quantile normalized and the dye-swapped 
samples compared in a 1-way ANOVA. Because there were only 2 biological replicates, a pseudo 
p-value is presented alongside a Significance Analysis of Microarrays (SAM) q-value. SAM 
parameters were Δ=1.87646, false discovery rate (median) = 0.05447. Mga2-dependent genes 
showed lower expression in sre1∆ mga2∆ versus sre1∆ cells. The microarray gene expression 
data described in this paper have been deposited in NCBI's Gene Expression Omnibus (146) and 
are accessible through GEO Series accession number GSE60544 
(http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE60544). 
Quantitative PCR - Yeast cells (1 x 108) growing exponentially in the presence or 
absence of oxygen were pelleted, resuspended in RNA STAT 60, and vortexed. Samples were 
mixed with chloroform to 16% (v/v), then centrifuged at 10,000 x g for 15 min at 4oC. The 
aqueous fraction was mixed with isopropanol to 33% (v/v), then centrifuged at 10,000 x g for 10 
min. Precipitated RNA was washed with 75% (v/v) EtOH and air-dried. cDNA was synthesized 
following DNase and reverse transcription instructions for M-MuLV Reverse Transcriptase. RT-
qPCR was performed using the indicated primers and GoTaq qPCR Master Mix. Each reaction 
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was performed with two technical replicates per the five biological replicates. Error bars are one 
standard deviation.  
Lipid extraction - Lipid extraction was performed as described previously (131,147,148). 
Six biological replicate cultures of wild-type and mga2∆ cells growing exponentially in the 
presence of oxygen (6.8 x 107 – 1.3 x 108 cells) were pelleted and washed twice in 155 mM 
ammonium acetate then frozen under liquid nitrogen. Lipids were extracted at 4°C by breaking 
cell pellet with beads, then 20 internal lipid standards were spiked into the lysate. Samples were 
subjected to 2-step extraction with chloroform/methanol. The collected lipid extracts were then 
vacuum-evaporated and dissolved in chloroform/methanol.  
Shotgun lipidomics – Mass spectrometry was performed as described previously 
(131,147,148). Extracts were analyzed on a LTQ Orbitrap XL mass spectrometer (Thermo Fisher 
Scientific) equipped with the robotic nanoflow ion source TriVersa NanoMate (Advion 
Biosciences).  
Lipidomics data analysis - Lipidomics data analysis was performed as described 
previously using ALEX software (147,148). Species were annotated using sum composition: 
<lipid class><total # of C in the fatty acid moieties>:<total # of double bonds in the fatty acid 
moieties>. Sphingolipids were annotated as <lipid class><total # C in the long-chain base and 
fatty acid moiety>:<total # of double bonds in the long-chain base and fatty acid moiety>;<total # 
OH groups in the long-chain base and fatty acid moiety>. Visualization and calculation of mol% 
values were performed using the commercially available Tableau Software 
(www.tableausoftware.com). p-values were calculated using a Mann-Whitney U test. p-values 
were corrected for multiple hypotheses post-hoc using Benjamini and Hochberg False Discovery 
Rate. The following equations were utilized to calculate the presented mol% values, where n is 
molar abundance of lipid species i belonging to lipid class j: 









*Mol% of monounsaturated fatty acids per lipid class =   
∑�ni,j×# double bonds�
Σ�ni,j ×# acyl chains per lipid molecule�
 ×100 
 
* Calculated based on the fact that that S. pombe only synthesizes saturated (SFA) and mono-
unsaturated fatty acids (MUFA) (27). In the case where fatty acid saturation was determined, lipid 
species were hydrolyzed in silico prior to normalization (148). For example for triacylglycerol 
(TAG) 42:2, two of the fatty acid moieties must be monounsaturated and one must be saturated; 
this is taken into account when tabulating the number of saturated and unsaturated fatty acids 
across all TAG species. Supplementary Table 3.6 lists the full results of the lipidomics analysis. 
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3.5 Figures 
FIGURE 3.1. Screen for gene deletions sensitive to low oxygen and cobalt chloride. A, Venn 
diagram of deletion collection screen results showing overlap between deletions defective for 
growth under low oxygen and those defective for growth on CoCl2. B, Western blots imaged by 
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film probed with anti-Sre1 IgG of lysates from wild-type cells or the indicated deletion strains 
grown for 0 or 6 h in the absence of oxygen. P and N denote precursor and cleaved N-terminal 
transcription factor forms, respectively. Different blots are separated by solid black lines. This 
experiment was performed one time. C-E, Wild-type or the indicated deletion strains carrying 
empty vector or a plasmid expressing sre1N (C-D) or with sre1N integrated at the endogenous 
locus (E) were grown as indicated for 4 days. Cells were plated in 10-fold serial dilutions (16 - 
1.6x106 cells). Each experiment was performed with at least 2 biological replicates. F, Indicated 
strains were grown for 0 or 4 h in the absence of oxygen, and cell lysates were immunoblotted 
with monoclonal anti-Sre1 5B4 IgG1κ and imaged by Li-Cor. N denotes Sre1 N-terminal form. 
This experiment was performed with 3 biological replicates. 
 
FIGURE 3.2. Sre1N does not rescue mga2∆ growth defect. Indicated strains were grown in 
liquid culture in the presence or absence of oxygen for 12 h. Cell density was measured by 
absorbance at 600 nm. Data points are average of three biological replicates. Error bars are one 
standard deviation (** p<0.01 by two-tailed student’s t-test for 12 hour time point).  A, 
Absorbance at time 0 among the samples ranged from 0.13-0.18. To focus on the difference in 
growth rate among conditions, we normalized the data for each sample to a value of 0.15 at time-
point 0 before averaging.  B, Absorbance at time 0 among the samples ranged from 0.09-0.16. To 
focus on the difference in growth rate among the 6 conditions, we normalized the data for each 
sample to a value of 0.13 at time-point 0 before averaging.  
 
FIGURE 3.3. Mga2 controls low oxygen gene expression. A, Wild-type and mga2∆ cells were 
grown for 4 h in the presence or absence of oxygen. qPCR analysis was performed for the 
indicated genes. Error bars are standard deviation of five biological replicates. Two technical 
replicates were performed per sample. *p-value < 0.05, **p-value < 0.005 by two-tailed student’s 
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t-test. The two graphs represent two independently performed sets of experiments. B, Pie chart 
comparing gene populations from different data sets: anaerobically upregulated genes from Todd 
et al., 2006 (54) reside in the circle; BLUE, Sre1 targets from Todd et al., 2006 (54); YELLOW, 
Mga2 targets from this study (Supplementary Table 3.5); GREEN, targets of both Sre1 and 
Mga2; WHITE, targets of neither Sre1 or Mga2. Mga2 targets that are not anaerobically 
upregulated are represented in a wedge outside of the circle. 
 
FIGURE 3.4. Mga2 regulates lipid homeostasis. WT or mga2∆ cells were grown to exponential 
phase in liquid culture in the presence of oxygen. High resolution shotgun lipidomics was 
performed on six biological replicates (two technical replicates) to quantify the abundances of 
lipid species in the S. pombe lipidome. Full results are available in Supplementary Table 3.6. 
Error bars represent one standard deviation. p-values were calculated using a two-tailed Mann-
Whitney U test and corrected for multiple comparisons using Benjamini and Hochberg’s method 
to produce a false discovery rate, q. *q-value < 0.05.  
 
FIGURE 3.5. Unsaturated fatty acids rescue mga2∆ growth defect. A, Saturation of fatty acyl 
chains in wild-type and mga2∆ cells. Saturation of each chain was determined rather than the 
saturation of a lipid species as a whole (see Experimental Procedures). SFA is saturated fatty 
acids and MUFA is monounsaturated fatty acids. Error bars are one standard deviation. p-values 
were calculated using a two-tailed Mann-Whitney U test and corrected for multiple comparisons 
using Benjamini and Hochberg’s method to produce a false discovery rate, q. *q-value < 0.05, 
**q-value < 0.01. B-C, WT and mga2∆ cells were grown for 12 hours in the presence (red) or 
absence (blue) of oxygen, with the addition of BSA alone or oleic acid (18:1) conjugated to BSA. 
Cell density was measured by absorbance at 600nm. Data points are average of three biological 
replicates. Error bars are one standard deviation. B, BSA alone or oleic acid (18:1) was added at 
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time 0. Absorbance at time 0 among the samples ranged from 0.13-0.18. To focus on the 
difference in growth rate among the conditions, we normalized the data for each sample to a 
value of 0.15 at time-point 0 before averaging. The BSA only data are identical to those in Fig. 
2A. C, Oleic acid (18:1) was added 16 hours prior to time 0, then cells were diluted into fresh 
oleic acid medium at time 0. Absorbance at time 0 among the samples ranged from 0.09-0.14. To 
focus on the difference in growth rate among the conditions, we normalized the data for each 




Table 3.1. S. pombe strain list 
Strains Genotype Source Figure 
ED666 h+ leu1-32 ura4-D18 ade6-M210 Bioneer Inc. 1 
Deletion 
strains 
h+ leu1-32 ura4-D18 ade6-M210 
∆[GOI]-D1::kanMX4 
Bioneer Inc. 1 
KGY425 h- leu1-32 ura4-D18 ade6-M210 his3-
D1 
ATCC 1,2,3,4,5 
PEY522 h- leu1-32 ura4-D18 ade6-M210 his3-
D1 ∆sre1-D1::kanMX6 
(Hughes et al., 
2005) 
1 
PEY1762 h- leu1-32 ura4-D18 ade6-M210 his3-
D1 ∆mga2-D1::kanMX6 
This study 1,2,3,4,5 





PEY1763 h+ leu1-32 ura4-D18 ade6-M210 his3-
D1 ∆mga2-D1::kanMX6 
This study 1,2 
PEY1764 h+ leu1-32 ura4-D18 ade6-M210 his3-
D1 ∆mga2-D1::kanMX6 sre1N 
This study 1,2 
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Table 3.2. Gene deletions sensitive to both hypoxia and cobalt chloride 
Strains from the Bioneer haploid deletion collection version 1 found sensitive to both hypoxia and 
cobalt chloride were tested for rescue of the growth defect by exogenous expression of Sre1 N.  
a Descriptions were obtained from PomBase (www.pombase.org) with some additional hand 
editing 
b + indicates accumulation of the Sre1N transcription factor to wild type levels 












DNA repair     
SPAC13C5.07 mre11 nuclease + n.d. 
SPAC644.14c rad51 RecA family recombinase Rad51/Rhp51 + n.d. 
SPCC338.08 ctp1 CtIP-related endonuclease + n.d. 
     
Transcription     
SPAC17G8.05 med20 mediator complex subunit + n.d. 
SPBC31F10.09c nut2 mediator complex subunit Med10 + n.d. 
SPCC18.06c caf1 CCR4-Not complex CAF1 family 
ribonuclease subunit 
+ n.d. 
SPAC26H5.05 mga2 IPT/TIG ankyrin repeat containing 
transcription regulator of FA biosynthesis  
- - 
     
Protein modification    
SPBC947.10 dsc1 Golgi Dsc E3 ligase complex subunit - + 
SPAC1486.02c dsc2 Golgi Dsc E3 ligase complex subunit - + 
SPAC20H4.02 dsc3 Golgi Dsc E3 ligase complex subunit - + 
SPAC4D7.11 dsc4 Golgi Dsc E3 ligase complex subunit - + 
SPBC4F6.06 kin1 microtubule affinity-regulating kinase + n.d. 
SPCC1919.03c amk2 AMP-activated protein kinase beta 
subunit 
+ n.d. 
     
Protein transport     
SPBC409.20c psh3 ER chaperone (SHR3 homolog) + n.d. 
     
Retrograde transport, endosome to Golgi   
SPAC4C5.02c ryh1 GTPase + n.d. 
SPAPJ696.01c vps17 retromer complex subunit + n.d. 
SPAC4G9.13c vps26 retromer complex subunit + n.d. 
SPCC777.13 vps35 retromer complex subunit + n.d. 
     
Late endosome to vacuole transport    
SPAC1142.07c vps32 ESCRT III complex subunit + n.d. 
     
     
Other     
SPBC12D12.07c trx2 mitochondrial thioredoxin - - 
SPAC4G8.11c atp10 mitochondrial F1-F0 ATPase assembly 
protein  
+ n.d. 
SPCC306.06c big1 ER membrane protein, BIG1 family  + n.d. 
SPAC821.05 tif38 translation initiation factor eIF3h  + - 
SPAC17G6.04c cpp1 protein farnesyltransferase beta subunit - - 
SPBC27B12.10c tom7 mitochondrial TOM complex subunit  + n.d. 
SPCC11E10.04 ppr6 mitochondrial PPR repeat protein - - 
SPBC16A3.03c ppr7 mitochondrial PPR repeat protein + n.d. 
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Table 3.3. mga2∆ transcriptional targets hypoxic microarray 
a Descriptions and homologs were obtained from PomBase (www.pombase.org) with some 
additional hand editing. 
b Data are presented as the average changes in expression of genes in sre1∆ (”WT”) samples 
after 1.5 hours without O2 compared to the expression of genes in sre1∆mga2∆ (“mga2∆”) 
samples after 1.5 hours without O2. For clarity, only data greater than 2 standard deviations from 
the average fold change are presented in this table. Full results are detailed in Supplementary 
Tables S4-S5. 
c Statistically significant target assignment from low oxygen microarray in Todd et al, MCB 2006. 
























SPAC1B3.16c vht1 VHT1 biotin transporter 2.69 - 





SPCC1450.16c ptl1 TGL3 triacylglycerol lipase 2.57 - 
SPAC1786.01c ptl2 TGL4,TGL5 triacylglycerol lipase 2.32 - 
SPAC30D11.11 - IZH3 Haemolysin-III family 
protein (homolog to 
adipoQ receptor) 
2.31 - 
SPAC589.09 csr101 CSR1 sec14 cytosolic factor 
family, 
glycerophospholipid 
transfer protein  
1.69 + 





SPCC1281.06c ole1 OLE1 acyl-CoA desaturase, 
ole1 
1.74 - 
SPCC1235.02 bio2 BIO2 biotin synthase 1.68 - 




SPAC4A8.10 rog1 ROG1 acylglycerol lipase 1.62 - 
SPAC22A12.06c fsh2 FSH2 serine hydrolase-like 
protein 
1.61 + 
SPBC646.07c tsc13 TSC13 enoyl reductase 
(predicted) 
1.60 - 





     




SPBC359.04c pfl7 - cell surface glycoprotein, 
DIPSY family 
3.05 - 
SPAC3G6.05 - YOR292C Mpv17/PMP22 family 
protein 1 
2.27 - 
SPBC359.02 alr2 - alanine racemase 2.18 - 
 
Unknown 
     
SPAC17A2.02c - TDA4 DUF887 family protein 2.01 - 
SPAC5H10.07 - - sequence orphan 1.54 - 
SPCP20C8.03 - - pseudogene 1.51 - 
SPCC1281.08 wtf11 - wtf element Wtf11 1.50 - 
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Table 3.4. Doubling time of WT and mga2∆ cells after oleate addition 
Doubling times for growth curves shown in Figure 3.5B. Cells were grown 
in BSA-oleate or BSA alone for 12 hours +/- oxygen. Doubling times calculated using 0 
and 6 hour or 6 and 12 hour optical density readings as indicated, using the formula: 
doubling time= culture time × log(2)
log(final OD) - log(initial OD)
  




Strain Oxygen -Oleate +Oleate -Oleate +Oleate 
WT + 3.1±0.1 2.9±0.2 2.2±0.1 2.1±0.0 
WT - 3.2±0.2 3.1±0.3 2.9±0.0 2.5±0.1 
mga2Δ + 5.8±0.6 5.1±0.4 7.3±0.5 2.8±0.1 





Strain Oxygen dt (h) 
WT + 2.6±0.1 
WT - 2.7±0.2 
mga2Δ + 3.1±0.1 
mga2Δ - 3.1±0.3 
Table 3.5. Doubling time of WT and mga2∆ 
cells after oleate preincubation 
Doubling times for growth curves shown in 
Figure 3.5C. Cells were grown for 16 hours in 
BSA-oleate under normoxia, then in BSA-oleate 
for 12 hours +/- oxygen. Doubling times 
calculated using 0 and12 hour optical density 
readings as indicated, using the formula: 
doubling time = culture time × log(2)
log(final OD) - log(initial OD)
  
Doubling times are displayed as mean± SD for 
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Coordinate regulation of yeast Sterol Regulatory Element-Binding Protein 












This chapter is an edited version of the manuscript, “Coordinate regulation of yeast Sterol 
Regulatory Element-Binding Protein (SREBP) and Mga2 transcription factors” by R. Burr, E. V. 
Stewart, and P. J. Espenshade, published in the Journal of Biological Chemistry, Volume 292, 
Issue 13, 5311-5324. © 2017 American Society for Biochemistry and Molecular Biology, Inc. 
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4.1 Summary 
The Mga2 and Sre1 transcription factors regulate oxygen-responsive lipid homeostasis in 
the fission yeast Schizosaccharomyces pombe in a manner analogous to the mammalian Sterol 
Regulatory Element-Binding Protein transcription factors SREBP-1 and SREBP-2. Recently, we 
found that the transcription factor Mga2 regulates triacylglycerol (TAG) and glycerophospholipid 
(GPL) homeostasis in S. pombe (70). Deletion of mga2 resulted in broad lipidome disruption, a 
decrease in fatty acid desaturation, and an Sre1 cleavage defect. Therefore, Mga2 and SREBP-1 
regulate triacylglycerol and glycerophospholipid synthesis, while Sre1 and SREBP-2 regulate 
sterol synthesis. In mammals, a shared activation mechanism allows for coordinate regulation of 
SREBP-1 and SREBP-2. In contrast, distinct pathways activate fission yeast Mga2 and Sre1. 
Therefore, it is unclear whether and how these two related pathways are coordinated to maintain 
lipid balance in fission yeast. Previously, we showed that Sre1 cleavage is defective in the 
absence of mga2. Here, we report that this defect is due to deficient unsaturated fatty acid 
synthesis resulting in a general membrane transport defect of multiple Golgi proteins. This defect 
is recapitulated by treatment with the fatty acid synthase inhibitor, cerulenin, and is rescued by 
addition of exogenous unsaturated fatty acids. We conclude that the Sre1 cleavage defect is due to 
mislocalization of Sre1 pathway components when fatty acid homeostasis is disrupted. Thus, Sre1 
is uniquely positioned to detect changes in membrane fatty acid homeostasis, due to the 
requirement for ER-to-Golgi transport of multiple Sre1 pathway components as well as positive 
feedback in the system, which magnifies small changes in Sre1 cleavage. Furthermore, we 
demonstrate that Mga2 cleavage in S. pombe is induced by treatment with cerulenin and inhibited 
by treatment with proteasome inhibitor. Chemical inhibition of sterol synthesis blocked Mga2-
dependent target gene expression. Together, these data demonstrate that Sre1 and Mga2 are each 
regulated by the lipid product of the other transcription factor pathway, providing a source of 
coordination for these two branches of lipid synthesis.   
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4.2 Results 
mga2∆ cells have reduced Sre1N accumulation in the presence and absence of oxygen – 
We previously screened the fission yeast deletion collection to identify regulators of Sre1 and 
found that mga2 deletion blocked Sre1 cleavage induction by low oxygen (70). Here, we 
confirmed this requirement by creating our own mga2 deletion strain (70). We cultured wild-type 
(WT), mga2Δ, dsc2Δ, and sre1Δ cells for 0 or 4 h minus oxygen. We then probed a western blot 
of whole cell lysates with antibody against Sre1N, which detects both the Sre1 inactive 
membrane-bound precursor form (P) and the cleaved N-terminal transcription factor form (N). As 
expected, WT cells accumulated cleaved Sre1N after 4 h minus oxygen, and the precursor 
increased due to Sre1N activation of sre1 transcription through positive feedback regulation (Fig. 
4.1A, lanes 1-2) (62). In contrast, deletion of the Dsc E3 ligase subunit dsc2 resulted in a failure 
to cleave Sre1 (Fig. 4.1A, lanes 5-6). As reported, deletion of mga2 also resulted in a failure to 
accumulate Sre1N (Fig. 4.1A, lanes 3-4), leading to a 4-fold decrease in Sre1N accumulation 
compared to WT (Fig. 4.1B, lane 2 vs 4). To test if Sre1 activation requires mga2 only under low 
oxygen, we assayed Sre1 cleavage in the presence of oxygen with addition of the statin drug 
compactin (CPN) that inhibits HMG-CoA reductase and blocks ergosterol synthesis (149). CPN 
induces Sre1 cleavage regardless of oxygen availability (62). CPN treatment induced Sre1 
cleavage in WT cells, but not mga2Δ cells (Fig. 4.1C-D). Therefore, we conclude that the Sre1N 
accumulation defect in the absence of mga2 is independent of oxygen supply. This is consistent 
with results from our previous study showing that loss of mga2 disrupts TAG and GPL 
homeostasis under normoxic conditions (70).  
Defect in Sre1 cleavage in the absence of mga2 is amplified by positive feedback - 
Interestingly, the Sre1N accumulation defect in mga2Δ cells was not as strong as in the control 
dsc2Δ(Fig. 4.1B,D, lane 4 vs 6). Although low oxygen or CPN could not induce 
Sre1N accumulation in the absence of mga2, basal levels of Sre1N in mga2Δ cells were close to 
WT in the presence of oxygen (Fig. 4.1A-D, compare lanes 1 and 3). This indicated that in the 
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absence of mga2 there was a failure to fully induce Sre1N accumulation rather than a strict block. 
To further dissect this, we examined Sre1N accumulation in a strain expressing sre1 from a 
mutant promoter (sre1-MP) in which Sre1 is not able to activate its own transcription via positive 
feedback (64). Thus, accumulation of Sre1N in this strain reflects only the rate of Sre1 cleavage 
and Sre1N degradation. While mga2Δ cells showed a 4- to 8-fold decrease in Sre1N accumulation 
compared to WT cells (Fig. 4.1A, lane 2 vs 4, Fig. 4.2A-B, lane 2 vs 4), mga2Δ sre1-MP cells 
exhibited only a 1.5-fold decrease in accumulation compared to sre1-MP cells (Fig. 4.2A-B, lane 
6 vs 8). These data indicate that positive feedback to the sre1 promoter accounts for the majority 
of the observed difference in Sre1N accumulation, and that mga2Δ cells likely fail to accumulate 
Sre1N to a threshold level that induces maximal sre1 transcription and positive feedback. Our 
previous work established that in the absence of mga2 Sre1 is successfully transcribed, translated, 
and induces its own transcription when expressed without the membrane-anchoring domain (70). 
Together, these data show that the defect occurs in a step after Sre1 translation and prior to 
membrane release of the Sre1N transcription factor, referred to hereafter as the cleavage step. 
Cleavage defect in mga2∆ cells occurs at a step downstream of Sre1-Scp1 complex formation and 
is not specific to Sre1 – We next wanted to further narrow down which step of Sre1 cleavage was 
defective in mga2∆ cells. A major point of regulation for the Sre1 pathway is the formation and 
ER-to-Golgi transport of the Sre1-Scp1 complex (65). Scp1 senses and responds to changes in 
sterol synthesis, transporting Sre1 to the Golgi for activation when sterols decrease (68). We 
showed previously that loss of Scp1 results in degradation of the Sre1 precursor via the Hrd1 E3 
ligase (64). In mga2∆ cells, we observed wild-type levels of Sre1 precursor (Fig. 4.1,4.2) and 
Scp1 (Fig. 4.3A, lane 2). Therefore, low scp1 expression does not account for the observed Sre1 
cleavage defect in mga2∆ cells. To test if complex formation between Scp1 and Sre1 was 
disrupted in mga2∆ cells, we assayed Sre1-Scp1 binding. Immunopurification of Scp1-13xMyc 
recovered Sre1 precursor from scp1-13xmyc cells in both the presence and absence of mga2 (Fig. 
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4.3B, lanes 4-5). Together, these data indicate that the Sre1-Scp1 complex forms normally in 
mga2∆ cells.  
Previous work in our lab established that Sre1-Scp1 transport to the Golgi for cleavage is 
regulated both by the rate of ER-to-Golgi transport as well as by the amount of Sre1-Scp1 
complex available in the ER (65). That model predicts that increasing Sre1-Scp1 complex 
concentration will increase Sre1 cleavage as long as no step of the pathway is completely blocked. 
Consistent with this, overexpressing scp1 in WT cells increased Sre1 cleavage under low oxygen 
(Fig. 4.3C, lanes 1-4) (150). Overexpression of scp1 in mga2∆ cells increased Sre1N to a similar 
proportion, although overall Sre1N accumulation was not rescued to WT levels (Fig. 4.3C, lanes 
5-8). As expected, expression of scp1 in scp1∆ cells supported wild-type levels of Sre1 cleavage 
(Fig. 4.3C, lanes 9-12). Thus, overexpression of scp1 partially rescues the Sre1 cleavage defect in 
the absence of mga2, further demonstrating that there is not a complete block in Sre1 cleavage in 
mga2∆ cells and that Sre1-Scp1 complex formation is normal. However, overexpression of scp1 
in mga2∆ cells does not rescue cleavage as well as overexpression of scp1 in scp1∆ cells, 
suggesting that the overexpressed Scp1 is affected by the same inhibition that blocks endogenous 
Sre1 cleavage in mga2∆ cells. This suggests that the defect in Sre1 activation in mga2∆ cells 
occurs at a step after Sre1-Scp1 complex formation. 
Given our observed block in Sre1N accumulation under normoxic conditions and the 
normal expression and function of Scp1 in the absence of mga2, we tested cleavage of the Sre1 
homolog Sre2 under normoxic conditions, where Sre2 is constitutively activated independently of 
Scp1 or sterol levels (62). We cultured WT, mga2Δ, dsc2Δ, and sre2Δ cells under normoxia and 
probed a western blot with antibody against the Sre2 N-terminus (Sre2N). As observed for Sre1, 
deletion of the Dsc E3 ligase subunit dsc2 resulted in a failure to cleave Sre2 and accumulation of 
Sre2 precursor (Fig. 4.3D, lane 3). Deletion of mga2 resulted in an intermediate Sre2 cleavage 
defect (Fig. 4.3D lane 2) resulting in a 2-fold decrease in Sre2N (Fig. 4.3E lane 1 vs 2). 
89
Therefore we conclude that Sre2 cleavage is also defective in the absence of mga2, and that the 
defect in these cells is not specific to the Sre1-Scp1 complex activity. 
Dsc E3 ligase is functional in mga2∆ cells – In addition to Sre1-Scp1 complex formation, 
Sre1 and Sre2 cleavage both require Dsc E3 ligase activity (68,69). To examine Dsc E3 ligase 
function in the absence of mga2, we first assayed Dsc E3 ligase complex assembly by 
immunopurifying Dsc2 in WT, dsc2Δ, or mga2∆ cells in the presence and absence of oxygen (Fig. 
4.4A). We efficiently purified the Dsc E3 ligase complex from WT, but not dsc2∆ cells, and 
found no difference in complex formation between WT and mga2Δ cells in both oxygen 
conditions (Fig. 4.4A, lanes 9-14). This result indicates that Dsc E3 ligase complex assembly is 
not disrupted in mga2∆ cells. 
 To confirm that the Dsc E3 ligase is not only assembled but also functional, we forced 
co-localization of the Dsc E3 ligase and Sre1 in the presence and absence of oxygen using 
Brefeldin A (BFA). In BFA-treated cells, the ER and Golgi compartments mix, the Dsc E3 ligase 
and Sre1 co-localize, and the Sre1 precursor is degraded in a Dsc-dependent manner (68). To 
assess function of the Dsc E3 ligase, we assayed Sre1 precursor degradation in mga2∆ cells after 
BFA treatment. As expected, Sre1 precursor decreased upon BFA treatment in WT cells in both 
the presence and absence of oxygen (Fig. 4.4B, lanes 1-2, 7-8). Degradation of Sre1 precursor 
upon BFA treatment was blocked in dsc1∆ cells (Fig. 4.4B, lanes 5-6, 11-12), indicating that this 
Sre1 precursor degradation requires Dsc E3 ligase activity (68). Interestingly, the Sre1 precursor 
level increased upon addition of BFA in dsc1∆ cells (Fig. 4.4B, lanes 5-6 and 11-12), suggesting 
that BFA treatment prevented degradation of Sre1 by multiple mechanisms in dsc1∆ cells. 
Notably, Sre1 precursor was degraded normally in mga2∆ cells, demonstrating that the Dsc E3 
ligase is functional in mga2∆ cells (Fig. 4.4B, lanes 3-4, 9-10). Therefore, the Sre1 cleavage 
defect in the absence of mga2 is not due to a defect in Dsc E3 ligase activity, suggesting that the 
defect occurs before Sre1 cleavage at the Golgi, such as during ER-to-Golgi transport of pathway 
components.  
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 We next tested whether the Dsc E3 ligase complex localizes properly to the Golgi (68). 
We can monitor Dsc E3 ligase localization by assaying maturation of Dsc1 N-linked 
glycosylation, which requires transport to the Golgi (73). As previously described, in WT cells 
transport of the Dsc E3 ligase to the Golgi led to the accumulation of Dsc1 primarily as a slower-
migrating, mature glycosylated form by SDS-PAGE (Fig. 4.4C-D, lane 1). In contrast, failure to 
properly assemble the Dsc E3 ligase complex in dsc2∆ cells resulted in detection of only the 
faster-migrating, incompletely glycosylated form due to ER retention of Dsc1 (Fig. 4.4C-D, lane 
3) (73). In mga2∆ cells, Dsc1 existed in both forms, representing accumulation of some 
incompletely glycosylated protein (Fig. 4.4C-D, lane 2). This suggested that the majority of Dsc1 
was appropriately glycosylated. However, there was a small decrease in the percentage of Dsc1 
that was fully glycosylated compared to WT, suggesting a defect in Dsc E3 ligase transport to the 
Golgi. These results demonstrate that the Dsc E3 ligase is assembled and functional in the 
absence of mga2, but that there may be a membrane trafficking defect in mga2∆ cells.  
 Membrane transport is disrupted in the absence of mga2 - We wondered if the small 
change in Golgi localization of the Dsc E3 ligase was due to a general defect in membrane 
transport caused by the altered lipid composition in mga2∆ cells. Lipid homeostasis, especially 
proper fatty acid saturation, is essential for proper membrane structure and fluidity (151). Defects 
in lipid homeostasis have wide ranging effects, including altering membrane-bound enzyme 
function and activating signal transduction pathways (70,152,153). To determine if general 
membrane transport is deficient in the absence of mga2, we visualized localization of the Golgi 
marker Anp1-GFP and the ER marker Ost1-mCherry. Previous work in our lab showed that Anp1 
localized to the ER when ER exit is blocked using a sar1ts mutant that is defective in COPII 
vesicle formation (68,154). Anp1-GFP localized to punctate Golgi structures in 98% of WT cells 
(Fig. 4.5A-B). However, 34% of mga2Δ cells exhibited altered Anp1-GFP localization 
phenotypes, defined as no discernable GFP signal or complete or partial co-localization with 
Ost1-mCherry in the ER (perinuclear and around the cell periphery) (Fig. 4.5A-B). Anp1-GFP 
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also localized to the vacuole in mga2Δ cells (Fig. 4.5A). In addition, we observed a 2-fold 
increase in the ER signal for Ost1-mCherry in mga2Δ cells (Fig. 4.5A,C).  
To determine whether changes in Anp1-GFP and Ost1-mCherry signal were due to changes in 
protein expression, we probed a western blot of whole cell lysate from these strains with 
antibodies against GFP, mCherry, and the loading control Dsc2 (Fig. 4.5D). In the absence of 
mga2 we observed a slight decrease in full-length Anp1-GFP signal and an increase in free GFP 
(Fig. 4.5D-E). This suggests that the vacuolar GFP staining observed by microscopy is free GFP 
from partially degraded Anp1-GFP. We detected no change in Ost1-mCherry expression (Fig. 
4.5D,F). This indicates that the observed increase in Ost1-mCherry signal in the ER is due to 
changes in localization rather than changes in expression. These data demonstrate that 
localization of the Golgi protein Anp1 and the ER protein Ost1 is altered in the absence of mga2. 
These two proteins are not components of the Sre1 pathway, suggesting that membrane transport 
is broadly defective in mga2∆ cells. 
Exogenous oleate addition rescues Sre1 cleavage and general membrane transport in 
mga2Δ cells - To examine whether the observed Sre1 cleavage and general membrane transport 
defects in mga2Δ cells result from defects in fatty acid homeostasis, we tested whether saturated 
(SFA) or unsaturated fatty acids (UFA) could rescue Sre1 cleavage in mga2Δ cells under low 
oxygen and CPN treatment. We assayed Sre1 cleavage with the addition of BSA-conjugated 
stearate (18:0), oleate (18:1), or BSA control. WT cells showed robust cleavage under low 
oxygen that was unaffected by addition of 18:0, 18:1, or both (Fig. 4.6A, lanes 1-5). Addition of 
18:1 alone, but not 18:0, rescued Sre1 cleavage under low oxygen in mga2Δ cells (Fig. 4.6A, 
lanes 7-9). Supplementing 18:1 with 18:0 had no additional effect on Sre1 cleavage (Fig. 4.6A, 
lane 10). Similarly, pre-incubation of mga2∆ cells with 18:1, but not 18:0, rescued CPN-induced 
Sre1 cleavage (Fig. 4.6B, lane 8). Therefore addition of exogenous oleate is sufficient to rescue 
the Sre1 cleavage defect in mga2∆ cells. 
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To test whether alterations in fatty acid composition also cause the observed defects in 
general membrane transport, we examined Anp1-GFP and Ost1-mCherry localization under 
parallel conditions. Incubation of mga2∆ cells with 18:1 or both 18:0 and 18:1 (referred to as 
18:X), but not 18:0 alone, significantly restored Golgi localization of Anp1-GFP, reducing the 
percentage of mutant cells to 14% and 12%, respectively (Fig. 4.6C-D). Similarly, all of the fatty 
acid treatments significantly reduced Ost1-mCherry intensity in the ER, but not to wild-type 
levels (Fig. 4.6C,E). These data suggest that defects in fatty acid homeostasis in mga2∆ cells are 
responsible for the observed Sre1 cleavage and membrane transport defects. 
Chemical inhibition of fatty acid homeostasis recapitulates mga2Δ phenotype – After 
observing rescue of membrane transport and Sre1 cleavage defects by 18:1 in mga2Δ cells (Fig. 
4.6A-B), we wanted to independently test whether fatty acid homeostasis regulates Sre1 cleavage 
and membrane transport in WT cells. We were unable to genetically modulate expression of the 
fatty acid desaturase ole1 by either knock down or overexpression (data not shown), and no Ole1 
inhibitor is available. Instead, we treated WT cells with cerulenin (CER), an irreversible fatty acid 
synthase inhibitor that affects both SFA and UFA homeostasis (21-23). To determine the effects 
of CER on S. pombe, we grew WT cells with CER or DMSO control for 6 h and measured 
growth (Fig. 4.7A). CER inhibited cell division after 3 h of treatment. We then tested the effects 
of CER on Sre1 cleavage. After 2 h of treatment with CER followed by 4 h of low oxygen 
treatment without CER, Sre1 cleavage was fully blocked in WT cells (Fig. 4.7B). Addition of 
exogenous 16:1 or 18:1 during the 4 h low oxygen treatment rescued this defect, but exogenous 
16:0 or 18:0 did not support full cleavage (Fig. 4.7C compare lanes 11,14 to lanes 10,13). 
Addition of 18:0 and 18:1 together showed similar cleavage rescue to 18:1 alone (Fig. 4.7C, lanes 
12,15). Therefore, CER treatment recapitulates the Sre1 cleavage defect and exogenous 18:1 
rescues Sre1 cleavage as observed in mga2∆ cells. 
We next examined Golgi localization of Anp1-GFP after 3 h of CER treatment. Anp1-
GFP localized to punctate Golgi structures in 99% of control WT cells (Fig. 4.7D-E, -CER 
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treatment). However in CER-treated cells, 75% of cells showed altered Anp1-GFP localization 
(Fig. 4.7D-E, BSA treatment). Addition of exogenous 18:0 had no effect on Anp1-GFP 
localization, while addition of 18:1 or both 18:0 and 18:1 partially rescued Anp1 localization to 
the Golgi (Fig. 4.7D-E). Treatment of cells with cerulenin increased Ost1-mCherry signal 2-fold, 
and only addition of both 18:0 and 18:1 significantly reduced Ost1-mCherry signal in the ER (Fig. 
4.7D,F). These data demonstrate that fatty acid homeostasis regulates both membrane transport 
and Sre1 cleavage in WT cells.  
Inhibition of sterol synthesis blocks Mga2 transcription factor activity – Having 
established that products of the Mga2 transcription factor pathway regulate Sre1 activity, we 
wanted to test whether products of the Sre1 pathway, namely sterols, regulate Mga2 cleavage and 
activity. To develop an Mga2 cleavage assay in fission yeast, we N-terminally tagged mga2 at the 
his3 locus with 2xFLAG to create a construct that allows detection of the full-length, precursor 
form and the cleaved, active N-terminal transcription factor form. To characterize the function of 
this fusion protein, we treated WT and 2xFLAG-mga2 cells with the proteasome inhibitor 
bortezomib (BZ) or cerulenin (CER) and examined Mga2 processing by western blot. Treatment 
of cells with BZ resulted in a strong accumulation of the precursor form and a slower migrating 
form of the Mga2 N-terminus that may represent an ubiquitylated species seen in S. cerevisiae 
(108). Conversely, treatment with CER induced Mga2 N-terminus accumulation and decreased 
the precursor form (Fig. 4.8A). These results were consistent with data in S. cerevisiae showing 
that the proteasome is required for Mga2 cleavage and that Mga2 activation is regulated by 
unsaturated fatty acids (108,155).  
To test whether sterols have an effect on Mga2 cleavage and activity, we treated 
2xFLAG-mga2 cells with the statin CPN or the lanosterol 14α-demethylase inhibitor itraconazole 
(ITR) alongside CER and BZ treatment controls, and we assayed Mga2 processing and target 
gene expression. CPN and ITR treatment caused accumulation of both the Mga2 precursor and N-
terminal transcription factor, but the ratio of the two forms remained the same (Fig. 4.8B, lanes 3-
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5). While the overall amount of Mga2 protein appears to change among these different treatments, 
there was no change in mga2 expression (Fig. 4.8B-C), indicating that the increase in Mga2 
protein results from a post-transcriptional mechanism. Importantly, treatment with of 2xFLAG-
mga2 cells with CPN induced Sre1 cleavage to the same level as WT cells (Fig. 4.8B, lane 2 vs 4), 
confirming that this tagged protein is functional. Consistent with the observed changes in Mga2 
N-terminus accumulation, CER treatment induced expression of the Mga2 target genes ole1 and 
vht1, while treatment with BZ reduced expression to levels seen in mga2Δ cells (Fig. 4.8D,E) 
(70). Interestingly, despite the increase in Mga2 N-terminus accumulation in CPN and ITR 
treated cells, ole1 expression was reduced to the basal level seen with BZ treatment (Fig. 4.8D). 
Likewise, inhibition of sterol synthesis reduced vht1 expression (Fig. 4.8E). These data 
demonstrate that the 2xFLAG-mga2 fusion protein is functional, and that Mga2 activation is 
regulated by fatty acids and requires the proteasome in S. pombe. Furthermore, Mga2 
transcriptional activity requires sterol synthesis.   
4.3 Discussion 
Taken as a whole, the data in this study show that unsaturated fatty acids regulate Sre1 
transcription factor activation in S. pombe. Disrupting fatty acid homeostasis, either through 
deletion of the mga2 transcription factor, which regulates fatty acid desaturation and TAG and 
GPL synthesis, or through treatment with the fatty acid synthase inhibitor CER, blocked 
induction of Sre1 cleavage by sterols or low oxygen (Fig. 4.1, Fig. 4.7B) (70). Importantly, the 
Sre1 cleavage defects in both mga2Δ and CER treated cells were rescued by addition of 
exogenous 18:1, indicating that UFA regulate Sre1 cleavage and that a defect in fatty acid 
homeostasis is responsible for the Sre1 cleavage defect (Fig. 4.6A-B, Fig. 4.7C). Interestingly, 
the Sre1 cleavage defect that results from CER treatment of WT cells was more fully rescued by 
UFA than that observed in the absence of mga2 (Fig. 4.6A-B vs Fig. 4.7C). This is likely due to 
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the fact that CER specifically inhibits fatty acid synthesis, while mga2 regulates a number of 
other lipid homeostasis pathways (70).  
Multiple lines of evidence indicate that SREBP cleavage is disrupted due to a kinetic 
defect in the membrane transport component of the SREBP activation pathway when fatty acid 
homeostasis is disrupted. First, the observed Sre1 cleavage defect is largely a failure to induce 
cleavage under low oxygen conditions and is magnified by positive feedback within the system 
(Fig. 4.1, 4.2), suggesting that the disruption in the absence of mga2 is incomplete and therefore 
more likely a kinetic defect than a complete block in cleavage. Second, overexpression of the 
Sre1 binding and trafficking partner scp1 increased Sre1 cleavage in mga2Δ cells to a similar 
extent as WT cells, suggesting the Sre1 cleavage defect in these cells can be bypassed and occurs 
at a step after Sre1-Scp1 complex formation (Fig. 4.3C). Third, the Sre1 homolog Sre2 also 
exhibited a cleavage defect in the absence of mga2, indicating a shared deficiency between these 
two pathways, which do not share Scp1 (Fig. 4.3D-E). Fourth, the Dsc E3 ligase was functional 
in mga2Δ cells, supporting the existence of a defect prior to cleavage at the Golgi and narrowing 
the defective step to transport of pathway components (Fig. 4.4). Finally, mga2 deletion or 
treatment of WT cells with the fatty acid synthesis inhibitor CER altered the localization of the 
Golgi-resident protein Anp1 and the ER-resident protein Ost1 (Fig. 4.5, Fig. 4.7D) indicating a 
general membrane transport defect when fatty acid homeostasis is disrupted. Both the Sre1 
cleavage defects and the Anp1/Ost1 localization defects were rescued by addition of unsaturated 
fatty acid (Fig. 4.6, Fig. 4.7). It is probable that the other components of the SREBP activation 
pathway are affected by these same membrane transport defects. Interestingly, the rescue of the 
Sre1 cleavage defect with exogenous 18:1 was more robust than the rescue of Anp1 and Ost1 
localization (Fig. 4.6, 4.7). These observations suggest that both the defects and rescue observed 
for membrane transport in these systems are small, but that they have a large effect on Sre1 N-
terminal accumulation. This is consistent with our observation that positive feedback in the 
system amplifies the small defect in membrane transport, and that in the absence of this positive 
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feedback Sre1 cleavage only decreases 1.5-fold (Fig. 4.2). Alternatively, if multiple Sre1 pathway 
components are negatively affected by the membrane transport defect, then small improvements 
in transport of all of those pathway components could combine to produce a larger improvement 
in Sre1 cleavage. We favor a model that incorporates both of these possibilities. Together, these 
data suggest that the observed Sre1 cleavage defects are due to membrane transport defects.  
While this study did not identify the precise step in membrane transport affected by fatty 
acid supply, membrane dynamics are highly sensitive to the lipid composition of the cell and 
alterations in lipid composition have wide-ranging effects, including on protein trafficking. 
Generally, increased saturated phospholipids, sterols, and sphingolipids result in more tightly 
packed, less fluid membranes, while phospholipid desaturation results in less densely packed, 
more fluid membranes (151). One possible source of the observed membrane transport defect that 
affects Sre1 and Sre2 cleavage is during COPII vesicle budding from the ER. Liposomes 
composed of diunsaturated glycerophospholipids form more COPII vesicles in vitro than 
liposomes composed of monounsaturated glycerophospholipids (156). This suggests that 
increasing saturated phospholipids reduces vesicle budding. Consistent with our study, treatment 
of S. cerevisiae with cerulenin blocked secretory protein transport from the transitional-ER to the 
Golgi (157). Membrane curvature and saturation are also important for vesicle targeting to the 
appropriate cellular compartment. Diunsaturated phospholipids with bulky headgroups favor 
membrane curvature, while sterols disfavor curvature (13). In mammalian cells, small artificial 
liposomes containing diunsaturated phospholipids bound to the Golgi more strongly than 
liposomes containing monounsaturated or saturated phospholipids, and binding also decreased 
with increasing liposome size (158). Because the Dsc E3 ligase showed some accumulation in the 
ER, mga2Δ cells are most likely defective in ER exit, although we cannot rule out additional 
effects on vesicle targeting and fusion to the Golgi.    
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In our previous report, we highlighted similarities between Mga2 and Sre1 regulation of 
lipid homeostasis in fission yeast and SREBP-1 and SREBP-2 regulation of lipid homeostasis in 
mammalian cells. Both Mga2 and SREBP-1 regulate TAG and GPL biosynthesis, most notably 
through the regulation of stearoyl-CoA desaturases (ole1 in S. pombe and SCD1 in mammals) 
(70,159). Likewise both Sre1 and SREBP-2 regulate sterol biosynthesis (62,160). Although 
regulation of mammalian SREBPs by sterols is well understood, how fatty acids regulate 
SREBPs is less clear (161-164). On the one hand, reports suggest that exogenous polyunsaturated 
fatty acids negatively regulate SREBP-1 cleavage (141,165-167). Another study showed that 
exogenous 18:1 does not impact SREBP cleavage under normal culture conditions, but rather 
potentiates inhibition of cleavage by exogenous sterols (168). On the other hand, others report a 
failure to induce SREBP-1 in the absence of SCD1, indicating that fatty acid desaturation is 
required for SREBP-1 activation (159). It will be important to continue this line of inquiry in the 
mammalian system to better understand the regulation of SREBPs by fatty acids and 
glycerophospholipids. 
Membrane fluidity affects multiple cellular functions ranging from secretion to apoptosis 
(169). Programmed co-regulation and coordination of sterol synthesis and TAG/GPL synthesis is 
necessary for maintenance of membrane fluidity. Despite parallels between the mammalian and 
yeast pathways, a crucial difference exists in how these cells coordinate sterol and TAG/GPL 
synthesis. In mammalian cells, SREBP-1 and SREBP-2 are activated by the same proteases and 
have a shared requirement for ER-to-Golgi transport by the Scp1 homolog SCAP, providing an 
opportunity for strict balance of these related metabolic pathways (160). In contrast, although 
both Mga2 and Sre1 are synthesized as membrane-anchored proteins, their mechanisms of 
activation are distinct, raising the question of how their activities are coordinated. 
Given the results presented here, we propose that regulation of Sre1 cleavage by 
unsaturated fatty acids (the products of Mga2 activity) and regulation of Mga2 cleavage by sterols 
(the products of Sre1 activity) is one mechanism for coordinating these two interdependent 
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pathways in fission yeast (Fig. 4.9). Coordination of the oxygen-responsive pathways at the 
transcription factor level would efficiently maintain cellular metabolic homeostasis, especially 
given the requirement for acetyl-CoA in lipid biosynthesis. Additionally, coordination of sterol 
levels with biosynthesis of their strongest membrane interactor, sphingolipids, is crucial to 
maintain membrane homeostasis (170). Interestingly, Covino et al. showed that sterols increased 
membrane order and stabilized S. cerevisiae Mga2 in an active conformation in vitro (110). In S. 
pombe, we observed an accumulation of Mga2 protein when sterol synthesis was inhibited with 
CPN or ITR (Fig. 4.8B). However, rather than induce expression of Mga2 target genes, CPN and 
ITR inhibited ole1 and vht1 expression to levels seen in mga2∆ cells (Fig. 4.8D-E) (70). Thus, 
Mga2 activity requires sterol synthesis. Understanding how sterols regulate Mga2 activity and 
protein levels will be the focus of future studies.  
Collectively, these results outline a model in which both Mga2 and Sre1 are feedback 
inhibited by their respective products, but are also regulated by products of the other pathway 
(Fig. 4.9). In this way, both arms of lipid synthesis communicate and the pathways can act in 
balance. While our results suggest that crosstalk exists, further studies are needed to demonstrate 
the role for this regulatory network in physiological control of lipid homeostasis. 
4.4 Experimental procedures 
Materials – General chemicals and materials were obtained from Sigma or Fisher. Other 
sources include: yeast extract, peptone, and agar from BD Biosciences; digitonin from EMD 
Chemicals; Brefeldin A, Compactin, Itraconazole, Cerulenin, Igepal CA-630 (NP-40), amino acid 
supplements, and 1X protease inhibitors (PI) (10 μg/ml leupeptin, 5 μg/ml pepstatin A, 0.5 μM 
PMSF) from Sigma; bortezomib from LC Laboratories; alkaline phosphatase (Cat #713023) and 
complete EDTA-free PI from Roche Applied Sciences; M-MuLV Reverse Transcriptase from 
New England Biolabs; RNA STAT-60 from Tel-Test; GoTaq qPCR Master Mix from Promega; 
oligonucleotides from Integrated DNA Technologies; horseradish peroxidase-conjugated, 
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affinity-purified donkey anti-rabbit and anti-mouse IgG from Jackson ImmunoResearch; IRDye 
donkey anti-rabbit and donkey anti-mouse from Li-Cor; Myc monoclonal 9E10 IgG and β-actin 
monoclonal C4 IgG from Santa Cruz Biotechnology, Inc; anti-Myc polyclonal IgG (#06-549) 
from Upstate Biotechnology; anti-FLAG M2 monoclonal IgG from Sigma (F1804); anti-GFP 
monoclonal IgG from Roche (1814460); anti-mCherry polyclonal IgG from Invitrogen (PA5-
34974); prestained protein standards from Bio-Rad; protein G magnetic beads from NEB; protein 
A Sepharose from GE; fatty acid free bovine serum albumin (BSA) from SeraCare Life Sciences.  
Antibodies - Rabbit polyclonal antibody anti-Sre1 IgG (aa 1-260) was generated using a 
standard protocol as described previously (62). Briefly, antigen was expressed in E. coli and 
affinity purified by an N-terminal polyhistidine tag. Sre1-specific antibodies were isolated from 
rabbit serum by affinity to the polyhistidine-tagged Sre1 antigen. Specificity of this antibody was 
assayed by loss of immunoreactivity in an sre1Δ strain. We generated rabbit polyclonal antibody 
anti-Sre2 IgG (aa 1-426) using a standard protocol as described above for anti-Sre1 (62).  
We generated monoclonal antibody 5B4 IgG1κ to Sre1 (aa 1–260) as described 
previously using recombinant protein that was purified from E. coli by nickel-affinity 
chromatography (Qiagen) and injected into BALB/c mice (70). Antibody specificity was tested 
by immunoblotting against S. pombe extracts from cells overexpressing sre1.  
Generation of polyclonal antibodies to Dsc E3 ligase complex members 1-5 (Dsc1-Dsc5) 
was described previously (68,69). Hexa-histidine tagged recombinant protein antigens, Dsc1 (aa 
20-319), Dsc2 (aa 250-372), Dsc3 (aa 1-190), Dsc4 (aa 150-281), and Dsc5 (aa 251-427) were 
purified from E. coli using Ni-NTA (Qiagen). Dsc1-5 antisera were generated by Covance using a 
standard protocol. Horseradish peroxidase (HRP) conjugation of Dsc2-Dsc5 antisera was 
prepared using the Thermo Scientific (Pierce) EZ-link Plus Activated Peroxidase kit, according to 
the manufacturer’s protocol. HRP conjugation of Dsc1 antiserum was performed using the One-
Hour Western Detection System (GenScript).  
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Monoclonal antibodies to 6xHis-Scp1 (aa 446–544) were made using recombinant 
protein that was purified from E. coli by nickel-affinity chromatography (Qiagen) as previously 
described (150). Antibody specificity of the final clones was tested by immunoblotting against S. 
pombe extracts from cells overexpressing scp1. 8G4C11 (IgG1k), 1G1D6 (IgG2ak), and 7B4A3 
(IgG1k) were mixed for western blotting. 
Antiserum to Cdc48 was the kind gift of R. Hartmann-Petersen (University of 
Copenhagen) (122). 
Yeast culture – Yeast strains are described in Table 4.1. S. pombe were cultured to 
exponential phase at 30°C in rich YES medium [0.5% (w/v) yeast extract plus 3% (w/v) glucose 
supplemented with 225 μg/ml each of uracil, adenine, leucine, histidine, and lysine (171)] unless 
otherwise indicated. For fatty acid supplementation, fatty acids were added to 1 mM in YES 
medium from a 12.7 mM stock in 12% (w/v) fatty acid free BSA. Fatty acids were conjugated to 
fatty acid free BSA as described previously (70). Brefeldin A was added from a stock 
concentration of 5 mg/mL EtOH to a final concentration of 100 µg/mL in 2% EtOH. Compactin 
was added to a final concentration of 200 µM from a 10 mM stock in 6% EtOH, 20 mM NaCl. 
Cerulenin was added to a final concentration 112 nM in media from a 1000x stock in DMSO. 
Sre1 cleavage assay - Cells were grown in YES medium to exponential phase inside an 
InVivo2 400 hypoxic workstation [Biotrace, Inc] and harvested for protein extraction and 
immunoblotting. Cell pellets were resuspended in 17 µl 1.85 M NaOH/7.4% (v/v) BME and 
vortexed. Samples were incubated on ice for 10 min. TCA was added to a final concentration of 
30% (w/v) and the samples were vortexed and incubated on ice for 10 min. Lysate was 
centrifuged at 20,000 x g for 10 min at 4°C and pellet was washed with cold acetone. Samples 
were centrifuged at 20,000 x g for 5 min at 4°C and dried completely under vacuum. Pellets were 
resuspended in 150 µl SDS lysis buffer [1% SDS, 150 mM NaCl, 50 mM Tris-HCl pH 8.0, 1x 
protease inhibitors] and sonicated 10 s. Protein was quantified using the BCA protein assay 
(Pierce). For alkaline phosphatase treatment, lysate was diluted at least 1:2 in 50 mM Tris-HCl 
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pH 8.0, then alkaline phosphatase was added to 20% (v/v). Samples were incubated at 37°C for 1 
h. SDS-polyacrylamide gels were loaded evenly for total protein, and consistent loading was 
confirmed following electroblotting by staining the membrane with Ponceau S. Blots were 
imaged using enhanced chemiluminescence and film or the Odyssey CLx infrared imaging 
system [Li-Cor] as noted in the figure legends. 
Dsc2 immunoprecipitation - Exponentially growing cells (5 x 108) were subjected to co-
immunoprecipitation as described previously (172). Briefly, cell pellets were resuspended in 200 
µl digitonin lysis buffer [50 mM HEPES pH 6.8, 50 mM KOAc, 2 mM MgOAc, 1 mM CaCl2, 
200 mM sorbitol, 1 mM NaF, 0.3 mM Na3VO4, 1% (w/v) digitonin, 2x PI, 1x Complete EDTA-
free PI]. Cells were lysed by bead beating for 10 min at 4°C, then beads were washed with 800 µl 
digitonin lysis buffer to collect all lysate. Lysate was incubated with rotation for 40 min at 4°C 
then centrifuged for 10 min at 100,000 x g to pellet insoluble material. 1.3 mg of supernatant 
protein was incubated with 10 µl anti-Dsc2 antiserum for 15 min then incubated with 80 µl 
Protein A Sepharose beads overnight at 4°C. Beads were washed 3x with digitonin lysis buffer 
and the bound fraction was eluted into SDS lysis buffer + 1x PI and 1x loading dye [30 mM Tris-
HCl, 3% SDS, 5% glycerol, 0.004% BPB, 2.5% 2-mercaptoethanol] at 95°C for 5 min. 
Dsc1 glycosylation assay - Exponentially growing cells (2.5 x 108) were collected and 
resuspended in 300 µl B88 buffer [20 mM HEPES pH 7.2, 150 mM KOAc, 5 mM Mg(OAc)2, 
250 mM sorbitol] + 1X protease inhibitors, 1x Complete EDTA-free PI. Cells were lysed using 
glass beads for 12 min then centrifuged for 5 min at 500 x g to clear cell debris. The supernatant 
was centrifuged at 20,000 x g for 20 min, and the pelleted membranes were resuspended in 100 µl 
B88 buffer with 1% NP-40 (v/v). The membranes were solubilized at 4oC for 1 h, then samples 
were centrifuged at 20,000 x g for 20 min and the supernatant was collected as detergent-
solubilized membrane. Loading dye was added and samples were incubated at 37oC for 1 h before 
running an SDS-PAGE gel. At no time were samples boiled as Dsc1 aggregates at high 
temperature. 
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Microsome preparation for Scp1 immunoblot – Cell pellets from exponentially growing 
cells (5 x 107) were resuspended in 50 µl B88 buffer + 2x PI. Cells were lysed by bead beating 10 
min with 200 µl glass beads at 4°C. Beads were washed with 500 µl B88 buffer + 1x PI and 
lysate was transferred to a new tube. Lysate was centrifuged for 5 min at 500 x g at 4°C. 80% of 
supernatant was transferred to a new tube and centrifuged for 10 min at 20,000 x g at 4°C. 
Supernatant was discarded and microsome pellet was resuspended in 50 µl SDS lysis buffer + 1x 
PI + 1x DTT. Microsomes were incubated at 37°C for 30 min before BCA assay. Samples were 
diluted 1:2 with Urea Buffer (50 mM Tris-HCl pH 6.8, 6 M urea, 2% SDS) and 1x loading dye 
before loading SDS-PAGE gel.  
Scp1-13x Myc immunoprecipitation – Cell pellets from exponentially growing cells (5 x 
108) were resuspended in 200 µl NP-40 lysis buffer [50 mM HEPES pH 7.4, 100 mM NaCl, 1.5 
mM MgCl2, 1% NP-40 (v/v), 2x PI, 2x Complete EDTA-free PI]. Cells were lysed by bead 
beating for 10 min at 4°C, then beads were washed with 800 µl NP-40 lysis buffer to collect all 
lysate. Lysate was incubated with rotation for 40 min at 4°C then centrifuged for 5 min at 500 x g 
to clear intact cells and nuclei. 3 mg of supernatant protein was incubated with 4 µg anti-Myc 
9E10 IgG (Santa Cruz) for 15 min then incubated with 80 µl protein G magnetic beads (NEB) for 
2 h at 4°C. Beads were washed 3x with NP-40 lysis buffer, and the bound fraction was eluted into 
SDS lysis buffer + 1x PI and 1x loading dye at 95°C for 5 min.  
Fluorescence microscopy – S. pombe cells expressing fluorescently-tagged proteins were 
imaged on 2% agarose pads using an AxioObserver.Z1 inverted microscope (Zeiss) with a 
Yokogawa CSU22 High-speed spinning Nipkow disk with microlenses (3i), 3 >40mW solid state 
lasers (473, 561, 658 nm), and a Cascade II, EM-CCD camera (Roper Scientific/Photometrics). 
Images were captured using a 100x oil objective and SlideBook software for data acquisition (3i). 
Images were analyzed using Image J software (NIH). All images were acquired and processed in 
an identical manner. For each frame a Z-stack was captured of 5 slices, 0.2 µm apart.  
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For analysis of microscopy data for Anp1-GFP localization, each slice was evaluated 
independently and quantification data from all slices was used to calculate the mean and standard 
deviation. For statistical analysis we divided the number of cells by 5 to account for the 5x 
sampling of each cell during analysis of all Z-slices. This method conservatively under-estimated 
the number of mutant cells in any frame, as a truly mutant cell may appear mutant in one Z-slice 
and WT in another. For quantification, cells were divided into 2 bins: WT (Golgi localization of 
Anp1, appearing as punctate signal with no ER staining around the nucleus or periphery), or 
mutant (3 different phenotypes: no specific signal, ER signal only, and both ER and Golgi signal). 
For each experiment, we performed pairwise chi-square analysis of all treatments (28 
comparisons) and a post-hoc Bonferroni correction.  
For analysis of microscopy data for Ost1-mCherry signal intensity, the middle Z-slice 
was selected from each frame and all images were normalized for overall signal. A straight line 
was drawn along the long axis of each cell through the nucleus and the Max and Min signal 
intensity values were recorded. To normalize for comparison between biological replicates and 
cell background, the Min value was subtracted from the Max value to get the normalized Ost1-
mCherry intensity. Experimental data was represented by box-and-whisker plot with the midline 
the median and the whiskers extending to the largest and smallest values. Experiments were 
compared by one-way ANOVA followed by post-hoc multiple comparison of means between all 
of the treatments and Bonferroni correction.  
  
Acknowledgments/Author contributions: The authors thank Dr. J. Mutchler (University of 
Massachusetts, Boston) for advice on statistical analysis and S. Zhao and other members of the 
Espenshade lab for help and advice. RB designed and conducted the experiments, analyzed the 
results, and wrote the manuscript. EVS conducted preliminary experiments for the Sre1 and Sre2 
cleavage assays and cerulenin Sre1 cleavage block, and generated the 2xFLAG-mga2 strain. PJE 
104
conceived of the project, designed experiments, and wrote the manuscript. All authors reviewed 
the results and approved the final version of this manuscript.  
4.5 Figures 
FIGURE 4.1. mga2∆ cells have reduced Sre1N accumulation in the presence and absence of 
oxygen. A and C, Western blots imaged by Li-Cor probed with monoclonal anti-Sre1 IgG (5B4) 
and polyclonal anti-Dsc5 IgG (for loading) of lysates treated with alkaline phosphatase for 1 h 
from WT, mga2Δ, dsc2Δ, or sre1Δ cells grown for 0 or 4 h in the absence of oxygen (A) or 6 h in 
the presence of the statin compactin (200 µM, CPN) or vehicle (0.12% EtOH, 400 µM NaCl) (C). 
P and N denote precursor and cleaved N-terminal transcription factor forms, respectively. 
Asterisks denote non-specific bands.  B and D, Quantification from (A) and (C) of three (A,B) or 
four (C,D) biological replicates normalized for loading to Dsc5 then normalized to maximum 
signal (WT N-terminus band after treatment, lane 2) for comparison between blots. Error bars are 
1 S.D. (**, p<0.01 for N-terminus by two-tailed student’s t-test). Quantities of precursor and 
nuclear form are stacked to give an approximation of total signal per treatment. Average percent 
cleavage is calculated by dividing the quantity of N-terminus by the sum of both N-terminus and 
precursor. 
 
FIGURE 4.2. Defect in Sre1 cleavage in the absence of mga2 is amplified by positive 
feedback. A, Western blot imaged by Li-Cor probed with monoclonal anti-Sre1 IgG (5B4) and 
polyclonal anti-Dsc5 IgG (for loading) of lysates treated with alkaline phosphatase for 1 h from 
WT, mga2Δ, or sre1Δ cells with WT or mutant promoter (MP) sre1 as indicated. Cells were 
grown for 0 or 4 h in the absence of oxygen. P and N denote precursor and cleaved N-terminal 
transcription factor forms, respectively. B, Quantification from (A) of four biological replicates 
normalized for loading to Dsc5 then normalized to maximum signal (WT N-terminus band after 
treatment, lane 2) for comparison between blots. Error bars are 1 S.D. (**, p<0.01 for N-terminus 
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by two-tailed student’s t-test). Quantities of precursor and nuclear form are stacked to give an 
approximation of total Sre1 signal per treatment.  
 
FIGURE 4.3. Cleavage defect in mga2∆ cells occurs at a step downstream of Sre1-Scp1 
complex formation and is not specific to Sre1. A, Western blot of cell lysates from the indicated 
strains grown in the presence of oxygen, probed with a mixture of anti-Scp1 IgG monoclonal 
antibodies 8G4C11, 1G1D6, and 7B4A3 (imaged by film) or anti-Dsc5 IgG (imaged by Li-Cor). 
Blot is representative of four biological replicates. B, WT or mga2Δ cells expressing scp1-13xmyc 
and mga2Δ cells expressing untagged scp1 were grown in the presence of oxygen, and Scp1-
13xMyc was immunoprecipitated from NP-40-solubilized membranes using monoclonal anti-
Myc 9E10 IgG as described in Experimental Procedures. Input and 5-fold enriched bound 
fractions were analyzed by western blot and imaged by Li-Cor using polyclonal anti-Sre1 IgG 
and polyclonal anti-Myc IgG. Blot is representative of three biological replicates. C, Indicated 
strains expressing vector (-) or scp1 (+) from a CaMV promoter were precultured in minimal 
medium lacking leucine, transferred to YES complete medium, and grown for 4 h in the presence 
or absence of oxygen. Western blot probed with anti-Sre1 IgG polyclonal antibody and imaged 
by Li-Cor is representative of five biological replicates. P and N denote Sre1 precursor and N-
terminal forms. Asterisks indicate non-specific bands. D, Western blots imaged by Li-Cor probed 
with polyclonal anti-Sre2 and polyclonal anti-Cdc48 (for loading) of lysates treated with alkaline 
phosphatase for 1 h from WT, mga2Δ, dsc2Δ, or sre2Δ cells grown in the presence of oxygen. E, 
Quantification from (D) of six biological replicates normalized for loading to Cdc48 then 
normalized to WT N-terminus band for comparison between blots. Error bars are 1 S.D. (**, 
p<0.01 for N-terminus by two-tailed student’s t-test). Quantities of precursor and nuclear form 
are stacked to give an approximation of total signal per treatment. Average percent cleavage is 
calculated by dividing the quantity of N-terminus by the sum of both N-terminus and precursor. 
 
106
FIGURE 4.4. Dsc E3 ligase is functional in mga2∆ cells. A, Digitonin-solubilized membrane 
protein was prepared from WT, mga2Δ, or dsc2Δ cells grown in the presence or absence of 
oxygen for 6 h, and the Dsc E3 ligase complex was immunoprecipitated with anti-Dsc2 
polyclonal IgG as described in Experimental Procedures. Equal quantities of input and unbound, 
and 10-fold bound fractions were analyzed by immunoblotting using HRP-conjugated antibodies 
against Dsc1, Dsc2, Dsc3, Dsc4, and Dsc5 (imaged by film). Blot is representative of three 
biological replicates. B, Western blot imaged by Li-Cor probed with polyclonal anti-Sre1 IgG and 
monoclonal anti-actin (for loading) of lysates from WT, mga2Δ, dsc1Δ, or sre1Δ yeast grown for 
2 h in the presence or absence of oxygen, then treated with Brefeldin A (100 µg/mL, BFA) or 
EtOH vehicle for another 2 h in the presence or absence of oxygen. Quantification of Sre1 
precursor (Sre1-P) normalized to WT vehicle in the absence of oxygen (lane 7) is shown below. 
Blot is representative of two biological replicates. C, Western blot imaged by Li-Cor probed with 
polyclonal anti-Dsc1 IgG of NP-40-solubilized membrane protein from WT, mga2Δ, or dsc2Δ 
cells grown in the presence of oxygen. M and I indicate mature and intermediate glycosylated 
forms, respectively. D, Quantification of Dsc1 from (C) of seven replicates. Quantity of M form 
was divided by total Dsc1 signal for % mature, allowing comparison between lanes and blots. 
Error bars are 1 S.D. (*, p<0.05, **, p<0.01 by two-tailed student’s t-test).  
 
FIGURE 4.5. mga2 deletion disrupts general membrane transport. A, anp1-GFP ost1-
mCherry (WT) and mga2Δ anp1-GFP ost1-mCherry (mga2Δ) cells were cultured in the presence 
of oxygen and 0.9% (w/v) BSA for 6 h and imaged by confocal microscopy. These images are 
representative of three biological replicates. Scale bar equals 5 µm. B, Quantification of cells with 
altered Anp1-GFP localization from (A) of three biological replicates denoted by different marker 
symbols. n ≥ 150 cells per replicate. Error bars are mean +/- 1 S.D. (**, p<0.01 by chi-square 
analysis with Bonferroni correction). C, Box-and-whisker quantification of normalized Ost1-
mCherry signal intensity from (A) of n ≥ 300 cells from three biological replicates. Whiskers are 
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the max and min intensity values. (**, p<0.01 by one-way ANOVA and post-hoc multiple 
comparisons with Bonferroni correction). D, Western blots imaged by Li-Cor probed with 
monoclonal anti-GFP IgG, polyclonal anti-mCherry IgG, and polyclonal anti-Dsc2 IgG (for 
loading) of lysates from anp1-GFP ost1-mCherry (WT) and mga2Δ anp1-GFP ost1-mCherry 
(mga2Δ) cells cultured in the presence of oxygen and 0.9% (w/v) BSA for 6 h. E, GFP 
quantification from (D) of three biological replicates represented by different marker symbols. 
Quantity of free GFP was divided by total GFP signal for % GFP that is free, allowing 
comparison between lanes and blots. Error bars are 1 S.D. (*, p<0.05 by paired two-tailed 
student’s t-test, with pairing of WT and mga2Δ data on same blot due to significant inter-blot 
variance in WT signal). F, mCherry quantification from (D) of four biological replicates 
represented by different marker symbols, normalized for loading to Anp1-GFP signal then 
normalized to WT signal for comparison between blots. (n.s. no significant difference by paired 
two-tailed student’s t-test). 
 
FIGURE 4.6. Exogenous oleate addition rescues Sre1 cleavage and membrane trafficking in 
mga2Δ cells. A-B, Western blot imaged by Li-Cor probed with monoclonal anti-Sre1 IgG (5B4) 
and polyclonal anti-Dsc5 IgG (for loading) of lysates treated with alkaline phosphatase for 1 h 
from WT or the indicated mutants grown for 4 h in the presence or absence of oxygen (A) or 6 h 
in the presence of 200 µM CPN or vehicle (0.12% EtOH, 400 µM NaCl) (B). All lanes contain 
0.9% (w/v) BSA, and lanes with supplemental fatty acids conjugated to BSA are indicated. A, 
BSA-conjugated fatty acids were added at time 0 and were present for 4 h of growth. B, Cells 
were grown overnight with the indicated fatty acid, washed with H2O, and then grown for 6 h 
with CPN or vehicle. P and N denote precursor and cleaved N-terminal transcription factor forms, 
respectively. Asterisks (*) indicate non-specific bands. Blots are representative of three biological 
replicates. C, anp1-GFP ost1-mCherry (WT) and mga2Δ anp1-GFP ost1-mCherry (mga2Δ) cells 
were cultured with the indicated fatty acid supplement for 6 h and imaged by confocal 
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microscopy. 18:X indicates supplementation of both 18:0 and 18:1. Experimental data for WT 
BSA and mga2Δ BSA are the same as reported in Fig. 5A-C. Images are representative of three 
biological replicates. Scale bar equals 5 µm. D, Quantification of cells with altered Anp1-GFP 
localization from (C) of three biological replicates denoted by different marker symbols. n ≥ 150 
cells per replicate. Error bars are mean +/- 1 S.D. (*, p<0.05, **, p<0.01 by chi-square analysis 
with Bonferroni correction). E, Box-and-whisker quantification of normalized Ost1-mCherry 
signal intensity from (C) of n ≥ 300 cells from three biological replicates. Whiskers are the max 
and min intensity values. (*, p<0.05, **, p<0.01 by one-way ANOVA and post-hoc multiple 
comparisons with Bonferroni correction).  
 
FIGURE 4.7. Disrupting fatty acid homeostasis blocks general membrane transport and 
Sre1 cleavage. A, WT cells were grown in liquid culture in 112 nM CER or 0.1% (v/v) DMSO 
for 6 h. Cell density was measured by absorbance at 600 nm. Data points are average of four 
biological replicates. Error bars are 1 S.D. Absorbance at time 0 among the samples ranged from 
0.10 to 0.29. To focus on the difference in growth rate between conditions, data were normalized 
for each sample to a value of 0.2 at time point 0 before averaging. B-C, Western blot imaged by 
Li-Cor probed with monoclonal anti-Sre1 IgG (5B4) and polyclonal anti-Dsc5 (for loading) of 
lysates treated with alkaline phosphatase for 1 h from WT cells. Cells were grown in 112 nM 
CER or 0.1% (v/v) DMSO for 2 h under normoxia. Cells were then washed, resuspended in fresh 
medium and grown without cerulenin for 4 h in the presence or absence of oxygen (B,C) with the 
indicated BSA-conjugated fatty acid supplemented (C). P and N denote precursor and cleaved N-
terminal transcription factor forms, respectively. Asterisks (*) indicate non-specific bands. Blots 
are representative of two biological replicates. D, anp1-GFP ost1-mCherry cells were pre-
cultured for 1 h in the indicated BSA-conjugated fatty acid. Then, 112 nM CER or 0.1% (v/v) 
DMSO (-CER) was added, and cells were cultured for an additional 3 h before imaging by 
confocal microscopy. 18:X indicates supplementation of both 18:0 and 18:1. Images are 
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representative of three biological replicates. Scale bar equals 5 µM. E, Quantification of cells 
with altered Anp1-GFP localization from (D) of three biological replicates denoted by different 
marker symbols. n ≥ 100 cells per replicate. Error bars are mean +/- 1 S.D. (**, p<0.01 by chi-
square analysis with Bonferroni correction). E, Box-and-whisker quantification of normalized 
Ost1-mCherry signal intensity from (D) of n ≥ 300 cells from three biological replicates. 
Whiskers are the max and min intensity values. (**, p<0.01 by one-way ANOVA and post-hoc 
multiple comparisons with Bonferroni correction). 
 
FIGURE 4.8. Inhibition of sterol synthesis blocks Mga2 transcription factor activity. A, 
Western blots imaged by Li-Cor probed with monoclonal anti-FLAG M2 IgG of lysates treated 
with alkaline phosphatase for 1 h from WT and 2xFLAG-mga2 cells grown for 2 h in 0.1% (v/v) 
DMSO (D), bortezomib (500 µM, BZ), or cerulenin (112 nM, CER). P and N denote precursor 
and cleaved N-terminal transcription factor forms, respectively. Asterisks denote non-specific 
bands. B, Western blots imaged by Li-Cor probed with monoclonal anti-FLAG M2 IgG, 
monoclonal anti-Sre1 IgG (5B4), and polyclonal anti-Dsc5 IgG (for loading) of lysates treated 
with alkaline phosphatase for 1 h from WT and 2xFLAG-mga2 cells grown in the following 
treatments: 8 h in vehicle (0.12% EtOH, 400 µM NaCl, V), compactin (200 µM, CPN), or 
itraconazole (2 µM, ITR) or 2 h in 0.1% (v/v) DMSO (D), bortezomib (500 µM, BZ), or 
cerulenin (112 nM, CER). P and N denote precursor and cleaved N-terminal transcription factor 
forms, respectively. Asterisks denote non-specific bands. C-E, qPCR of the indicated genes of 
lysates from 2xFLAG-mga2 cells treated as indicated. Error bars are mean +/- 1 S.D. of three 
biological replicates normalized to DMSO treatment. (*, p<0.05, **, p<0.01, by two-tailed 
student’s t-test).  
 
FIGURE 4.9. Model of coordination of Mga2 and Sre1 pathways. Sterol and TAG/GPL lipid 
biosynthetic pathways are positively regulated by the transcription factors Sre1 and Mga2, 
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respectively. Both Sre1 and Mga2 are product inhibited; Sre1 by sterols and Mga2 by UFA. 
Mga2 regulates Sre1 through the requirement for UFA, and Sre1 regulates Mga2 through the 

















Table 4.1. S. pombe strain list 
Strains Genotype Source Figure 
KGY425 h- leu1-32 ura4-D18 ade6-M210 his3-
D1 
ATCC 1,2,3,4,5,6 
PEY1762 h- leu1-32 ura4-D18 ade6-M210 his3-
D1 ∆mga2-D1::kanMX6 
(Burr et al., 2016) 1,2,3,4,5 
PEY1792 h+ leu1-32 ura4-D18 ade6-M210 his3-
D1 ∆dsc2-D1::kanMX6 
This study 1,3,5 
PEY522 h- leu1-32 ura4-D18 ade6-M210 his3-
D1 ∆sre1-D1::kanMX6 
(Hughes et al., 
2005) 
1,2,3,4,5 
PEY888 h- leu1-32 ura4-D18 ade6-M210 his3-
D1 sre1-MP (mutant promoter) 
(Hughes et al., 
2009) 
2 
PEY1793 h+ leu1-32 ura4-D18 ade6-M210 his3-
D1 sre1-MP ∆mga2-D1::kanMX6 
This study 2 
PEY1794 h- leu1-32 ade6-M216 ∆dsc2-
D1::kanMX6, anp1-mCherry::ura4+, 
his3::dsc2-6xmGFP-his3 
This study 3 




This study 3,5 
PEY1569 h+ ∆dsc1-D1::kanMX6 This study 3,5 
PEY554 h- leu1-32 ura4-D18 ade6-M210 his3-
D1 ∆scp1-D1::kanMX6   
(Hughes et al., 
2005) 
4 
PEY546 h- ura4-D18 leu1-32 his3-D1 ade6-
M210 scp1-13xmyc::kanMX6 
(Burg et al., 2008) 4 
PEY1796 h+ ura4-D18 leu1-32 his3-D1 ade6-
M210 scp1-13xmyc::kanMX6 ∆mga2-
D1::natMX6 
This study 4 
PEY1797 h+ leu1-32 his3-D1 ade6-M216 anp1-
GFP::ura4+, ost1-mCherry::ura4+  








































clvg. (%) 25.3 64.1 32.7 51.2 15.2 26.4
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This chapter is an edited version of the manuscript, “Oxygen-responsive transcriptional regulation 
of lipid homeostasis in fungi: Implications for anti-fungal drug development” by R. Burr and P. J. 
Espenshade, under revision at Seminars in Cell and Developmental Biology. It also incorporates 
material from the manuscript, “Dsc E3 ligase localization to the Golgi requires the ATPase Cdc48 
and cofactor Ufd1 for activation of Sterol Regulatory Element-binding Protein in fission yeast” 
by R. Burr, D. Ribbens, S. Raychaudhuri, E. V. Stewart, J. Ho, and P. J. Espenshade, under 
revision at the Journal of Biological Chemistry, the manuscript, “Mga2 transcription factor 
regulates an oxygen-responsive lipid homeostasis pathway in fission yeast” by R. Burr, E. V. 
Stewart, W. Shao, S. Zhao, H. K. Hannibal-Bach, C. S. Ejsing, and P. J. Espenshade, published in 
the Journal of Biological Chemistry, Volume 291, Issue 23, 12171-12183. © 2016 American 
Society for Biochemistry and Molecular Biology, Inc., and the manuscript, “Coordinate 
regulation of yeast Sterol Regulatory Element-Binding Protein (SREBP) and Mga2 transcription 
factors” by R. Burr, E. V. Stewart, and P. J. Espenshade, published in the Journal of Biological 
Chemistry, Volume 292, Issue 13, 5311-5324. © 2017 American Society for Biochemistry and 
Molecular Biology, Inc. 
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5.1 Summary 
In my graduate work, I determined that Cdc48 plays multiple roles during SREBP 
cleavage in S. pombe. In addition to the previously described role at Rbd2, I discovered that 
Cdc48 and its cofactor Ufd1 are required at an earlier step of the pathway, namely during Dsc E3 
ligase Golgi localization. Importantly, Ufd1 does not interact with Rbd2, suggesting that these 
two roles for Cdc48 are performed by distinct complexes. This work highlights the versatility of 
Cdc48, the need to focus on cofactors in order to characterize specific functions of Cdc48, and the 
important role that cellular localization of pathway components plays during SREBP activation. 
In separate work, I defined Mga2 as the transcription factor that regulates fatty acid 
metabolism during low oxygen adaptation in fission yeast. This places Mga2 alongside Sre1 in 
regulating the low oxygen lipid response and supports my hypothesis that Mga2 and Sre1 mimic 
mammalian SREBP-1 and SREBP-2, respectively, in their joint regulation of lipid homeostasis. 
Further, I showed that Mga2 and Sre1 activities are coordinated via a unique mechanism of 
product cross talk. Therefore, evolution has devised a way to retain coordination of these two 
lipid homeostasis pathways in fission yeast despite lacking the shared activation mechanism of 
the mammalian SREBP system. This suggests that coordination of sterol and fatty acid 
biosynthesis is crucial for overall lipid homeostasis.  
  
Many intriguing questions arise from these results. I expand upon three of these in this chapter:  
1. What is the effect of the cdc48 mutants on Cdc48 function, and what roles is Cdc48 playing 
during Dsc E3 ligase transport and at Rbd2?  
2. What regulates the other genes that respond to low oxygen? 
3. Are these pathways and their coordination conserved in other fungi? 
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5.2 What is Cdc48 doing during Dsc E3 ligase transport? 
The specific function for Cdc48-Ufd1 during Dsc E3 ligase Golgi localization is 
unknown. Further understanding of how the cdc48 point mutations characterized in this study 
affect Cdc48 activity could be helpful in elucidating that function. The mutations are spread 
throughout the D1 and D2 domains, are notably absent from the N-domain, and are not clustered 
in three-dimensional space. Two of the mutations (E325K and A366D) are in or near the ATP-
binding region of the D1 domain. Although the enzymatic consequence of a lysine mutation at 
E325 is untested, the homologous residue has been extensively studied in both budding yeast and 
mammalian cells and has effects on the ATP hydrolysis rate of the D1 domain (81,173). 
Interestingly, a report in fission yeast independently isolated the E325K mutation as a cold-
sensitive suppressor of the temperature sensitive cdc48-353 (G338D) mutation (174). The authors 
concluded that E325K likely alters Cdc48 structure in a way that is compensatory to the effects of 
cdc48-353. Therefore, fission yeast cdc48-8 (E325K), and possibly cdc48-9 (A366D), may 
produce structural changes that impact Cdc48 ATPase activity. 
Because our cdc48 mutants are distributed throughout the sequence and do not cluster in 
three-dimensional space, the mutations are unlikely to directly impact a single binding interaction 
with a specific cofactor or substrate in order to cause the observed SREBP cleavage defects. 
Instead they may alter hexamer assembly, ATPase activity, or substrate release, thereby reducing 
enzymatic efficiency. Similarly, of the three ufd1 mutants, only ufd1-7 has a mutation in the 
predicted Cdc48-binding region (aa 219-235 based on homology to S. cerevisiae), and none are 
mutant in the predicted Npl4 binding region (aa 251-266) (115,119). It may be that these mutants 
more generally destabilize the protein, or that the binding regions in S. pombe are different from 
those in S. cerevisiae.  
In contrast, the known VCP IBMPFD disease mutations are all clustered in the N and D1 
domains at the N-D1 interface (ClinVar). These mutations increase ATPase activity and alter 
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cofactor binding, resulting in defects in autophagy (especially clearance of damaged 
mitochondria), lysosomal degradation, and endosomal trafficking (83,84,86,88,90). The disease 
mechanism for these VCP mutations is related to mitochondrial uncoupling and a decrease in 
cellular ATP followed by a failure to clear these damaged mitochondria (87,91,175,176). It is 
difficult to imagine a way in which our cdc48 point mutations are having a similar effect in S. 
pombe, with the downstream result being a defect in SREBP activation at the Golgi.  
As an alternative, our previous work showed that the Dsc E3 ligase enzymatic function is 
required for proper Golgi localization (73). One attractive hypothesis is that both Dsc E3 ligase 
function and Cdc48 activity are required for the same process, which permits traffic of the Dsc E3 
ligase to the Golgi. Perhaps there is a protein in the ER that binds the Dsc E3 ligase and represses 
traffic to the Golgi, possibly by inhibiting packaging into COPII vesicles. To appropriately traffic 
to the Golgi, the Dsc E3 ligase may need to ubiquitylate the repressor, and then Cdc48 would 
extract it from the complex and/or membrane for degradation by the proteasome. This function 
would be consistent with Cdc48’s activity as a separase, and is indeed analogous to its role in 
ERAD. This would provide a quality control mechanism to ensure that the Dsc E3 ligase is 
functional before being shipped to its final destination. Consistent with this hypothesis, the Sre1 
precursor is not degraded in the cdc48 mutants after Brefeldin A treatment, suggesting that the 
Dsc E3 ligase is unable to ubiquitylate Sre1 (Fig. A.3A). To determine the identity of the 
repressor, I performed an overexpression screen, reasoning that overexpression of a repressor of 
Dsc E3 ligase transport would result in a failure to cleave Sre1 (Fig. A.4-A.6). That screen failed 
to identify the repressor, but it may be that the removal of the repressor by the Dsc E3 ligase 
under normal conditions is too rapid for overexpression of the repressor to inhibit Sre1 cleavage. 
Future work may instead try to identify proteins bound to the Dsc E3 ligase under transport-
inhibited conditions, such as in the cdc48 mutants. 
Beyond a role during Dsc E3 ligase Golgi localization, it is still relatively unclear what 
role Cdc48 is playing when bound to Rbd2. I hypothesize that Cdc48 could impact three steps of 
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substrate cleavage by Rbd2: (1) substrate identification/binding including substrate positioning, 
(2) enzymatic catalysis, and/or (3) substrate extraction after cleavage. Because Rbd2 functions 
after the Dsc E3 ligase in the SREBP cleavage activation pathway, it is difficult to dissect the 
impact of our cdc48 point mutants on Cdc48 function at Rbd2. However, it is possible that these 
point mutants are also having an impact on cleavage by Rbd2, and that the effects we observe on 
SREBP cleavage are additive of both of these roles for Cdc48. In lieu of being able to study the 
effects of the cdc48 point mutants on Rbd2, a previous report utilized mutation of the Cdc48 
binding domain (SHP) on Rbd2 (71). That study concluded that Cdc48 functions as a substrate 
adaptor for Rbd2, bringing the SREBP and Rbd2 together in the Golgi membrane for cleavage. 
This hypothesis was based on the observation that overexpression of Rbd2 lacking the SHP 
domain, which cannot bind Cdc48, was able to rescue the SREBP cleavage defect of an rbd2Δ 
strain, indicating that Cdc48 binding to Rbd2 is not strictly required for cleavage (71). 
Additionally, no membrane-bound cleavage intermediate was observed in the absence of Cdc48 
binding, as might be expected from a defect in substrate extraction. The literature suggests that 
rhomboid proteases have relatively little substrate affinity, and that substrate interaction is rate-
limiting to cleavage (177). Therefore, an adaptor that increases interaction between Rbd2 and the 
SREBP would be very beneficial to the rate of SREBP activation, especially given that SREBPs 
are degraded by the proteasome when not cleaved by Rbd2, possibly in a time-dependent manner 
(71). Additionally, a recent report indicated that the length of the ubiquitin chain determines the 
ability of Cdc48 to unfold the client protein, with short chains showing interaction with Cdc48 
but not induction of ATPase activity (81). Therefore it is possible that a short ubiquitin chain on 
the SREBP would allow recognition by Cdc48 without unfolding. 
In counterpoint, while Cdc48 binding to Rbd2 can be readily observed in the cell, Cdc48 
interaction with the SREBP substrate has not been shown (71). This may be due to the rapid 
processing and release of the SREBP under normal conditions, but it could also indicate that the 
Cdc48-Rbd2 interaction is more stable than the Cdc48-SREBP interaction, calling into question 
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its ability to bring substrates to Rbd2. Further, while the conclusion that Cdc48 acts as a substrate 
adaptor for Rbd2 is consistent with the expected mechanism for a rhomboid protease, it is not 
consistent with the Cdc48 literature. In fact, to my knowledge, such a role would be completely 
unprecedented in any species. Instead, Cdc48 has been very well described to perform the 
mechanical function of pulling and separating ubiquitylated substrates from protein complexes or 
membranes. This canonical function could be used to reorient the SREBP transmembrane domain 
for access by Rbd2, for example, if it was poorly positioned in the Golgi membrane. This role 
would still occur prior to Rbd2 cleavage, but would be more consistent with known activities of 
Cdc48. 
Alternatively, a requirement for Cdc48 during extraction of the cleaved SREBP substrate 
from the Golgi membrane after cleavage (Step 3) would be completely consistent with the 
literature. Indeed, such a mechanism was demonstrated in mammals for substrate extraction after 
cleavage by the rhomboid protease RHBDL4 during ERAD (76). Consistently, Rbd2 is predicted 
to cleave the SREBP in the second transmembrane segment or luminal loop, leaving the N-
terminus attached to the Golgi via the first transmembrane domain (71). A second Golgi protease 
could release the final transcription factor, but so far none has been identified. Instead, Cdc48 
bound to Rbd2 could extract this intermediate from both the membrane and the complex with 
Rbd2, making it available to cytoplasmic proteases for further processing. If substrate extraction 
is the main role for Cdc48 at Rbd2, mutation of the SHP domain would be expected to produce 
SREBP cleavage intermediates trapped in the Golgi membrane. However, if extraction of the 
substrate by Cdc48 is required to release Rbd2 for subsequent rounds of catalytic activity, then 
the unextracted substrate could quickly clog and inhibit the available Rbd2, resulting in a 
cleavage block and accumulation of only a very small amount of cleavage intermediate that may 
not be visible by western blot. This would be improved by overexpression of the SHP mutant 
Rbd2, as was observed. Future work differentiating these potential roles for Cdc48 at Rbd2 would 
be aided by identification of cofactors involved in this process, and genetic bypass of the role for 
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Cdc48 at the Dsc E3 ligase (through identification of the repressor) so that the impact of the 
cdc48 point mutants at this step can be evaluated.  
5.3 What regulates other oxygen-responsive genes? 
Only 38% of S. pombe anaerobically upregulated genes are transcriptional targets of 
either Mga2 or Sre1 (Fig. 3.3B). Thus, additional transcriptional regulators of low oxygen-
responsive pathways remain to be discovered in both this and other fungal species (54). 
Carbohydrate catabolism and aerobic respiration are two conserved regulated pathways (Fig. 1.1). 
Enriched GO terms upregulated by low oxygen include carbohydrate metabolic process 
(GO:0005975), glucose catabolic process (GO:0006007), acetyl-CoA biosynthetic process from 
acetate (GO:0019427), and generation of precursor metabolites and energy (GO:0006091). In 
contrast, GO terms downregulated by low oxygen include aerobic respiration (GO:0009060) and 
respiratory electron transport chain (GO:0022904). Each molecule of glucose consumed via 
aerobic respiration requires six molecules of oxygen for full ATP output, whereas glucose 
metabolism via ethanol fermentation requires no oxygen (178). Therefore under low oxygen 
conditions, glycolysis is upregulated while aerobic respiration is downregulated. This serves to 
efficiently produce ATP and acetyl-CoA for lipid biosynthesis.  
Regulation of carbohydrate synthesis in response to low oxygen has been relatively 
poorly studied in any fungal species. S. cerevisiae exhibit a unique reliance on fermentation even 
in the presence of oxygen due to a strong glucose-repression circuit, a phenomenon known as the 
Crabtree effect (179,180). Therefore S. cerevisiae have little regulation of carbohydrate 
metabolism in response to oxygen and only upregulate carbohydrate metabolic process 
(GO:0005975), instead showing regulation of carbohydrate metabolism almost entirely by carbon 
source (55,181). In contrast, carbohydrate metabolism in other fungi is more clearly regulated by 
oxygen. In C. albicans, the soluble bHLH transcription factor Tye7 and the soluble Gal4 
transcription factor upregulate glycolytic gene expression in fermentative conditions as well as in 
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response to low oxygen (182). Interestingly, Tye7 is an Sre1N homolog (127). When tye7 was 
deleted, C. albicans accumulated trehalose and glycogen under normoxic conditions, suggesting 
that tye7 is required for directing the cells towards glycolysis and away from storage lipids (182). 
The homologs of tye7 and gal4 in S. cerevisiae also regulate glycolysis, although not in response 
to oxygen (183). In C. parapsilosis, glycolytic genes are induced by Upc2 in response to low 
oxygen, although to a lesser extent than ergosterol synthesis genes (57).  
The transcriptional regulator of carbohydrate metabolism in S. pombe is unknown. This 
thesis work reports the full results of the first screen of the S. pombe non-essential haploid 
deletion collection version 1.0 for gene deletions sensitive to low oxygen (68,70). We expected 
that deletion of a transcription factor required for low oxygen adaptation would be sensitive to 
low oxygen and CoCl2. However, mga2 was the only transcription factor that satisfied these 
characteristics (Supplementary Table 3.1). It is possible that lipid homeostasis is more sensitive 
to low oxygen than other pathways. However, it is also the case that this deletion collection does 
not contain deletions of all non-essential genes, not to mention essential genes. Screening 
conditions may also have resulted in missed hits. Ryuko et al. previously performed a screen of 
the 3,004 S. pombe deletion collection version 2.0 strains for growth on 3.5 mM CoCl2 (184). We 
used 1.6 mM CoCl2 in our screen. They found 54 gene deletions sensitive to CoCl2 and 56 gene 
deletions resistant to CoCl2. Of the 67 deletions that we found sensitive to CoCl2, only 11 were 
also identified by Ryuko et al. as sensitive to CoCl2 (Supplementary Table 3.3). The small 
overlap between these studies may be due to the different concentrations of CoCl2 used, leading 
to selection for different responses to the chemical. We chose a concentration sufficient to inhibit 
growth of sre1∆ cells in order to mimic hypoxia. By screening under two conditions (low oxygen 
and CoCl2), we focused our search to those genes most likely to be involved in low oxygen 
response. Additionally, another group recently screened the 669 strains of deletion collection 
version 2.0 that are not present in deletion collection version 1.0 (screened in this study) for 
growth on both CoCl2 and under low oxygen. They identified 33 genes required for growth under 
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low-oxygen and/or CoCl2 conditions, although they only reported the identity of one, the 
rhomboid protease rbd2 (138). A directed evaluation of transcription factor deletions or knock 
down in fission yeast may yet identify additional factors required for low oxygen adaptation that 
were missed in our screen.  
Despite not identifying any additional transcription factor candidates, this deletion 
collection screen identified 105 gene deletions that resulted in sensitivity to low oxygen and/or 
the low oxygen mimetic CoCl2, with 27 deletions resulting in sensitivity to both (68,70). 
Interestingly, we identified 19 genes that are required for adaptation to low oxygen stress but are 
not deficient in Sre1N accumulation (Table 3.2). These genes may represent other pathways 
required to adapt to oxygen stress. These genes include multiple players of three separate 
pathways (Supplementary Tables 3.2-3.3).  
The first highly represented pathway sensitive to low oxygen and CoCl2 is transport 
between the endosome and the Golgi or the vacuole (ryh1, sec28, vsp8, vps17, vps24, vps26, 
vps29, vps32, vps35, vps36). This transport could be required to maintain V-type H+ ATPase at 
the vacuole. It has been shown in budding yeast that in the absence of V-ATPase function, the 
cytosol acidifies (185). Normally, the plasma membrane proton pump Pma1 would compensate 
by hydrolyzing ATP and pumping out protons (186). However under low oxygen, reduced 
oxidative respiration may decrease cellular ATP (187), creating conditions that require full V-
ATPase activity to maintain cytosolic pH.  
The second pathway sensitive to both low oxygen and CoCl2 is Mediator (med20, nut2). 
Highly conserved from yeast to humans, the Mediator complex, composed of 13 subunits in 
fission yeast, is required for regulated expression of most RNA polymerase II-dependent genes 
(188,189). A potential role of Mediator in regulating low oxygen adaptation in fission yeast is 
consistent with data in humans and C. elegans showing that Mediator is required for SREBP 
transcriptional activation of target genes, as well as lipid homeostasis and fatty acid desaturation 
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(190). Because mediator is required at a post-cleavage step in the SREBP pathway, the effects of 
these mutants may not be apparent in a cleavage assay.  
A third pathway sensitive to only low oxygen in our screen is miRNA biogenesis (arb1, 
arb2, dcr1). Interestingly, a number of recent papers have suggested that chronic hypoxia induces 
downregulation of miRNA biogenesis in order to maintain HIFα induction in vascular endothelial 
and cancer cell lines (191-193). This adaptation is correlated with tumor progression and poor 
prognosis (192,193). However, other recent work has identified the micro-RNA miR-210 as a 
“master” hypoxia-regulated miRNA, exhibiting upregulation by HIF-1α under conditions of 
hypoxia (194-196). miR-210 promotes cell-cycle progression and evasion of apoptosis while 
compromising mitochondrial integrity and DNA repair in numerous cancer cell lines (196). 
Additional work is required to fully understand the complex interplay between miRNA 
biogenesis and hypoxia adaptation in human cells, as well as in fission yeast, which lack a HIF 
homolog.  
In addition to mga2, this screen identified three genes that were required for Sre1N 
accumulation but were not rescued by exogenous Sre1N (Fig. 3.1C). Cpp1 is a subunit of protein 
farnesyltransferase required for farnesylation of small GTPases such as Ras and Rheb. cpp1∆ 
exhibits severe normoxia growth defects and temperature sensitivity as well as morphological 
defects, indicating a role for farnesylation in a number of processes, one of which may be Sre1 
activation (197). Trx2 is a mitochondrial oxidoreductase that helps to maintain the mitochondrial 
redox state, especially in the absence of glutathione (198,199). Ppr6 is a mitochondrial membrane 
protein that regulates the mRNA stability of the mitochondrial ATP synthase subunit atp9. In the 
absence of ppr6, atp9 mRNA is reduced and cells become sensitive to galactose and antimycin, 
indicating defects in aerobic respiration (200). Taken together, these data suggest a role for 
mitochondrial function in regulating Sre1 activation and cellular adaptation to low oxygen and 
CoCl2, consistent with the microarray results. 
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5.4 Are these pathways conserved in other fungal species? 
We believe the requirement for metabolic changes during successful adaptation to low 
oxygen is an exploitable “Achilles heel” of pathogenic fungal infection and a potential source of 
new antifungal targets. The success of azole drugs, which target ergosterol biosynthesis, supports 
this hypothesis. However, azoles only target a single enzyme of the ergosterol biosynthesis 
pathway, and there is nothing unique about sterol biosynthesis that makes it a preferred drug 
target over other metabolic pathways. Therefore, we consider ergosterol biosynthesis, fatty acid 
biosynthesis, and carbohydrate metabolism to be attractive open fields for targeted drug 
development. Conservation of the regulation of lipid homeostasis in response to low oxygen by 
Sre1 and Mga2 in other fungal species would indicate potential for targeting these pathways with 
antifungal drugs. Indeed over 20 fungal species, including human and plant pathogens, have 
predicted Sre1 homologs (Table 1.1), suggesting that this pathway may be a common mechanism 
for sterol regulation in response to oxygen. In the human pathogen Aspergillus fumigatus, the 
Sre1 homolog SrbA is activated by the Dsc E3 ligase homologs DscA-D and the Rbd2 homolog 
RbdB. This pathway is required for hypoxia adaptation and virulence in Invasive Pulmonary 
Aspergillosis mouse models (125,126,201). Interestingly there is no scp1 homolog in A. 
fumigatus (202). Therefore it is unknown how SrbA cleavage is regulated by oxygen. Similarly in 
Histoplasma capsulatum, the sre1 homolog srb1 regulates ergosterol biosynthesis in response to 
low oxygen and is required for virulence in intranasal mouse infectivity studies (128). An sre1 
homolog called srbA was also recently identified in Paracoccidioides species, and rbd2 is 
conserved in Neurospora crassa (201,203). No role for homologs of other pathway components 
has yet been examined in these species. Thus, the role of Sre1 homologs in the oxygen response 
and sterol regulation is conserved in other Ascomycota fungal species and is crucial for virulence 
in several pathogens. 
Interestingly, Cryptococcus fungal species also have predicted sre1 homologs, but the 
mechanism of activation is distinct from that described in S. pombe. In Cryptococcus neoformans, 
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the Sre1 low oxygen response is required for virulence in mouse models of meningoencephalitis 
(204). However, C. neoformans Sre1 is activated by a mammalian Site-2 protease homolog, Stp1, 
instead of the Dsc E3 ligase and rhomboid protease required in S. pombe (205). Site-2 protease 
homologs are predicted in at least seven Basidiomycota (including Cryptococcus) and 
Zygomycota fungal species. Interestingly, no Basidiomycetes have rbd2 or dsc4 homologs (Table 
1.1). Therefore C. neoformans appears to have retained the Site-2 protease cleavage mechanism 
that was present in the common ancestor of fungi and humans (for an excellent review on the 
evolution of hypoxic gene regulation see (202)).  
 In contrast, during the evolution of Saccharomycotina fungi, including Saccharomyces 
cerevisiae and Candida spp., SREBP homologs (like hms1 and cph2) lost the C-terminal 
DUF2014 domain and with it their role as regulators of sterol biosynthesis (59). This domain is 
required for Sre1 binding to Scp1; therefore it is likely that cph2 proteins cannot sense and 
respond to sterol levels (206). Instead, cph2 transcription factors regulate hyphal growth (207). 
Regulating sterol biosynthesis in their place is upc2 (also called mox4), a GAL4-type zinc finger 
transcription factor. The last species that contains full-length orthologs of both sre1 and upc2 
transcription factors is Yarrowia lipolytica, where Upc2 plays the predominant role in low oxygen 
sterol regulation, while Sre1 primarily regulates filamentation (59). Upc2 was initially 
characterized in S. cerevisiae, where it upregulates transcription of genes required for ergosterol 
biosynthesis in response to low sterols and low oxygen in a semi-redundant fashion with the 
homologous transcription factor Ecm22 (208-210). Like Sre1, Upc2 binds SRE elements in its 
own promoter, creating positive feedback within the system (210). Further studies in Candida 
albicans, Candida glabrata, Candida parapsilosis, and Candida tropicalis showed that Upc2 
regulates ergosterol biosynthesis and sterol uptake (211-215). Recent structural and biophysical 
studies showed that Upc2 has a C-terminal ligand-binding domain that binds ergosterol in vivo 
(216). Additionally, Upc2, Ecm22, and C. albicans Upc2 form ligand-independent homodimers 
through interactions of the ligand binding domains (216). 
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Data on the cellular localization and activation mechanism of S. cerevisiae Upc2 and 
Ecm22 are conflicting. Prediction programs such as Phobius, TMHMM, and TMPred predict 
between 0-4 transmembrane domains with a single transmembrane domain near the C-terminus 
scoring the highest confidence. A C-terminally GFP-tagged Upc2 had ER or Golgi localization 
under normal conditions, and became more cytoplasmic and perinuclear upon inhibition of 
ergosterol biosynthesis (217). This result was replicated by indirect immunofluorescence using C-
terminally FLAG-tagged Upc2. The authors proposed an SREBP-like activation mechanism for 
Upc2, where membrane-tethering through the transmembrane domain(s) inactivates Upc2 until 
low ergosterol conditions allow for membrane release (217). 
In contrast, a recent report showed that N-terminally GFP-tagged Upc2, designed to 
avoid adverse interactions between GFP and the C-terminal ligand binding and activation 
domains, exhibited cytosolic localization in ergosterol-replete conditions and nuclear localization 
in ergosterol-depleted conditions (216). This nuclear localization is consistent with the role of 
Upc2 as a transcription factor. Importantly, Upc2 has an intrinsic nuclear localization sequence, 
and deletion of the ligand-binding domain caused constitutive nuclear localization, suggesting 
that ergosterol binding excludes Upc2 from the nucleus (216). However, it is important to note 
that the ligand-binding domain encompasses the strongest predicted transmembrane domain, and 
the effects of its deletion on potential membrane binding were not examined. These authors 
concluded that Upc2 is normally cytoplasmic, and that it senses ergosterol by extracting sterol 
from the plasma membrane based on the ability of Upc2 to extract ergosterol from liposomes in 
vitro (216). It is unclear what the dynamic range of ergosterol sensing would be for such a 
mechanism. Future studies will be needed to determine whether Upc2 is membrane-bound or 
cytosolic and to provide a clearer mechanism for ergosterol sensing in this system. 
 In addition to activation of ergosterol synthesis by Upc2, S. cerevisiae evolved a 
repressive system to turn off hypoxic-responsive genes under aerobic conditions. This system 
relies on two soluble transcriptional repressors, Mot3 and Rox1, a C2H2 zinc finger transcription 
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factor and an HMG-box Sox family transcription factor, respectively (218-222). Mot3 and Rox1 
are in turn repressed by the soluble Hap1 GAL4-like zinc-finger transcription factor in a heme-
dependent manner (223-225). Under normoxic conditions, Hap1 binds heme causing it to stop 
repressing Mot3 and Rox1, which go on to repress expression of low oxygen-responsive genes 
(225). Under low oxygen conditions, when heme is not synthesized, Hap1 repression of Mot3 and 
Rox1 allows expression of low oxygen-responsive genes. Mot3 and Rox1 work together with 
Upc2 to regulate ergosterol synthesis, but they also regulate the DAN/TIR group of hypoxic 
responsive genes involved in remodeling the cell wall in response to low oxygen (210,225). 
Interestingly, Rox1 is also thought to repress expression of the Δ9 fatty acid desaturase OLE1 
(226). Conservation of the Mot3-Rox1 regulation of ergosterol in response to oxygen has not 
been shown in other organisms, and Sre1 and Upc2 are thought to be the primary regulators of the 
sterol low oxygen response in fungi. 
Interestingly, S. cerevisiae does have homologs to S. pombe ofd1 and nro1 called TPA1 
and ETT1, respectively. Deletion of either protein caused increased stop-codon read-through, 
suggesting that TPA1 and ETT1 act in the same direction, rather than ETT1 inhibiting TPA1 
(227,228). More recent studies suggested that the effect on read-through is context dependent, 
with read-through in the absence of TPA1 increasing in some cases and decreasing in others (94). 
These effects of Tpa1 on translational fidelity stem from Tpa1’s role in the dihydroxylation of 
ribosomal protein Rps23 (94). Strikingly, a recent study found that Tpa1 is also involved in DNA 
damage repair, and deletion of TPA1 resulted in sensitivity to alkylating agents that appears to be 
distinct from any role in stop-codon read through (229). Additional work is needed to understand 
how Tpa1 functions in genome maintenance and whether Tpa1 plays a role in the S. cerevisiae 
low oxygen response. 
While Mga2 homologs in S. cerevisiae are well-established regulators of fatty acid 
desaturation and the fatty acid transcriptional response to low oxygen, conservation in other fungi 
has been less studied. One important consideration is that most fungi express multiple oxygen-
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dependent fatty acid desaturases, Δ9, Δ12, and Δ15, and each desaturase may be regulated by a 
different transcription factor (230). Nevertheless, mga2 has apparent homologs in at least 35 
fungal species, including the fungal pathogens A. fumigatus, A. flavus, H. capsulatum, C. 
neoformans, C. gattii, C. albicans, and C. glabrata. These homologs are characterized by an IPT 
immunoglobulin-like DNA binding domain, an Ankyrin repeat, and a transmembrane domain 
near the C-terminus (231,232) (Table 1.1). Work in Kluyveromyces lactis showed that Mga2 
regulates squalene epoxidase, fatty acid synthase, and alcohol acetyltransferase in response to low 
oxygen (233). Deletion of MGA2 resulted in increased oleate, decreased polyunsaturated fatty 
acids, and decreased membrane fluidity (233). In C. albicans, SPT23 (an MGA2 homolog) is 
required for OLE1 expression, and knock down of SPT23 results in cell inviability and a 
reduction in unsaturated fatty acids (234). However, another group analyzed the C. albicans 
transcriptional response to hypoxia and found that the soluble bHLH transcription factor EFG1, 
which regulates glycolysis, oxidative metabolism, and filamentous growth under normoxia, is 
required for the upregulation of fatty acid biosynthesis genes including OLE1 under low oxygen 
(235). Further, they observed decreases in polyunsaturated fatty acids in the absence of EFG1 
under low oxygen conditions (235). It is not known whether SPT23 and EFG1 regulate fatty acid 
biosynthesis separately or in concert in C. albicans, but numerous studies of EFG1 homologs in 
other fungi have not yet identified a role in regulation of fatty acid biosynthesis under low oxygen 
conditions. Clearly the MGA2 family of transcription factors is conserved in a number of fungal 
species, but like for SREBPs, additional mechanisms for regulating fatty acid desaturation, GPL, 
and TAG biosynthesis may have evolved over time. Future studies will characterize mga2 
homologs in these organisms to determine if they also regulate pathways required for low oxygen 
adaptation and fungal virulence. 
The coordination of these two oxygen responsive pathways in fission yeast may also be 
conserved in the over 20 fungal species that have predicted Sre1 and Mga2 homologs (Table 1.1). 
But whether and how the carbohydrate response is coordinated with lipid homeostasis in fission 
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yeast is yet to be determined. Other models of coordination exist in the literature. One alternative 
method to coordinate these disparate pathways is through a shared master transcription factor or 
transcription factor cascade. In C. parapsilosis, sterol and carbohydrate biosynthesis are both 
regulated by Upc2 (57). In K. lactis, low oxygen induction of MGA2 is dependent on the plasma 
membrane glucose sensor Rag4, previously shown to inhibit the GAL4-like zinc-finger 
transcriptional repressor Rgt1 (233,236). This suggests that the K. lactis low oxygen lipid 
response is dependent on glucose availability. In S. cerevisiae, sphingolipid biosynthesis is 
dependent on sterols, although the mechanism of this coordination is not known (237).  
Conservation of these low oxygen-responsive pathways and their coordination in other 
fungal species is important if these discoveries are to translate to antifungal drug development. 
Available research supports the relevance of these pathways to fungal pathogenesis. Sites of 
fungal infection are hypoxic and fungal pathogens require SREBP to adapt to these conditions 
and remain virulent, demonstrating conservation of this low oxygen-responsive pathway across 
yeast species (238). Consequently, the SREBP pathway is an important antifungal drug target 
(205,238-240). Indeed in A. fumigatus, srbA, the Dsc E3 ligase, and the rhomboid protease are 
required for azole drug resistance (125,201). Importantly, inhibition of the Sre1 pathway in C. 
neoformans not only reduced azole drug tolerance, but also converted azole drugs from 
fungistatic to fungicidal agents (204,205). This suggests synergy may exist between future 
inhibitors of the Sre1 activation pathway and current azole drugs. In contrast, in S. cerevisiae, C. 
albicans, C. glabrata, C. parapsilosis, and C. tropicalis, where there are no SREBP homologs, 
UPC2 is required for azole resistance, suggesting that regardless of the transcription factor 
employed, transcriptional regulation of ergosterol biosynthesis affects the efficacy of azole drugs 
(211-216).  
Finally, the Mga2 pathway represents a new avenue for antifungal drug discovery. 
Although no currently available antifungal drugs target the fatty acid biosynthesis pathway 
headed by Mga2, the antifungal cerulenin is used in biochemical studies to block fatty acid 
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synthase activity and has low (ug/mL) minimal inhibitory concentrations in a number of 
pathogenic fungal species (241). Therefore, there is potential for success in future development of 
antifungal drugs targeting this pathway. Additionally, unlike the SREBP transcription factors, 
Mga2 has no apparent homologs in humans, limiting the potential toxic effects of drugs targeting 
this pathway. Given the reported coordination between the fatty acid and sterol biosynthesis 
pathways, targeting of fatty acid biosynthesis may hit both of these important adaptations with a 
single drug. These data suggest that mechanisms of low oxygen adaptation are a largely untapped 
source for advances in treatment of pathogenic fungal infection. 
5.5 Final thoughts 
 Recent years have yielded great advances in our understanding of the transcriptional 
regulation of the low oxygen response, resulting in the identification of many conserved pathways. 
However, in order to develop antifungal therapies that target low oxygen adaptation, additional 
work is needed to understand the mechanisms of these pathways. The identification of over a 
dozen regulators of low oxygen lipid homeostasis holds promise for targeted drug development 
(Table 1.1). But understanding how each of these proteins regulates the low oxygen response, as 
well as whether they play additional off-pathway roles in the cell, will be important for predicting 
drug outcomes. In addition to lipid homeostasis, changes in carbohydrate metabolism and aerobic 
respiration are important low oxygen responses, but the transcriptional regulators of this response 
are largely unidentified. S. pombe and S. cerevisiae, as well as the highly-annotated pathogens A. 
fumigatus and C. albicans, will prove valuable models for identification and dissection of these 
transcriptional pathways.  
Experiments in pathogenic fungi highlight the importance of these metabolic pathways in 
low oxygen adaptation and virulence. However, many questions still remain about the pathogenic 
low oxygen response in the host. In addition to changes in oxygen availability, the host 
environment is distinct in other ways, including pH, carbon dioxide, and nutrient levels. It is 
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unknown how the pathogenic low oxygen response is coordinated with responses to these other 
factors. A broader view of the pathogen host response could be achieved through the combination 
of CRISPR/Cas9 gene deletion and pooled screening methods, in order to identify genes required 
for host adaptation directly in the animal (242-245). This analysis will be important to focus on 
the most important pathways for further research.  
Finally, in the development of drugs targeting these pathways, a few important 
considerations need to be addressed. Can the promising results gained with deletion of 
transcription factors be recapitulated with chemical inhibition of these transcriptional pathways? 
Particularly, what is the time scale in which chemical inhibition of transcription leads to a block 
in pathogen growth, and how does this compare with the time scale of disease? There is a 
fundamental difference between pathogens that cannot initiate an infection due to chronic absence 
of a gene and those infections that are successfully treated by acute chemical inhibition of that 
gene product. If inhibition at the level of transcription takes too long to result in effective changes 
in lipid homeostasis, the host may succumb to the infection before the pathogen succumbs to the 
therapy. In this case, targeting enzymes in these metabolic pathways rather than transcription 
factors may be the most effective route. Additionally, does coordination of oxygen-responsive 
transcriptional pathways lend itself to development of drugs with pleiotropic effects? And what 
synergies exist between new targets and existing antifungal therapies? Multidrug combinations 
have the greatest promise for fungicidal effects and slowing of the development of antifungal 
resistance. Therefore, it will be important to test a variety of drug combinations and consider 
pathway coordination for greatest treatment success. 
With growing concern about the threat of pathogenic fungi and the rise of antifungal 
resistance, the next decade is likely to produce answers to many of these questions as we see a 












































 My thesis work answered many fundamental questions regarding how fission yeast 
regulate lipid homeostasis in response to oxygen, but a number of holes are yet to be filled, 
especially regarding the role of Cdc48 during SREBP cleavage. This section reports a few 
preliminary results that alone are largely inconclusive, but support the previous results or indicate 
an answer to these remaining questions. Future work and repetition is needed to evaluate the 
significance and meaning of these results. 
A.2 Results 
sum3 does not have a large effect on Sre1 cleavage – The RNA helicase sum3 was 
identified as required for Sre1 activity by whole genome sequencing of two linked MMS 
mutagenesis strains (Fig. 2.1). To test whether a failure to produce Sre1N caused the observed 
growth rescue on 5-FOA, we expressed sre1N from a plasmid and assayed growth on CoCl2. We 
observed rescue of growth for the control sre1Δ strain, but no rescue of growth for the sum3-1 
strain (Fig. A.1A). To directly assess Sre1N production in the sum3-1 mutant, we assayed Sre1 
cleavage by western blot. We cultured wild-type, sre1Δ, and sum3-1 mutant cells for 4 h plus or 
minus oxygen. We then probed whole cell lysates with anti-Sre1N, which detects both the full-
length ER-membrane bound precursor form (P) as well as the cleaved N-terminal transcription 
factor form (N). Wild-type cells accumulated Sre1N after 4 hours of growth under low oxygen 
(Fig. A.1B, lanes 1-2). The sum3-1 mutant strain showed a partial Sre1N accumulation defect 
(Fig. A.1B, lanes 10-11). Together, these data suggest that sum3-1 does not play a large role in 
Sre1 activation, and is likely affecting more general rates of translation during the stress response 
to 5-FOA. 
ubx3 required for efficient Sre1 activation – The p47 homolog ubx3 was identified in the 
Cdc48 binding protein mass spectrometry analysis (Fig. 2.4). To test whether it is required for 
low oxygen adaptation, we assayed growth of the deletion on CoCl2 with sre1N or empty vector 
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expressed on a plasmid. Growth of the deletion was partially defective on CoCl2, and that defect 
was rescued with sre1N expression (Fig. A.2A). To determine the effects of ubx3 deletion on Sre1 
cleavage, we assayed Sre1N accumulation by western blot. We cultured wild-type, ubx3Δ, and 
sre1Δ cells in anoxic conditions for 0 or 4 hours. ubx3Δ cells displayed a partial Sre1 cleavage 
defect under low oxygen conditions (Fig. A.2B) indicating that ubx3 is required for efficient Sre1 
activation. To determine whether that role for ubx3 is during Dsc E3 ligase transport to the Golgi, 
we examined Dsc1 glycosylation in the ubx3Δ cells. In the absence of ubx3, the glycosylation 
pattern looked similar to wild-type, with accumulation of primarily the mature glycosylated form 
indicating arrival of Dsc1 in the Golgi (Fig. A.2C, lanes 1-2). This is in contrast to cdc48-8 and 
dsc2Δ, which accumulated the intermediate, ER localized Dsc1 (Fig. A.2C, lanes 3-4). Therefore, 
we conclude that ubx3 may have a role in Sre1 activation but it is not during Dsc E3 ligase Golgi 
localization.  
Instead, ubx3 could be required during the interaction between Cdc48 and Rbd2 (71). To 
determine whether Ubx3 physically associates with Cdc48 when bound to Rbd2, we performed 
an in vitro pull-down experiment from ufd1-13xmyc and ubx3-13xmyc lysates using GST-tagged 
Dsc5 UBX domain, GST-tagged Rbd2 SHP domain, or GST alone. As previously shown, Ufd1-
13xMyc was pulled down by GST-UBX but not GST-SHP (Fig. A.2D, lanes 11 vs 13). In 
contrast, Ubx3-13xMyc was not pulled down by either domain, suggesting that Ubx3 does not 
interact with Cdc48 at Dsc5 or Rbd2 (Fig. A.2D, lanes 12 and 14). However, direct 
immunoprecipitation of Cdc48 in the ubx3-13xmyc and ufd1-13xmyc cells also pulled down very 
little Ubx3-13xMyc relative to the amount of Ufd1-13xMyc (Fig. A.2E, lanes 5 vs 6). Further, the 
reciprocal immunoprecipitation against Myc showed the opposite result, with much more Cdc48 
pulled down from the ubx3-13xmyc cells relative to the ufd1-13xmyc cells (Fig. A.2F, lanes 8 vs 
9). This is despite the fact that both showed similar input levels and both were similarly enriched 
in the Cdc48 mass spectrometry results (Table 2.1). It is possible that the polyclonal Cdc48 
antibody interferes with the interaction between Cdc48 and its cofactors. It may be that the GST-
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tagged Cdc48 binding domains also interfere with this interaction, leaving open the possibility 
that Ubx3 interacts with Cdc48 while at Rbd2. 
What is Cdc48 doing at the Dsc E3 ligase? – Our published data indicate that Cdc48-
Ufd1 is required for Dsc E3 ligase Golgi localization, but it is unclear what specifically it is doing 
there. To determine why the Dsc E3 ligase is mislocalized in the cdc48 mutants, we assayed Dsc 
E3 ligase complex function using a Brefeldin A (BFA) assay. BFA blocks transport from the ER 
to the Golgi, thereby merging the ER and Golgi compartments since Golgi proteins recycle to the 
ER (68). We previously showed that incubation of fission yeast with BFA results in degradation 
of the Sre1 precursor in a Dsc E3 ligase-dependent manner (68). Therefore, this assay reports on 
the function of the Dsc E3 ligase in mutant strains. After 2 h incubation with BFA, WT cells 
showed degradation of Sre1-P as expected (Fig. A.3A, lane 2). In contrast, in dsc2Δ cells, Sre1-P 
was stabilized after 2 h incubation with BFA, confirming that the Dsc E3 ligase is required for the 
degradation observed in WT cells (Fig. A.3A, lane 12). In all the cdc48 mutants tested, Sre1-P 
was also stabilized after 2 h incubation with BFA (Fig. A.3A, lanes 3-10). This suggests that 
cdc48 is required, not just for Dsc E3 ligase localization, but for Dsc E3 ligase-dependent 
degradation of SREBP, and that without this Cdc48 activity the E3 ligase fails to traffic to the 
Golgi and cleave SREBPs. However, because cdc48 is required for a number of cellular 
degradative processes, a caveat of this experiment is that cdc48 may be required for the 
degradation of the Sre1-P subsequent to its ubiquitylation, rather than ubiquitylation by the Dsc 
E3 ligase, resulting in stabilizing of the Sre1-P. However, in that case we might expect 
accumulation of a higher molecular weight ubiquitylated Sre1-P band in the 2 h lanes when cdc48 
is mutated, which is not observed upon three repeated experiments. 
 In addition to the role for Cdc48 at the Dsc E3 ligase, it is also unclear what effect the 
cdc48 and ufd1 mutants are having on the Cdc48-Ufd1 complex. To assay the effect of these 
mutants on Cdc48-Ufd1 complex formation, we performed immunoprecipitations of either Ufd1-
13xMyc (anti-Myc) in the cdc48 mutant backgrounds, or Cdc48 in the ufd1 mutant backgrounds. 
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Interestingly, Ufd1-13xMyc binding to Cdc48 was weakest in the wild-type strains and stronger 
in the mutant strains (Fig. A3.B, lanes 8,11 vs 9,10,12-14). The reciprocal experiment analyzing 
ufd1 mutants was less easy to interpret, because expression level of Ufd1-13xMyc was variable 
(Fig. A3.C). A strengthened interaction between Cdc48 and its cofactor resulting in a phenotypic 
defect has precedent in the literature, and may indicate a reduced rate of ATP hydrolysis (81,246).  
Overexpression screen for genes repressing Sre1 activity – Based on the role for Cdc48-
Ufd1 during Dsc E3 ligase Golgi localization, we hypothesized that there may be a protein that 
represses Dsc E3 ligase export from the ER unless ubiquitylated by Dsc1 and extracted by 
Cdc48-Ufd1 (see Chapter 5.2). To identify such a repressor, we reasoned that overexpression of 
that protein may inhibit Sre1 cleavage. Therefore we generated a reporter strain in which Sre1 
binding sites were in the promoter of the ura4 gene, so that when Sre1 is functional, orotidine 5'-
phosphate decarboxylase (Ura4) is produced (69). We deleted the Sre1 inhibitor ofd1 in this strain 
so that basal Sre1 activity would be increased and to avoid isolating regulators of the Ofd1-Nro1 
interaction (95). When this reporter strain was plated on 5-fluoroorotic acid (5-FOA), it was 
converted to the toxic 5-fluorouracil by Ura4 and killed the cells. We transformed this reporter 
strain with an S. pombe cDNA library, and reasoned that any gene whose overexpression blocked 
Sre1 cleavage would rescue growth on 5-FOA.  
This experiment screened 6.1 × 105 transformants and isolated 183 colonies that were 
resistant to 5-FOA, encompassing 86 genes (Supplementary Table A.1). As expected based on 
the screen design, ofd1 was the most common gene, isolated 22 times. To approximate the 
likelihood that a gene was a false positive, we compared the cellular RNA abundance of that gene 
(247) to the number of times it was isolated from the screen. Therefore, ofd1 had a ratio of 0.23, 
whereas a highly abundant gene that was isolated only once could have a ratio of 160 or more. 
All plasmids with ratios less than 3 were retransformed into the selection strain and retested for 
rescue of growth on 5-FOA. 26/30 of those were reconfirmed to rescue growth (Supplementary 
Table A.2).  
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To determine the effects of overexpressing these genes on Sre1 cleavage, we assayed 
Sre1N accumulation by western blot. We cultured wild-type and cells overexpressing the 
indicated gene in EMM-L overnight, then transferred to YES rich medium and cultured in 
normoxic or anoxic conditions for 4 hours and assayed Sre1N accumulation by western blot (Fig. 
A.4). Of the genes tested, dsc5, SPBC1E8.02 (E8.02), sre1-C (C-terminus truncation), ofd1, 
SPAC24B11.05 (11.05), ppk1, and erg27 overexpression showed Sre1 cleavage defects (Fig. A.4). 
Repeated transformation of the SPBC1E8.02 plasmid did not recapitulate the Sre1 cleavage result 
(data not shown). To determine whether any of these genes affected Dsc E3 ligase localization, 
we examined Dsc1 glycosylation in the transformed cells. No gene expression blocked Dsc1 
glycosylation as compared with dsc2Δ, although dsc5 appeared to have an effect on Dsc1 
expression (Fig. A.5). Therefore, we conclude that none of these genes is affecting Sre1 activity 
by inhibiting Dsc E3 ligase transport.  
Despite not identifying a repressor of Dsc E3 ligase transport, a few interesting 
preliminary conclusions can be made from this screen. SPAC24B11.05 is expected to cause 
increased resistance to 5-FOA, outside of its effects on the Sre1 pathway (248). However, it also 
appeared to result in loss of the Sre1 precursor, therefore it may be playing a role in transcription 
(Fig. A.4). First, dap1 (cytochrome p450 regulator) and erg27 (3-keto sterol reductase) promote 
sterol biosynthesis, while sur2 (sphingosine hydroxylase) promotes sphingolipid biosynthesis. 
When we evaluated Sre1 cleavage over a low oxygen time course of 2 h in these overexpression 
strains, we observed a delay in Sre1 cleavage induction rather than a complete block (Fig. A.6A-
B). This may indicate that when these genes are overexpressed, basal sterol levels in the ER 
increase resulting in a delay in Sre1 activation by low oxygen.  
Second, we observed a defect in Sre1 cleavage when dsc5 was overexpressed, despite the 
fact that deletion of dsc5 also blocked Sre1 cleavage (69). When we evaluated expression of Dsc 
complex members in this overexpression strain, we observed decreased Dsc1, Dsc3, and Dsc4 
levels (Fig. A.6C). Previous work in the lab had noted that when dsc2 was deleted, Dsc4 
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expression was also reduced (172). That work also found that in addition to the 5-member Dsc E3 
ligase complex, Dsc2 and Dsc5 can form an independent subcomplex in wild-type cells, the 
function of which is unknown (172). Considering that data, it is possible that overexpression of 
Dsc5 sequesters some Dsc2 away from the Dsc E3 ligase complex, resulting in reduced Dsc4 
stability and blocking Sre1 cleavage. Whether we can see that change in complex formation by 
immunoprecipitation and why it would result in such a strong block in cleavage is yet to be 
determined. 
Finally, this screen identified 16 cDNAs expressing Sre1 that blocked Sre1 cleavage 
(Supplementary Table A.1). This is counterintuitive, but closer inspection revealed that all of 
these lacked the N-terminus of the gene (11 different start sites), and the majority of these did not 
contain the full bHLH transcription factor domain, indicating that they would not produce a 
functional Sre1N transcription factor (Fig. A.6D). Therefore, this result suggests that 
overexpression of the Sre1 C-terminus inhibits Sre1 cleavage. As the C-terminus is the domain 
that binds Scp1, it may be that overexpressing the C-terminus sequesters Scp1 away from full 
length Sre1, blocking it from trafficking to the Golgi for cleavage.     
A.3 Experimental procedures 
 Whole genome sequencing – Strains PEY1516, ESY58-25, ESY58-329 were grown to a 
cell density of 1 × 108 cells/ml in 10 ml and resuspended in 1 ml sterile water. To collect genomic 
DNA, samples were divided into 2, cells were pelleted the resuspended in 500 µl Buffer A [2% 
Triton X-100, 1% SDS, 100 mM NaCl, 10 mM Tris-HCl pH 8.0, 1 mM EDTA pH 8.0], 500 µl 
phenol:chloroform:isoamylalcohol (25:24:1), and 200 µl glass beads. Tubes were vortexed for 3 
min at 4°C then centrifuged 10 min, 14,000 rpm, at 4°C. Aqueous layer was removed to a new 
tube and 1 ml 100% EtOH was added. Samples were incubated at -20°C for 15 min then 
centrifuged 10 min, 14,000 rpm, at 4°C to pellet DNA. Pellet was resuspended in 200 µl Tris-
HCl/EDTA + 50 µg/ml RNase and incubated at room temperature for 30 min. DNA was 
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precipitated with 20 µl 3M NaOAc and 1 ml 100% EtOH by incubation at -20°C for 15 min. 
Samples were centrifuged 15 min, 14,000 rpm, at 4°C to pellet DNA, supernatant was aspirated 
and pellets were rinsed with 250 µl ice-cold 70% EtOH. Pellets were dried by aspirating and 
resuspended in 20 µl Tris-HCl/EDTA.  
All DNA quantification for library preparation was performed using Quant-iT Pico Green 
dsDNA assay [Thermo Fisher] for improved accuracy over Nanodrop. Samples were diluted with 
elution buffer [10 mM Tris-Cl, pH 8.5, Qiagen] to a DNA concentration of 0.1-10 µg/µl. 
Genomic DNA was sheared 5 min per sample to ~200 bp on a Covaris E220 [Covaris Inc.]. 
Libraries were prepared with NEBNext DNA Library Prep Master Mix Set [Illumina, NEB 
#E6040S] using multiplex oligos following manufacturer’s instructions. 6 cycles of PCR were 
used during enrichment of adaptor ligated DNA. 7.5 ng/µl library in 5 µl was assayed using a 
Qubit Fluorometric Quantitation [Thermo Fisher] and a Bioanalyzer DNA High-Sensitivity Chip 
[Agilent] for determination of library quantity, quality, and size distribution. Samples were 
diluted to 2 nM and analyzed in a single lane on an Illumina HiSeq 2000 by the Genomic 
Research Core Facility. Sequences were aligned using ClustalW and SNP analysis was performed 
against the reference genome (972h-). I then compared the ESY58 SNPs with those present in 
PEY1516. Accounting for mutational hotspots and assuming the mutation should be in the coding 
region to have an effect, sum3 was the top hit.  
 Overexpression screen – Strain REBY206 (ura4-D18::4xSRE Ura4::KanR, his3-
D1::4xSRE lacZ::KanR, ofd1Δ::KanR) was generated as described previously using four tandem 
copies of the Tf2–1 sterol-regulatory element to drive ura4+ and lacZ+ reporter gene activation 
(92). The strain included deletion of the Sre1 inhibitor ofd1 to increase the amount of Sre1 
activity under normoxic, uninduced conditions. REBY206 cells were grown to a cell density of 1 
× 107 cells/ml in 10 ml then washed 4x with 1 ml ice-cold 1.2M sorbitol. Cells were resuspended 
in 1.2M sorbitol at a density of 2 × 106 cells/ml and 1 µg SPLE-1 library or pLEV3 vector was 
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added. The SPLE-1 cDNA library was a kind gift from C. Hoffman (Boston College University) 
and contains 6 × 105 clones promoted by adh, 67% of which carry inserts of 1 kb or more (249). 
Cell suspension was transferred to an electroporation cuvette and cells were transformed by 
electroporation at 2.25 kV, 200 Ω, 25 µF. 1% of cell suspension was plated on EMM-Leu [2% 
(w/v) agar, 20 g/L glucose, 225 mg/L each of adenine and histidine, 50.25 mg/L uracil] for 
determination of transformation efficiency. The remainder was plated on EMM-Leu, incubated at 
30°C for 48 h, then replica plated to EMM-Leu+5-FOA [2% (w/v) agar, 20 g/L glucose, 225 
mg/L each of adenine and histidine, 50.25 mg/L uracil, 0.1% (w/v) 5-FOA]. Plates were wrapped 
in foil and incubated at 30°C for 7 days. Colonies were picked and restreaked onto EMM-Leu+5-
FOA twice. Surviving colonies were patched onto EMM-Leu+5-FOA. This process was repeated 
12 times at a transformation efficiency of 2-8 × 104 for a total of 6.1 × 105 colonies examined, or 
about 1x coverage of the library. Rescue plasmids were isolated by collecting total DNA from 
strains of interest then directly transforming electrocompetent E. coli and plating on selective 
plates before isolating plasmids by miniprep. Plasmids were sequenced using a primer in the 
backbone for insert identification. Plasmids were retransformed into REBY206 for confirmation 
of result and downstream analysis. 
 Immunoprecipitation - Exponentially growing cells (5 x 108) were resuspended in 200 µl 
NP-40 lysis buffer [50 mM HEPES pH 7.4, 100 mM NaCl, 1.5 mM MgCl2, 1% NP-40 (v/v), 2x 
PI, 2x Complete EDTA-free PI]. Cells were lysed by bead beating for 10 min at 4°C, then beads 
were washed with 800 µl NP-40 lysis buffer to collect all lysate. Lysate was incubated with 
rotation for 40 min at 4°C then centrifuged for 5 min at 500 x g to clear intact cells and nuclei. 3 
mg of supernatant protein was incubated with 4 µg relevant antiserum for 15 min then incubated 
with 80 µl protein A or G magnetic beads (NEB) for 2 h at 4°C. Beads were washed 3x with NP-
40 lysis buffer, and the bound fraction was eluted into SDS lysis buffer + 1x PI and 1x loading 
dye at 95°C for 5 min. 
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A.4 Figures 
FIGURE A.1 sum3 does not have a large effect on Sre1 cleavage. A, wild-type or the indicated 
mutant strains carrying empty vector or a plasmid expressing sre1N were grown on YES+CoCl2 
or selection medium + 5-FOA plates. B, western blots imaged by film probed with anti-Sre1 IgG 
of lysates from wild-type cells or the indicated mutant strains grown for 4 h in the presence or 
absence of oxygen. P and N denote precursor and cleaved N-terminal transcription factor forms, 
respectively.  
 
FIGURE A.2 ubx3 required for efficient Sre1 activation. A, wild-type or the indicated deletion 
strains carrying empty vector or a plasmid expressing sre1N were grown on YES or YES+CoCl2 
plates. B, western blots imaged by film probed with anti-Sre1 IgG of lysates from wild-type cells 
or the indicated mutant strains grown for 0 or 4 h in the absence of oxygen. P and N denote 
precursor and cleaved N-terminal transcription factor forms, respectively. C, western blot imaged 
by film probed with polyclonal anti-Dsc1 IgG of NP-40-solubilized membrane protein from WT, 
ubx3Δ, cdc48-8, or dsc2Δ cells grown in the presence of oxygen. M and I indicate mature and 
intermediate glycosylated forms, respectively. D, recombinant GST-HA-V5 control (GST), GST-
Dsc5 UBX (Dsc5323–425, UBX), and GST-Rbd2 C-terminus (Rbd2200–251, SHP) were bound to 
GST magnetic beads and incubated with S. pombe cytosol from ufd1-13xmyc or ubx3-13xmyc 
cells. Input, unbound, and 10-fold enriched bound fractions were probed with monoclonal anti-
Myc IgG, polyclonal anti-Cdc48 IgG, and monoclonal anti-GST IgG. E-F, WT, ufd1-13xmyc, or 
ubx3-13xmyc cells were grown in the presence of oxygen, and Cdc48 (E) or Myc (F) was 
immunoprecipitated from NP-40-solubilized cell lysate. Input, unbound, and 10-fold enriched 
bound fractions were analyzed by western blot and imaged by Li-Cor using polyclonal anti-
Cdc48 IgG and polyclonal anti-Myc IgG. 
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FIGURE A.3 What is Cdc48 doing at the Dsc E3 ligase? A, western blot imaged by Li-Cor 
probed with polyclonal anti-Sre1 IgG and monoclonal anti-actin (for loading) of lysates from WT, 
cdc48 mutant, or dsc2Δ cells treated with Brefeldin A (100 µg/mL, BFA) or EtOH vehicle for 2 h 
in the presence of oxygen. B-C, cdc48m ufd1-13xmyc (B), or ufd1m-13xmyc (C) cells were grown 
in the presence of oxygen, and Myc (B) or Cdc48 (C) was immunoprecipitated from NP-40-
solubilized cell lysate. Input, unbound, and 10-fold enriched bound fractions were analyzed by 
western blot and imaged by Li-Cor using polyclonal anti-Cdc48 IgG and polyclonal anti-Myc 
IgG. 
 
FIGURE A.4 Overexpression screen for genes repressing Sre1 activity – Sre1 cleavage 
effects. western blots imaged by Li-Cor probed with anti-Sre1 IgG of lysates from REBY206 
cells transformed with the indicated overexpression plasmids and grown for 4 h in YES in the 
presence or absence of oxygen. P and N denote precursor and cleaved N-terminal transcription 
factor forms, respectively. 
 
FIGURE A.5 Overexpression screen for genes repressing Sre1 activity – Dsc1 glycosylation 
effects. western blots imaged by Li-Cor probed with polyclonal anti-Dsc1 IgG of NP-40-
solubilized membrane protein from REBY206 cells transformed with the indicated 
overexpression plasmids and grown in the presence of oxygen. M and I indicate mature and 
intermediate glycosylated forms, respectively. 
 
FIGURE A.6 Overexpression screen for genes repressing Sre1 activity – preliminary 
conclusions. A-B, western blots imaged by Li-Cor probed with anti-Sre1 IgG of lysates from 
sre1Δ cells or REBY206 cells transformed with the indicated overexpression plasmids and grown 
for 0-2 h in YES in the absence of oxygen. P and N denote precursor and cleaved N-terminal 
transcription factor forms, respectively. C, western blots imaged by Li-Cor probed with the 
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indicated IgG of lysates from REBY206 cells transformed with vector or dsc5 overexpression 
plasmid. D, alignment against the Sre1 coding sequence (blue) of sre1 inserts isolated during the 
overexpression screen. Unfilled portion indicates non-homologous (vector) sequence, red 
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